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OBSERVATIONS ON SCARLET FEVER 
AND ITS SPECIFIC THERAPY. 
I. INTRODUCTORY. 
Few diseases, exhibiting themselves in 
their typical symptom -complexes are more readily 
diagnosed than is Scarlet Fever. No disease, occur- 
ring in mild or atypical forms, taxes the acumen of 
the clinician to a greater degree than does this 
particular pathological entity. The more intimate 
one's experience of Scarlatina, the more respect one 
has for its protean manifestations. 
In the past, the Specialist in Infectious Dis- 
eases has done much to lighten the onus of diagnosis 
for those whose duty it is to secure the best possible 
treatment of illness, but, until comparatively recently, 
it was impossible to combine laboratory and clinical 
methods in an attempt to elucidate the cause of a 
departure from the normal, when suspicion pointed to 
the possibility of Scarlet Fever. 
With the exception of the last few years, the 
treatment of Scarlatina has been empirical and symptom- 
atic. Hospitalisation has made expert nursing avail- 
able for cases of the disease and at the same time 
has tended to reduce the spread of infection. The 
specialised/ 
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specialised knowledge of those entrusted with the care 
of sufferers has helped to minimise the likelihood of 
permanent ill-health or physical crippling which may 
result. But there has been no specific treatment, 
which, because it is directed against the cause of the 
illness, is bound to have an influence for good, even 
if incomplete knowledge concerning it and its rational 
application may be responsible for results far from 
ideal. 
Because of the co_operation between the clinician 
and the laboratory worker, it is now possible to pre- 
dict with accuracy certain things when dealing with 
Scarlet Fever in a given community. For example, 
susceptibles may be separated from insusceptibles by 
a simple intra_cutaneous test. Or, again, previous 
knowledge that a person was not immune to Scarlet 
Hover at the beginning of an indefinite illness may 
be the very detail required to establish a diagnosis 
of Scarlet Fever, 
The laboratory has come to the aid of the clin_ 
ician, too, in the supervision of contacts of Scarla- 
tina and the possibility of producing a definite, if 
transitory, passive immunity to the disease in those 
persons exposed to it and not immune, is a powerful 
weapon in dealing with hospital communities, when 
accidental mixed infection has been introduced, 
New/ 
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New diagnostic methods and therapies call forth 
both protagonists and antagonists. Some workers are 
willing to give unqualified praise, while others are 
critical, but, with the criticism of a mind already 
biassed against the innovations. As in other realms, 
so in Medicine the middle path is not uncommonly found 
to be the one trodden by those observers most capable 
of rational deduction. Whatever may be the merits or 
demerits of the comparatively new diagnostic and 
therapeutic agents in Scarlet Fever, one thing is 
certain and that is, that only prolonged tests and 
their common-sense interpretation can decide whether 
the new regime is a definite advance on the old, or 
whether the laboratory is so far impotent to lend 
material aid in combating a disease which is still 
far too common. 
The causative organism of Scarlet Fever has been 
debated for many years, even though it has been known 
since l88 that haemolytic streptococci could be 
i recovered from the throats of scarlatina,l patients. 
It was not until 1923 that a very definite fillip was 
given to the laboratory investigation of the disease. 
In that year, the classical experimental work of 
Drs George and Gladys Dick was carried out, establish- 
ing almost at once and practically beyond reasonable 
doubt the specific relationship between a haemolytic 
streptococcus/ 
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streptococcus and Scarlet Fever. Pursuing their 
scientific work, the same observers experimented with 
the toxin found in the filtrate from cultures of the 
already isolated organism and they elaborated the 
technique of the intradermal test now bearing their 
name. 
Some seven years before the Dicks produced experi- 
mental Scarlet Fever in volunteers, very important and 
now universally recognised observations had been made 
by Schultz and Charlton, Interest in these researches 
was now revived and the two sets of experiments were 
correlated. Several points are noteworthy, as for 
example, the that the of 
persons giving a positive Dick Reaction does not have 
the quality of causing blanching of a scarlatinal rash. 
On the other hand, persons who do not react to the 
Dick Test are possessed of blood_serum which will give 
a positive Schultz_Charlton Reaction, It is also 
true that blood serum with the property of blanching 
the scarlatinal eruption need not necessarily be 
obtained from persons convalescent from Scarlet Fever, 
the phenomenon being observed sometimes when the 
reagent is obtained from ordinary healthy individuals 
with no history of an attack of Scarlet Fever. 
The very interesting observation that the disappearance 
of the rash at the site of injection does not occur 
when/ 
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when the serum of patients in the early stages of 
Scarlet Fever is used, shows clearly that the reaction 
is due to the development of a special quality, as a 
result of having overcome an attack of Scarlet Fever 
or of having otherwise acquired an immunity to it. 
Since the time of the experiments of Schultz and 
Charlton and the Dicks, a tremendous amount of research 
work has been done on the relation of streptococci to 
Scarlet Fever, The problem is not entirely, nor even 
principally, an academic one, for the clinical aim of 
the work is twofold, namely, to enhance the treatment 
of patients suffering from Scarlatina and to protect 
susceptible persons against an attack of the disease, 
either by the production of an active immunity or, 
in emergencies, by bestowing a temporary passive 
immunity. 
Unfortunately, the scientific exactness of the 
laboratory cannot always be observed in the clinical 
application of bacteriological and serological methods. 
Tests which are constant in vitro, may be very dif_ 
ficuit to interpret or may even be quite useless on 
occasion in the hospital ward. For instance, one 
sees cases of Scarlet Fever, where the course of the 
disease ultimately establishes the diagnosis, but in 
which the Dick Test is already negative on admission 
and in which the rash is so faded and characterless 
that 
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that the Schultz Chariton reaction is very unsatis- 
factory. When one remembers, too, that in adults 
particularly, the appearance of the tongue and throat 
may be much modified in comparatively mild forms of 
the disease, it is easy to understand that in certain 
cases, usually, the very ones where definite tests 
would be of paramount value, laboratory methods may 
fall short of the ideal. Sometimes, in cases which 
are clinically Scarlet Fever on admission, a perfectly 
good rash is not blanched by the Schultz Chariton test. 
But it must be admitted that one seldom sees instances 
in which a diagnosis of Scarlet Fever is later con_ 
firmed by the clinical course, where all the laboratory 
tests are negative. Perhaps the most useful test is 
the Repeated Dick Test, the changing from a positive, 
in the early stages, to a negative reaction later being 
absolutely diagnostic of Scarlet Fever. Such repeated 
tests presume, of course, that in the meantime, the 
patient has not been treated by the injection of 
Specific Anti_Serum, 
The control of diagnostic tests is admirable, 
teat and control being carried out on the same person, 
but the same cannot be said for the therapeutic aspect 
of the question. All scientific tests must necessarily 
be controlled, but the real point at issue seems to 
be :_ Is the clinical application of a laboratory 
recommendation/ 
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recommendation strictly a scientific test? In the 
series of cases included in this thesis, the earlier 
work of collection included "controls ", which I dis_ 
carded later for reasons noted below. 
It is pre -eminently in the realms of Tuberculosis 
that we consider the "soil" as fully as the "seed ", 
but in all diseases the invader is only one element 
in the combination which allows of varying clinical 
manifestations in the same disease. If the type of 
disease_producing organism is a constant, as it most 
probably is in Scarlet Fever, then the only justifiable 
means of interpreting the value of any agent specific- 
ally modifying the action of that constant, is by 
comparing the clinical course of the disease in a 
"natural" subject with the clinical course in a 
specifically modified, but otherwise identical, subject. 
For example, it seems useless to say that the admin_ 
istration of Scarlet Fever Anti_Serum showed that cases 
so treated had only one_third of the number of compli_ 
cations found in untreated cases, unless it is known 
that before the attack of Scarlet Fever, both treated 
and untreated groups were physiologically and patho- 
logically identical, One finds in actual practice 
that patients who, before admission, suffered from 
enlarged tonsils and adenoids are more likely to 
develop such complications as Rhinitis and Otitis 
than/ 
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than patients whose throats were hitherto apparently 
normal, Similarly, it seems unfair to compare, either 
as a serum_treated case or as a control, the course of 
the disease in a child with obvious Congenital Syphilis 
with that in an apparently normal child. Again, chil- 
dren with Tuberculous Adenitis show, in one's experi- 
ence, a greater tendency to suppurative conditions of 
the glands of the neck during the course of Scarlet 
Fever, than do ordinary, apparently healthy, children. 
One could multiply instances of the incongruity 
of many reputed clinical "controls ", but perhaps the 
following three cases may bear witness at least to 
the cogency of the arguments given above, 
(1) A boy of 8 years was admitted to one of the 
Diphtheria Wards from a General Hospital, At this 
time, the particular ward of that General Hospital was 
infected with Scarlet Fever, Measles and Diphtheria 
and the Fever Hospital for the City had to accommodate 
the cases. Incidentally, it was not known at this 
time that there was mixed infection in the General 
Hospital Ward. It was believed that the cases were 
from quite separate wards, The boy had Diphtheria 
quite definitely, but was not a serious case, Two 
days after his admission, a diphtheria patient lying 
next to him and from the same General Hospital Ward 
developed Scarlet Fever and was of course appropriately 
dealt 
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dealt with at once. The Medical Officer of the ward 
did not passively immunise those susceptible. Four 
days later, our patient developed Scarlet Fever, the 
case being, to all appearances, the mildest possible. 
During the course of the disease, there were Otitis, 
followed by Mastoiditis requiring surgical interference, 
Bmpyema, also requiring operation, and cardiac failure 
of a degree causing great anxiety. The case had been 
treated at once by specific therapy, but no doubt the 
second infectious disease being consequent on Diphtheria 
had much lass than the usual resistance offered by 
the tissues which were already crippled by the diph- 
theritic toxins. But such an experience is no argu- 
ment against the efficacy of Scarlet Fever Anti_Serum, 
although admittedly, it would compare badly with other 
mild cases receiving no specific therapy and yet 
presenting no complications. 
(2) The second case was one of well_marked Con- 
genital Syphilis admitted with typical, but not severe, 
Scarlet Fever. The child was given Anti_Serum and did 
quite well until Rhinitis made its appearance. This 
child was over five months in hospital, all kinds of 
treatment, including removal of tonsils, being tried 
to clear up the condition. Like the first case, this 
one affords no evidence at all against the usefulness 
of specific therapy. 
The 
lo. 
(3) The third case was one in which there were 
quite definite Tuberculous Glands in the neck, but 
without the slightest sign of breaking down when the 
patient was admitted with Scarlet Fever. Serum therapy 
was not used at all in this Hospital and the patient 
developed suppurative adenitis which necessitated a 
stay of over 4 months in hospital. 
It may be said that since patients in whom pre- 
vious pathological conditions existed are found both 
among serum_treated cases and "controls ", there is no 
need to take special notice of them at all; the one 
will balance the other and the percentage results will 
remain unaltered. But even if they do, the whole 
comparison is a very unscientific one and the "control" 
loses its significance in dealing with comparatively 
small numbers. 
It is not necessary, however, to cite cases of 
Scarlet Fever in which the physical condition of the 
patient prior to the attack played a part in modifying 
the course of the disease, in order to realise the 
impossibility to ensuring real control cases in the 
average Fever Hospital. Probably in very large 
Fever Hospitals such as those under the London County 
Council, it is possible during one epidemic to have 
such a wealth of cases that they can be paired off, 
one for specific therapy and one for "control ", each 
pair/ 
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pair comprising clinically identical cases. But even 
this is doubtful, when one remembers the abandon with 
which Scarlet Fever pursues its clinical course. 
All who have had a fairly wide experience in Fever 
Hospital Practice can call to mind numerous cases 
which defied anything resembling a definite prognosis. 
Sometimes the apparently mildest case possible, ex- 
hibits more than one troublesome and even dangerous 
complication; sometimes patients who, on admission, 
are extraordinarily ill, make an absolutely uncom- 
plicated recovery. If there is one disease, other 
than Pulmonary Tuberculosis, in which, having made a 
definite diagnosis, it is unwise to venture a prognosis, 
it is Scarlet Fever, 
Another factor which renders "controls" almost 
useless is relative overcrowding of Fever Hospitals 
during epidemics. By the term "overcrowding" no 
implication of failing to observe the Ministry of 
Health's Regulations as to cubic space per patient 
is intended; it merely signifies that a ward is 
fuller than usual. At such times it is not uncommon 
to get "Ward Epidemics" of Rhinitis or Otorrhoea or 
Cervical Adenitis. In my experience, such "epidemics" 
flourish particularly among cases which have not been 
treated by specific serum, but that does not invalidate 
the argument that it was principally the comparative 
congestion/ 
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congestion of the wards and not Scarlet Fever to blame 
for the per centage of complications occurring. 
It has long been known that the chief complication of 
measles, namely Broncho_Pneumonia, is most evident in 
"overcrowded" wards, but it is probable that this 
particular observation has been stressed because its 
dramatic significance sharpens our powers of deductive 
reasoning; whereas a few extra cases of Otitis or 
Adenitis cause little commotion in hospital routine 
and may fail to excite our curiosity. 
If, then, controls are to merit the real meaning 
of the word, what conditions are necessary for select_ 
ing them? The following, at least, require considera_ 
tion, First of all, the previous physical condition 
of the patient should be known. In this respect, I 
believe the School Medical Service could be of infinite 
value in the scientific investigation of clinical 
therapeutics, Every school child's medical record is 
carefully kept and the results of physical examinations 
are accurately recorded. Cooperation between School 
Medical Departments and Infectious Diseases Hospitals 
would do much to raise the standard of clinical 
"controls" 
Secondly, only very large Fever Hospitals, where 
one epidemic will give several hundreds at least of 
"treated" cases and "controls ", can hope to be able 
to/ 
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to make selections of cases in pairs which can be said 
to be reasonably free from gross error. 
Thirdly, hospital wards which are being used for 
experimental therapy should never be allowed to be 
filled to capacity, for if they are, the difficulties 
arising from "Ward Epidemics" of complications will 
upset the accuracy of results. 
But surely the work in smaller Fever Hospitals 
has some value, even if a control system is, in the 
writer's opinion, unscientific. I think there is no 
doubt of that, but one must look elsewhere for a means 
of comparison between the results of "treated" and 
"untreated" cases. If Scarlet Fever Anti_Serum is 
specific, and apparently it has fulfilled all the 
conditions for such a description, cases treated with 
it should compare favourably with the text_book 
picture of the disease and its clinical course. 
After all, statistics which have been collected for 
years and whose averages are based on hundreds of 
thousands of observations must have a very small 
margin of error. There will be included, cases whose 
previous histories were definite liabilities as well 
as others whose physiological conditions prior to the 
attack were definite assets. There will be among the 
number, numerous instances of the apparently initially 
mild but eventually seriously complicated disease as 
well 
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well as of cases which at first looked unusually severe 
but made straight for restored health without a single 
untoward incident. Good environment and bad environ- 
ment previous to attack will be represented. Indeed, 
all manner of combinations of factors and fates will 
have subscribed their quota to the tabulated records. 
Granting that the text_book error of averages is 
very small and assuming that Scarlet Fever Anti_Serum 
is specific and that only clinically or serologically 
definite cases of Scarlet Fever have been included 
in the experimental therapy, one should find that the 
clinical course of "treated" cases compares very 
favourably with the traditional records. If, in the 
discussion which follows, it cannot be shown that the 
administration of Scarlet Fever Anti_Serum increases 
the usefulness of the ordinary comparatively small 
Fever Hospital by reducing the Length of Stay in 
Hospital per average case as well as by minimising 
the incidence of complications both as regards number 
and severity, then it would seem that the therapy falls 
far short of the ideal. 
It must be remembered, that the real value _ if 
any exists _ of specific treatment in Scarlet Fever 
can only be assessed with the passage of years. 
Two points are particularly important in this con- 
nection:_ (1) Will the temporary passive immunity 
conferred/ 
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conferred by the serum prevent the development of an 
active immunity to the disease, thereby rendering 
future attacks more likely in the same persons? 
Some authorities assert that the passive immunity 
obtained from Anti_Diphtheria Serum hinders the pro_ 
duction of an active immunity as can be demonstrated 
by the number of antitoxin_treated patients who are 
subsequently Schick_positive, (2) Will the type 
of the disease change, as the result of the much 
modified environment to which the causal organisms 
are suddenly subjected with the institution of specific 
therapy? It must be admitted that this is more likely 
in connection with Active Immunisation, but the con- 
stant subjection of invading organisms to an induced 
specifically antagonistic environment appears to 
justify the hypothesis that alteration in virulence 
in one direction or the other may occur. And such 
change may not necessarily imply a parallel mutation 
in infectivity, so that epidemiological complications, 
at present entirely unforeseen, may arise. 
But for the present thesis, only the immediate 
effects of treating definite cases of Scarlet Fever 
with a definite serum are being dealt with. A com_ 
paratively novel treatment, especially one which is 
strengthened by advocacy from the laboratory, at once 
calls forth criticisms, some well-informed and some 
worthless/ 
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worthless. The layman deprecates "new fashioned" 
ideas and strongly objects to his children being the 
victims of experiment, It is of little use pointing 
out to him that what is experiment to_day may be 
routine to_morrow. Statistics are so confusing that 
even educated citizens are doubtful whether an advance 
has really been made. 
On the other hand, the medical profession and 
Hospital Authorities are disappointed that Scarlet 
Fever is still a prevalent disease, in spite of the 
notification and isolation of cases and in spite of 
all the precautions consequent on these. Scarlet Fever 
is not a serious disease in the sense of being respons_ 
ible for a large proportion of the death_rate, but 
failure to diminish its incidence appreciably and 
consciousness of the expense incurred in its treatment 
have made it expedient that new methods of attack on 
the disease should be made. 
The best treatment for any disease is prevention, 
but apart from the avoidance of infection, it is 
difficult to sway the public mind in this direction. 
The "Dick Test ", followed where necessary by Active 
Immunisation is the ideal method of attacking Scarlet 
Fever, but until the time comes when specific prophy_ 
taxis against Scarlet Fever becomes part of the 
routine existence of a child, there will be many cases 
of/ 
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of Scarlet Fever requiring treatment and better treat_ 
ment than has been possible hitherto. 
This prompts the question of how infection occurs. 
One cannot always associate present cases of Scarlet 
Fever with a definite source of infection. Certainly 
nothing resembling actual contact is necessary. No 
doubt fomites play a not unimportant part; but chain 
infection by a system of carriers may be much more 
important than is sometimes thought. About 4% of 
discharged Scarlet Fever Patients, free from all com- 
plications, still retain virulent streptococci in the 
naso_pharynx. Their temporary or permanent immunity 
to these germs makes such persons a real source of 
danger to others. I believe this percentage to be a 
very conservative estimate, for it is quite astonishing, 
when one has ample opportunity of following up dis_ 
charged cases, as those medical officers combining 
public Health and School Medical Work have, to note, 
especially in winter, the number of cases of rhinor_ 
rhoea apparently dating from about a week or so after 
discharge from hospital. 
Missed cases may also be more commonly associated 
with the spread of infection than is commonly allowed. 
During the past three years, at Routine Medical School 
Inspections, I have seen quite a number of children 
with definitely desquamating palms and soles. On careful 
enquiry/ 
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enquiry., a history which was strongly suggestive of 
recent Scarlet Fever could be obtained in nearly every 
instance. 
Another, and I think quite considerable cause of 
the spread of infection, is the person who has gained 
an active immunity from sub_infective doses of the 
causal organism. The large percentage of "Dick - 
Negative" reactions obtained in testing adults who 
have no history of an attack of Scarlet Fever strength_ 
(3) 
ens such an argument. Pilot and Davis found haemo- 
lytic streptococci in over 9010 of a large number of 
persons in the bacteriological examination of normal 
throats. Cases of Scarlet Fever occur, too, where 
one is almost forced to the conclusion of auto_ 
infection, namely a few days after the removal of 
adenoids and diseased tonsils. Patients who have 
been thus operated on appear to have harboured virulent 
haemolytic streptococci without developing an immunity 
to them or at least having only developed a very low 
degree of immunity which counted for very little when 
massive infection occurred through the fresh throat 
wound. The same relationship of enlarged infected 
tonsils to Scarlet Fever seems to be inferred by 
(27) 
Hamer, when he says that the removal of enlarged 
tonsils and adenoids in children who have not had 
Scarlet Fever is a measure which affords a considerable 
degree 
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degree of protection. 
Direct evidence of the infectivity of desquamated 
scales is lacking. Moore of Huddersfield, along 
with 
many others, holds that the presence of desquamation 
may be disregarded as evidence of infectivity in 
persons otherwise clinically convalescent from Scarlet 
Fever. He places groat emphasis of the persistence 
of the infective agent in the nose and accessory 
sinuses. There seems to be little doubt that desquama- 
tion is simply the end result of a pathological pro_ 
liferation of the skin layers in response to the 
dilatation of the peripheral bloodvessels; the latter 
is occasioned by the toxins of the disease. In favour 
of the infectivity of desquemated scales it is some 
times argued that the most evident desquamation occurs 
in parts where the rash has not been seen _ namely 
the palms and soles. Such is simply due to the skin 
in those regions being so dense as to make changes 
in the underlying capillaries and skin papillae 
imperceptible and does not mean that identical changes 
do not occur. As a result of failure to demonstrate 
the infectivity of desquamated skin, most Hospitals 
now discharge patients who are otherwise apparently 
normal on the 28th day and several, since the institu- 
tion of specific therapy consider 21 days a sufficient 
period of isolation for the uncomplicated case. 
In/ 
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in order to show that a "return" case had been infected 
by the scales of a patient discharged while still 
desquamating, it would be necessary to demonstrate 
that the discharged patient gave negative bacterio- 
logical results from swabs of the naso_pharyngeal 
region, 
The streptococcus of Scarlet Fever clings heroic- 
ally to life, thus rendering necessary the utmost care 
in dealing with utensils, garments and bedding in 
Scarlet never Wards, Unless nurses are particularly 
careful, they may be unwilling carriers of the disease 
(27) 
to persons outside the Hospital, for Ruth Tunicliff 
states that she has found the streptococcus on the 
masks worn by nurses, In this connection, all nurses 
do not wear masks and therefore it is likely that 
their nasal, buccal and pharyngeal secretions retain 
the organism for some time after contact with cases, 
Milk has several times been closely associated 
with an outbreak of Scarlet Fever, and local epidemics 
where no other evident source of infection is found, 
should occasion suspicion of the milk supply, 
But it must be admitted with regard to the spread 
of infection that practically in no instance is it 
possible to exclude chain infection _ either direct 
or indirect - or at least to show that there has not 
been close association between the case and some person 
harbouring/ 
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harbouring virulent haemolytic straptococci capable 
of causing Scarlet Fever, as a result of having had 
the disease, or of having been in close contact with 
some person who has recently "recovered" from the 
disease, or of being an immune chronic carrier. 
Reverting for a moment to the question of auto_ 
infection, one reads in all the text_books of the 
association of Scarlet Fever with Burns and I have 
been interested in quite a few definite cases during 
the past few years. I have never seen the disease 
follow minor burns and in this connection I think that 
in extensive burning it is not necessary to postulate 
the wounds themselves as the site of entry into the 
deeper tissues of streptococci already present in the 
skin, for I have convinced myself that there is a wide_ 
spread inflammation of the mucosae and secretory 
tissues of the body _ whether sympathetic or as the 
result of the general toxaemia or both, I am not 
prepared to argue - and keeping in mind the very high 
proportion of healthy throats harbouring haemolytic 
streptococci, it is not unreasonable to presume an 
enhancing of virulence and a resulting attack of 
Scarlet Fever. 
Confronted as we are with innumerable difficulties 
in relation to Scarlet Fever; the expensiveness of 
its treatment, the inability to prognose with any 
degree/ 
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degree of certainty, the reluctance on the part of the 
public to submit their children to Active Immunisation, 
we should welcome a new era in the treatment of the 
disease. Now that the specificity of the causal 
organism is beyond all reasonable doubt, as was, for 
all practical purposes, conclusively demonstrated by 
the Dicks in 1923, we look to Anti_Serum Treatment to 
revolutionise our statistics on Scarlet Fever, pending 
the time when public opinion will accumulate sufficient 
enthusiasm to take the final step in the complete 
ousting of a cause of much suffering and in some cases, 
considerable consequent physical disability; that step 
is Universal Active Immunisation, 
It is therefore proposed to discuss in this 
Thesis;_ 
The effect of the Specific Therapy of Scarlet Fever on ;_ 
(a) Initial Toxaemia, 
(b) Incidence of Complications. 
(c) Length of Stay in Hospital. 
(d) Per centage of Return Cases. 
(e) Contacts (as a prophylactic). 
23. 
OBSERVATIONS ON SCARLET FEVER 
AND ITS SPECIFIC THERAPY. 
II. HISTORICAL:- PART I, 
Sydenham first described Scarlet Fever in 
1675, differentiating it as a clinical entity distinct 
from Measles. Nothing of its bacteriology was known 
until 1885, when Haemolytic Streptococci were discovered 
in the throats of Scarlet Fever patients. Apparently, 
little interest was created in any possible specific 
relationship between this organism and the disease 
with which it had been found in association, for ten 
(66) 
years elapsed before Marmorek prepared an "antitoxic" 
serum by actively immunising a horse against the 
Haemolytic Streptococcus recovered from Scarlet Fever. 
There are no exact details of the potency of this 
serum as compared with that of present day preparations, 
but probably its antitoxic value was relatively low, 
for we are told that the results of treatment were 
very indefinite. 
Other workers copied the example set by Marmorek 
and notable among these was Moser, who, in 1902, made 
a similar preparation and gave a favourable report of 
its usefulness in cases of Scarlet Fever, His findings 
were not upheld by other observers. 
It is interesting to note that almost the first 
contact/ 
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contact with the bacteriology and immunology of Scarlet 
Fever opened a controversy over the causative agent 
and arguments for and against a specific relationship 
with one of the Haemolytic Streptococci continue right 
up to the present, 
(86) 
Jockmann reviewed the work done in those early 
years and in 1905 he published a critical survey, 
expressing the opinion that the haemolytic strepto_ 
coccus was not the cause of Scarlet Fever, but was a 
secondary invader, This work must have been con- 
sidered of some merit, for the bacteriology of the 
disease was not further investigated by anyone of 
repute until nine years had elapsed, 
(47) 
In 1914, Mallory described certain bodies to 
which he gave the name C yclasterion scarlatinale, 
They were polymorphic in form and occurred inside the 
epidermal cells of the Scarlet Fever patient as well 
as in the lymph spaces and lymph vessels of the skin 
proper, No confirmation was forthcoming that those 
bodies were in any way the specific cause of Scarlet 
Fever, Mallory later reported the finding of a small 
bacillus which he considered had some claim to being 
the causative organism, 
An important advance was made in 1917, when 
Schultz and Charlton experimented on the rash of 
Scarlet Fever, using serum from convalescent patients, 
They/ 
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They found that the intradermal injection of such a 
serum in acute cases of the disease, caused the dis_ 
appearance of the rash at the site of the injection. 
Incidentally, a point which is often insufficiently 
stressed is that the rash does not appear again in 
the slightest degree in the tested area. Schultz and 
Chariton further found that the blood serum from a 
considerable per centage of ordinary individuals who 
had never, to their knowledge, suffered from Scarlet 
Fever, gave the same blanching phenomenon, but in no 
case could a positive reaction (blanching) be observed 
if the serum from early cases of the disease was used. 
At the time of discovery, comparatively little interest 
was taken in those clinical serological experiments, 
though now the Schultz Charlton Reaction is known to 
every student of Medicine. Two things at least were 
very clearly demonstrated by the two observers 
mentioned :_ (1) That the blood of patients convales_ 
cent from Scarlet Fever contained an antitoxin which 
counteracted in a clinically specific manner the local 
toxic effects of Scarlet Fever on the skin. 
(2) That this clinically specific antitoxic property 
was developed in the blood_serum of many persons who, 
apparently, had never suffered from Scarlet Fever. 
In this connection, it was mentioned in the 
introductory chapter that the part played by immune 
chronic/ 
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chronic carriers in the dissemination of the disease 
should not be underestimated. Here is evidence, 
sufficiently accurate to be clinically valuable at 
least, that a considerable percentage of healthy 
individuals have developed such a degree of immunity 
to the disease that they can, without detriment to 
themselves, carry virulent Strept. scarlatinae and 
thus be a real danger to others. 
(18) 
Two years later, in 1919, Dochez, along with 
Avery and Lancefield divided the haemolytic strepto_ 
cocci into groups by the direct agglutination method. 
They worked on cultures of haemolytic streptococci 
prepared after swabbing the throat and naso_pharynx 
of soldiers in camp and they decided that six distinct 
groups could be made out. All six were toxigenic 
entities and antitoxins for each group were specific. 
During the next year, Gordon experimented with haemo_ 
lytic streptococci recovered from cases of Scarlatina 
and he reported that 80% of these showed identical 
(61) 
agglutination characteristics. But Park and Williams 
found, on experimenting with haemolytic streptococci 
isolated from 60 early cases of Scarlet Fever, that 
only 28% of the strains fell into one serological 
group, as tested by complete cross absorption. They 
also found that 15% of strains of non..scarlet fever 
cases fell into the same group as the above. 
Drs/ 
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Drs George and Gladys Dick carried out most 
valuable experimental work on the relation of Haemo- 
lytic Streptococci to Scarlet Fever in 1923. The 
throats of nine volunteers were swabbed with a pure 
culture of haemolytic streptococci isolated from 
the 
pus of a sore on the finger of a nurse, who developed 
Scarlet Fever. Two of the nine developed the typical 
disease, None of the subjects used for experiment had 
previously had Scarlet Fever, but it has to be re- 
membered here, that the Dick Test was not yet dis- 
covered and there is therefore no proof that all or 
any of the seven, who did not develop symptoms, were 
in fact susceptible to Scarlatina, 
(46) 
Mair was at this time experimenting with the 
Schultz Charlton phenomenon and read a'paper on the 
subject before the Ulster Medical Society on Dec, 3, 
(46) 
1925. He records in the Lancet that serum obtained 
for the test from a convalescent diphtheria patient 
gave a negative reaction in the blanching phenomenon, 
Thirty_eight days later, serum from the same patient, 
who had contracted Scarlet Fever four days after the 
initial test, gave a positive Schultz Charlton Reaction 
when injected intradermally in cases of Scarlet Fever. 
Mair suggested that the blanching is a toxin_antitoxin 
reaction and that the rash disappears because of the 
neutralisation of the local toxin which has been 
responsible/ 
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responsible for the abnormal dilatation of the peri- 
pheral capillaries. He further states that no such 
blanching quality is found in the serum of infants 
unless it has been present in the mother's blood when 
the child was born, and that this specific quality is 
acquired as the result of an attack of Scarlet Fever. 
He notes, however, that at the time, the case may not 
have been diagnosed as Scarlatina. 
(46) 
In his 1925 paper quoted above, Mair states that 
"The negative reaction (Schultz Charlton) of the sera 
of acute cases of scarlet fever is simply due to the 
fact that antitoxin has not yet developed ". 
Drs George and Gladys Dick, still pursuing their 
work on the strain of streptococcus isolated by them 
and which they considered had a specific relationship 
to Scarlet Fever, published in the Journal of the 
American Medical Association in 1924, the identifica- 
tion of a toxin, which gave a positive skin reaction, 
akin to the Schick Test in Diphtheria, in early cases 
of scarlet Fever, Such a reaction was absent in 
convalescent Scarlet Fever patients and could be 
prevented in early cases of the disease by the previous 
intradermal injection of convalescent serum at the 
(51) 
site of experiment. Park and Williams corroborated 
their findings. 
So far, then, experimental evidence had given 
some/ 
29. 
some very suggestive results, making it highly pro_ 
bable that a haemolytic streptococcus had a very 
definite relationship to Scarlet Fever; that it pro_ 
duced an exotoxin capable of antitoxic neutralisation 
by means of a specially prepared antiserum. The 
practical therapeutic value of a possible specific 
anti_serum suggested itself at once. Already the 
serum or whole blood from convalescent patients had 
been used in various parts of the world in the treat- 
ment of early toxic cases of the disease. Experience 
had so far been rather limited, but results suggesting 
a wider clinical application had been obtained. 
Reiss and Jungman suggested that convalescent serum, 
after being carefully tested to exclude Syphilis,and 
the donors minutely examined to obviate the posai_ 
bility of their being tuberculous, should be pooled 
and that 50 cc, to 100 cc, should be given intra- 
venously in the treatment of severe cases of Scarlet 
Fever. Zingher used whole convalescent blood and 
advocated intramuscular administration, which has 
obvious advantages and apparently causes little local 
disturbance. He reported the effect of his therapy 
in 15 very toxic cases treated at the Willard Parker 
Hospital; 5 cases were strikingly improved, g others 




Soon after describing their experiments with a 
toxin produced from the Berkefeld filtrate of media 
in which a certain haemolytic streptococcus isolated 
from a case of Scarlet fever had been grown, the 
Dicks published a report on the production of an anti_ 
toxin, prepared by the active immunisation of the 
horse with increasing doses of media filtrate, 
Apparently, the therapeutic results of its use were 
very satisfactory, 
In the same year (1924) Dr Dochez of New York 
contrived, by a most ingenious method, to produce an 
antitoxic serum against the Streptococcus scarlatinae, 
He succeeded in introducing an agar culture medium 
into the cellular tissues of a horse's neck and after 
allowing solidification to occur, this was inoculated 
with Streptococcus scarlatinae, The bacteria produced 
a toxin which, on reaching the circulation of the 
horse, excited the formation of an antitoxin, After 
allowing the antitoxin - forming process to continue 
for six months, the horse was bled and clinical teats 
of the potency of the serum made, 
(86) 
Blake, Trask and Lynch reported very good results 
from Dochez Serum, a single intramuscular injection 
in early cases being followed by a rapid convalescence 
without complications, They also noted that the intra_ 
dermal 
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intradermal injection of the serum in cases with 
early 
Scarlatina.l rash, gave the Schultz Chariton phenomenon. 
The rapidity with which the toxins of early scarlet 
fever blood serum were neutralised was also demons_ 
trated by periodically bleeding the patient before 
treatment with the antitoxic serum and at short inter- 
vals afterwards. Negative Dick tests with the serum 
of treated cases were obtained as early as four hours 
(3F) 
after the administration of the serum. Robb, of 
Belfast, gives some interesting details of the applica_ 
tion of Dochez's original antiserum in cases of Scarlet 
Fever; they will be discussed in the appropriate place. 
In 1925, Messrs Parke, Davis & Co, claimed to 
have produced an anti -serum which was antibacterial 
as well as antitoxic, by immunising horses with in- 
jections of both toxin and of the living organisms. 
Reports of treating some thirty cases of Scarlet Fever 
with such a serum in Detroit have been published but 
the day of disease on which the serum was administered 
in each case is not stated, thus detracting from the 
clinical value of the work, 
The experimental work of inducing an attack of 
Scarlet Fever in a manner identical to that employed 
by the Dicks in 1923 was repeated by various workers 
and results confirmatory of the original experiment 
were announced from Russia ing 1925, Park also records 
an/ 
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an accidental infection in one of his laboratory 
workers, who developed the typical disease, 
The bacteriology of the complications of Scarlet 
(57) 
never has not escaped notice, O'Brien, after a con- 
vincing argument in favour of the existence of a 
Streptococcus scarlatinae, goes on to say that Steven 
and Dochez and other workers obtained Haemolytic 
Streptococci, identical with those found in Scarlet 
Fever, in such septic complications of the disease as 
(58) 
Otitis and Septic Adenitis, Okell takes the view that 
the role of the Streptococcus in Scarlet Fever is a 
dual one; it is toxic and pyogenic, The toxic effects 
are the result of the local infection, whereas the 
pyogenic results occur when the organism has reached 
(58) 
the general circulation, Okell states that anti_serum 
therapy has no effect once septic complications have 
been established, but that it appears to be valuable 
in the toxic phase of the disease, 
From the foregoing summary of the historical 
investigation of the cause of Scarlet Fever, combining 
with that study the experiments to try and discover 
an anti_serum which will have a definite clinical 
value, the consensus of opinion seems to be in favour 
of a specific haemolytic streptococcus (or toxi_ 
genically identical group of haemolytic streptococci) 
as the cause of the disease and that antitoxic serum 
prepared/ 
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prepared by special means therefrom is an important 
therapeutic agent in the treatment of Scarlet Fever, 
(8) 
girkhaug gives vary strong evidence in favour of this 
specific relationship when he records that he isolated 
Streptococcus scarlatinae from 97% of the throats 
of 500 cases of Scarlet Fever and he says, "The signif_ 
¡canoe of Streptococcus scarlatinae in its relation 
to Scarlet Fever is an established fact ". He also 
believes that in scarlatinal antitoxic therapy we have 
a highly curative method of treatment. His early 
observations with Dochez's serum brought him to the 
conclusion that, given early in the disease, it 
hastened recovery and cases were uncomplicated. 
(el) 
Park and Williams, reviewing the history of the 
bacteriological and serological investigations of the 
causative organism of Scarlet Fever and problems 
resulting therefrom, have made the following deductions, 
which appear to provide an apt ending to this portion 
of the historical survey. 
" 1. They (Haemolytic Streptococci) are found more 
" frequently and in larger numbers early in scarlet 
"fever throats than early in other diseased throats," 
"2. They subside with the disease, but more sequelae 
"produced by streptococcus occur after scarlet than 
"after other diseases." 
"3 
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"3, Serum from scarlet fever convalescents agglutinates 
" streptococci from Scarlet fever throats ", 
"4, Serum from animals after multiple inoculations with 
" haemolytic streptococci from scarlet throats agglut- 
" inates the majority of strains from other scarlet 
" throats, and not strains from other diseases," 
"5, The serum from a horse inoculated in a special way 
" by a haemolytic streptococcus from scarlet fever, 
" produces blanching in scarlet fever rashes on intra_ 
" cutaneous inoculations just as does human convalescent 
" serum (Schultz_Charlton reaction), Some normal 
" serums blanche scarlet rashes but only from those 
" who have had scarlet fever, or who give a negative 
" Dick test," 
"6, A toxic filtrate from cultures of haemolytic 
" streptococci from scarlet fever gives a positive 
" intracutaneous reaction in beginning scarlet fever 
t, cases and a negative one in convalescents from 
" scarlet fever, It is neutralised by convalescent 
u scarlet fever serum and by serum from horses 
u inoculated with the toxic filtrate, Many more 
u investigations must be made before we can consider 
the relationship of haemolytic streptococci to 
" scarlet as proved, We have already corroborated 
" the Dicks' observations" 
35. 
HISTORICAL:- PART II. 
The very exact methods of the laboratory are 
apt to detract from the gradual unfolding of such 
clinical skill as is evidenced by reference to the 
general records of the disease. As was pointed out 
at the beginning of the introductory chapter, there 
is probably no disease which tries harder, and un- 
fortunately, sometimes with success, to elude clinical 
ability in diagnosis than does Scarlet Fever. But 
this very difficulty has been a great urge to more 
detailed knowledge and this in turn has pointed the 
way to more successful treatment and more elaborate 
precautionary methods anent the spread of the disease. 
probably, too, the tremendous obstacles in finally 
elucidating the bacteriology of Scarlet Fever are in 
part due to experimental complications which must 
arise when the laboratory worker seeks the co_operation 
of the clinician. If one could separate susceptibles 
from insusceptibles simply by their having a negative 
or positive history of a diagnosis of Scarlet Fever, 
quite apart from the added difficulty of assessing 
those who may have become immune by repeated or 
hoarded sub_infective doses of the causative organism, 
there would at least be a much greater percentage of 
young/ 
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young children in whom the uniform clinical experi- 
mental results in the realms of prophylaxis and thera_ 
peutics would be very convincing. There must be very 
many cases of Scarlet Fever missed; perhaps because 
medical aid has never been sought; perhaps because 
of unfamiliarity with the very early or very late 
signs and symptoms; perhaps because the case was 
atypical or some localising sign (e,g, endocarditis 
or arthritis) compelled the attention, to the exclusion 
of a zymotic cause. 
A few notes on atypical cases of Scarlet Fever 
during the last hundred years may be edifying, espec- 
ially as some were quite severe but without any rash, 
and others which in the infecting case had a typical 
rash gave rise to instances with no exanthem what- 
ever. All of which goes to strengthen the writer's 
opinion that although the "seed" is very important, 
the "soil" is of even more moment in deciding what 
characters the acquired disease may exhibit and to 
what complications the attack is likely to give rise. 
In 1839, Taupin)described five cases of Scarlet 
Fever from a common infective source; two of the 
patients exhibited no eruption. Shortly before this 
(22) 
(1838), Eiselt published details of a case of severe 
Scarlet Fever in a woman of twenty, where there was 




Buttura, in 1857, described a series of cases 
the first of which had a copious eruption, which had 
followed very protracted throat symptoms and signs. 
Four days after the appearance of the rash, another 
member of the family developed a sore throat, the 
disease being later diagnosed Scarlet Fever, although 
there was at no time, during its course, the slightest 
evidence of erythema. Another member of the family 
became ill, with very marked throat symptoms, but in 
this case too, no eruption ever made its appearance, 
although the case proved itself to be Scarlet Fever. 
(13) 
In the same treatise, Buttura reviews reports of 
cases of Scarlet Fever without rash dating from 1829. 
It is not intended to detail all the historical 
accounts of cases of Scarlet Fever without eruption, 
such being only one of the anomalous forms of the 
disease, Afebrile Scarlet Fever is not so uncommon 
(48) 
as is generally believed. McClanaghan described 
several such in a report of 150 cases of Scarlet Fever, 
The skin disease Erythema Scarlatiniforme probably 
exists as a clinical entity, but one cannot help 
feeling that some at least are cases of Scarlatina 
without rise of temperature, 
(21) 
Fourth Disease, as described by Clement Duke in 
the Lancet in 1894, need only be mentioned, as its 
existence/ 
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existence is not now regarded as having been established. 
From the above extracts of the literature, it is 
abundantly clear that;_ 
(1) Scarlet Fever is at times a difficult disease 
to diagnose. 
(2) Cases may show a well developed rash without any 
co_existing abnormality of temperature. 
(3) There may be marked pyrexia and serious intoxica- 
tion followed by troublesome complications, 
although no exanthem has been noted throughout 
the disease. In this connection, the peripheral 
hyperaemia observed during the rash of scarlet 
fever does not appear to be a necessary antecedent 
of desquamation, the occurrence of which is 
repeatedly described in cases of the disease 
exhibiting no eruption. 
Although the disease cannot be said to be a 
serious one at the present time, the average case 
mortality being between 1 and 3 per cent, the disease 
was not always so benign and indeed, judging by the 
long and short periodicities of other comparable 
diseases, it may be that scarlet fever is passing 
through a phase of low virulence in its cycle. 
Its prevalence, infectivity and comparatively high 
case mortality occasioned great concern 60 or 70 years 
ago 
39. 
ago and were responsible for its inclusion in the 
various Acts of Parliament dealing with the notifica_ 
tion and prevention of Infectious Diseases. Hospital- 
isation of cases and the investigation of the source 
of the disease as well as the supervision of contacts 
followed as natural sequences, Infectious Diseases 
Hospitals sprang up all over the country as well as 
in other countries and attempted by segregation of 
the patients to decrease the percentage number of 
deaths; to minimise the number of complicated cases 
and to curtail the spread of the disease, The first 
hospital for Infectious Diseases in London was opened 
by the Metropolitan Asylums' Board in 1871. At the 
present time there are nine such hospitals under that 
Body, In 1895, the first large Hospital for Infectious 
Diseases in Boston (U.S.A.) was opened; previous to 
this, there had only been such accommodation for cases 
as was provided by the erection of a pavilion by the 
trustees of the Boston City Hospital, 
The Public Health Act 1875 provided in some 
measure for the prevention of the spread of infectious 
diseases Sanitary Authorities were given power, 
subject to the necessary certificates having been 
completed, to cleanse and disinfect any house or part 
of a house so filthy as to endanger health or likely 
to promote the spread of infectious diseases, 
Hospital/ 
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Hospital accommodation could also be provided, as well 
as suitable apparatus for dealing with the disinfection 
of articles removed from the infected patient and his 
dwelling. 
Further powers to facilitate the hastened sub- 
sidence of epidemics of infectious diseases were 
conferred on Sanitary Authorities by the Epidemic and 
Other Diseases (prevention) Acts 1883. The Infectious 
Diseases (Notification) Act 1899 made the corresponding 
adoptive Act of 1889 compulsory, so that it was now 
the duty of anyone in attendance on a case of certain 
scheduled Infectious Diseases, of which Scarlet Fever 
was one, to notify the case to the Medical Officer of 
Health of the district in which the disease occurred. 
At first, the compulsory notification of cases 
of Infectious Disease was not viewed with favour by 
some sections of the medical profession; it was re- 
garded by many as a breach of confidence, while others 
considered that the fee offered was not commensurate 
with the time and trouble involved. Nowadays, no 
practitioner thinks of notification as other than one 
of the details of the day's routine, 
41. 
OBSERVATIONS ON SCARLET FEVER 
AND ITS SPECIFIC THERAPY, 
III, AETIOLOGY AND DIAGNOSIS. 
The strict division of diseases into 
"epidemic ", "endemic" and "sporadic" has become more 
difficult as science and its philosophic interpretation 
have advanced. More and more it is realised that 
natural processes _ and even disease may be included 
in the most comprehensive meaning of that term _ 
progress in curves. Not only are there long periodic 
curves, but, if these be represented graphically, it 
is also found that each one is itself made up of a 
series of curves, each of which constitutes a minor 
period. In the case of Scarlet Fever, it appears 
that at intervals of something like thirty years there 
has been completed a cycle of the infective and morbid 
variability. During this period, about six minor 
exacerbations occur, each showing a tendency to 
regular increase and decrease within limits which 
are modified by the position of the minor period on 
the curve of the major period. Further, the five_ 
yearly period is itself divisible, each year showing 
a season of prevalence of the disease with an inter_ 
vening period of comparatively low incidence. The 
whole of the epidemic curve is linked up by the per_ 
sistence/ 
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persistence of endemic cases, which occur particularly 
in populous areas. 
In dealing with the epidemiology of Epidemic 
Influenza the term "Epidemic Constitution" has been 
frequently used; terms implying the same idea date 
back to the earliest days of medicine. It seems that 
the formation of an epidemic constitution depends 
partly at least on the increasing percentage of 
susceptibles in a community and determines not only 
the number of cases likely to occur, but also the 
severity of the disease and the probable case mortality. 
It is very suggestive in Scarlet Fever that the minor 
epidemic period is five years and that the largest 
number of cases in an epidemic occurs in children in 
the second quinquennial age group. Scarlet Fever is 
uncommon in the first year of life, even in epidemic 
periods. If a child of that age has just escaped 
infection during an epidemic, the probability is that 
he will not, other things being equal, contract Scarlet 
Fever during the ordinary seasonal outbreaks. Thus 
he arrives at the age of six years when the next five_ 
yearly exacerbation occurs. There must be, at each 
epidemic period, a very great proportion of such 
susceptible people available, according to the above 
hypothesis, leading, as it were, to a rapid as well 
as an ideal subculturing scheme which increases the 




When a certain proportion of the susceptible 
population has been infected, with the production of 
an active immunity, either with or without external 
evidence of the disease, the infective powers and the 
virulence of the organism diminish and the epidemic 
draws to an end. This is a most likely and important 
factor in the epidemiology of the periodicity of 
Scarlet Fever. But that there are other considerations 
is evident when we remember that, during the epidemic 
itself, the case mortality is lowest when the disease 
is most prevalent and that there is evidence, in com- 
paring corresponding seasons of the year, of an inverse 
ratio between the number of cases occurring and the 
amount of rainfall. 
With regard to the first of these, the causative 
organism may gradually undergo some change in its 
character; this may be the result of a continued re_ 
newal of an adverse environment (commencing active 
immunity) as the infecting agent is carried from person 
to person. Successive generations of the causative 
organisms probably undergo progressive crippling as 
the result of their ancestors' battle for existence. 
Thus, although the infective powers of the germs may 
yet remain undiminished, the virulence is gradually 
decreased. Continuance of an adverse environment, 
with/ 
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with the additional fact that the likelihood of fresh 
soil lessens as the percentage of immune persons rises, 
may further modify the organism so that it now lives 
almost as a commensal, In this way its infectivity is 
lowered, On this theory, the virulence is decreased 
before the infective powers and would account for the 
period of highest case mortality failing to coincide 
with the period of greatest incidence in an epidemic. 
In actual fact, that order is observed, 
With reference to the second point, the increase 
in rainfall may not be so mysterious in its effect 
on the prevalence of Scarlet Never as at first appears, 
The common obvious things may be missed if we begin 
at once to probe for a learned scientific explanation, 
One thing that does happen in rainy weather is that 
susceptibles _ mostly children _ are less frequently 
in close contact with each other, having to remain 
indoors, But, of course, the laying of dust carried 
out by rain may also be important and there may be 
other obscure influences resulting from the barometric 
conditions which make rain possible, For example, 
a decrease of atmospheric pressure may cause an 
increased peripheral circulation, in which the mucous 
membranes probably share, thus being fore -armed with 




Predis osing Causal : - Any factor, physiological 
or pathological, which puts a strain on the maintenance 
of health, is important in rendering a susceptible 
individual less resistant to Scarlet Fever. The most 
important may be grouped generally under three head- 
ings, viz, (1) Local (2) General (3) Environmental. 
Local causes are principally those affecting the 
naso_pharynx and fauces and the chief is probably 
enlarged tonsils. Accompanying enlargement of the 
tonsils, adenoids are frequently found and not un- 
commonly the person so affected is a mouth- breather, 
thus fulfilling all the conditions necessary for the 
successful lodgment of organisms in the throat region. 
Catarrh of the nose and chronic congestion of the 
throat from such conditions as cough may also play 
some part in increasing the likelihood of infection. 
Of general predisposing causes, a division may 
be made into temporary and chronic, Convalescence 
from another illness, excessive fatigue at the time 
of exposure to infection, anaemia, are all instances 
of the former, while congenital syphilis, tuberculosis 
and malnutrition are among the chronic group, 
Environmental predisposing factors are self 
evident: Poverty, overcrowding, insanitary condition 
of the dwelling and clothing and uncleanliness of the 
body all tend towards lowered vitality and render 
infection more likely. 
4R. 
Infection :_ The spread of Scarlet Dever may be 
either direct or indirect. It is often quite impos_ 
sible to relate a case of the disease to some previous 
known case, but, bearing in mind the probability that 
many children almost certainly pass through very mild 
and undiagnosed attacks of Scarlatina, the writer is 
of the opinion that direct spread is much commoner than 
is generally stated. Infection is possible from the 
time the first symptom of the disease occurs; the 
duration of infectivity is very uncertain, there being 
no rapid laboratory method, such as can be utilised 
in the case of Diphtheria, of assessing the convales- 
cent's freedom from infection. The chronic carrier 
must also be remembered, although his role is more 
properly described under indirect methods of spread. 
Fomites plays a part in the spread of Scarlet 
Fever, but not uncommonly this particular method is 
stressed unduly. Clothes, toys, bedding, books have 
all been incriminated and in some cities and towns 
books from public libraries are destroyed, when these 
are discovered in an infected house. In this latter 
(36) 
connection, Nesbit has recently shown that although 
he carefully traced the redistribution of library 
books which had been in the possession of persons 
contracting Scarlet Fever during an epidemic, he 
could not find a single instance where the volumes 
in/ 
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in question could be said to be responsible for the 
spread of infection. 
In his book, "Sources and Modes of Infection" 
Chapin of Michigan states that he does not now carry 
out disinfection when a case of Scarlet Fever is 
removed to Hospital and apparently there is no notice_ 
able increase in the prevalence of the disease, 
Common towels and handkerchiefs, cups and cutlery 
readily convey infection, as also do tongue depressors 
and appliances used in the treatment of scarlatina) 
throats. 
It has been said in the past that schools play 
a considerable part in the dissemination of Scarlet 
Fever, but the consensus of opinion now is that they 
are relatively unimportant. I have personally made 
extensive and close investigations on this point 
during epidemics and so far I have been unable to 
satisfy myself that attendance at school is potentially 
dangerous during an outbreak of the disease. 
Domestic animals and vermin have also had atten- 
tion in connection with the spread of infection, but 
evidence of their culpability is far from convincing. 
Kerabates that the prevalence of Scarlet Fever 
synchonises to some extent with the prevalence of 
fleas, It was Hamer who first cited the apparent 
connection between the prevalence of fleas and the 
increase/ 
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increase in the number of cases of Scarlatina, but 
(27) 
Goodall is inclined to think there is no close con_ 
nection between them. He says that in London the 
period of increased incidence of Scarlet Fever shows 
no close correspondence to the period of maximum flea 
prevalence and he further points out that although 
the disease was very much in evidence in 1920 and 1921, 
those years showed the lowest recorded "flea- curves ". 
Infection has never been traced to water or to 
sewage, but the milk supply has been quite definitely 
associated with local and even more widely distributed 
outbreaks of Scarlet Fever, The Hendon epidemic is 
the classical instance, But it has to be remembered 
that milk is in close association with human beings 
during its production and distribution and may thus 
become inoculated, apart from any ulcerated condition 
of the udders and teats of the cows. Indeed, the 
sores themselves may be the result of infection from 
a human agency, thus, at the outset at least, being 
simultaneously infected with the milk and not having 
any primary causal relationship to the infected milk, 
W.G. Savage has put forward the view that ulcerated 
udders may merely act as carriers of the microorganism, 
which is quite innocuous to the cow but capable of 
producing disease in human beings, 
Auto_infection is possible too, as was mentioned 
in the introductory chapter, Scarlet Fever may develop 
within/ 
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within a few days of the removal of tonsils and adenoids 
and also soon after extensive burning. 
Age and Sex ;_ On the question of the age_period 
showing the greatest incidence, all the textbooks 
appear to be agreed. Scarlet Fever is overwhelmingly 
a disease of young persons, the second quinquennial 
period furnishing the largest number of cases. 
(27) 
Goodall states that after the age_period of greatest 
jnoidence, the remaining five -yearly age -periods take 
their places of relative importance in the order of 
(36) 
their succession_. Ker says that only a small pro- 
portion of the total cases is made up of persons over 
(73) 
15 years of age. Tidy is of the opinion that over 
(64) 
80% of cases are under 10 years of age. Pope, in 
analysing the statistics of Chapin, in Providence, 
finds that the age of greatest incidence is 6 years. 
Further, he deduces from the figures that practically 
75% of cases are under 10 years and nearly 90% of 
oases are under fifteen years. 
In the 106 cases, in which the writer is to 
discuss the effects of serum therapy in Scarlet Fever, 
the following is an analysis of the age incidence;_ 
Age 
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A$e Distribution of Cases. 
Age 




0 32 26 8 31 8 1 106 
Per- 
centage 0 30.2% 24.5/ 7.6% 29.2% 7.6% 0.9% 100% 
With regard to the importance of sex in statistics 
(36) 
of the disease, opinion is divided. Ker gives it as 
his experience that sex has little influence on the 
incidence of the disease, but that females appear to 
be slightly more susceptible than males, particularly 
(27) 
after the age of 10 years. Goodall states quite 
definitely that more females than males are attacked 
(64) 
at all ages. Pope came to the conclusion, after a 
very detailed analytical study of records of 40 years' 
cases, that, up to the age of six years, males pro- 
vided a slender majority of cases, but after the age 
of 7 years, there was a marked excess of females at 
all ages. 
The following table shows the sex distribution 
of cases for each age group for 106 cases of Scarlet 
Fever. 
Sex Distribution of Cases for each Age Group. 
n6v 
period 0_1 1.5 5_10 10_15 15 25 25..35 35_45 
Sex M F M F M F M F M F MF MF 
Number 
Caáes. 
0 0 17 15 9 17 2 6 9 22 3 5 0 1 
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It will be seen at once that this series of cases 
tears unmistakeable witness to Pope's assertion, 
Diagnosis:_ Why it has been chosen to discuss 
a few points in the clinical and serological diagnosis 
of Scarlet Fever in connection with this treatise is 
that the maximum possible benefit from specific 
therapy cannot possibly be attained until cases are 
sent to hospital earlier than obtains at present, 
Day of Disease on admission in each A.e and Sex Group, 
Group 0 - 1 1 _ 5 5 - 10 10 _ 15 15 _ 25 25 _35 35 _ 45 
Sex M F M F M F M F M F M F M F 
1st Day _ _ 2 4 1 2 - 1 - 1 - _ _ 
2nd Day _ _ 7 3 5 7 - 3 2 5 _ 3 - 1 
3rd Day _ _ 3 2 2 5 2 1 3 8 2 - - - 
4th Day _ _ 3 2 _ 3 - - 3 8 1 1 _ - 
5th Day - _ 1 1 1 - - 1 1 1 _ 1 - _ 
After _ _ 1 3 _ - _ _ - 3 - - _ _ 
5th Day 
It will be readily seen from the above tabular 
representation that practically half of the cases which 
will be under special discussion later, were admitted 
on or after the third day of disease, 
On attempting to make a diagnosis of Scarlet Fever, 
undue prominence should neither be given to clinical 
findings nor to serological methods to the exclusion of 
the 
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the other, All the advantages of both should be made 
use of and any symptom_complex which still leaves grave 
doubts as to the possibility of the disease being 
Scarlet Fever is almost certainly not due to that 
particular zymotic disease, Naturally, this only 
applies when dealing with early cases, for one not 
uncommonly sees children who may have had a mild 
attack three or four weeks previously and in whom 
little remains except some desquamation of the hands 
and feet, To apply the Dick Test in such a case and, 
getting a negative result, thereby diagnose Scarlet 
Fever is quite illogical, unless there is a. definite 
record that at a very recent date (2 months or so 
previously) the child was Dick_positive, In this 
connection, much help could be given by Medical Officers 
of Health who are also School Medical Officers if 
every child were Dick_tested on entering school and 
at subsequent Routine Medical Inspections, For it is 
generally either the M,O,H, himself or one of his 
assistants with special knowledge of Infectious Dis_ 
eases who is called in to consult on difficult cases, 
If it were known that a certain child was definitely 
Dick_negative, a negative diagnosis could readily be 
given in the majority of cases, Of course, the test 
can be applied when the patient is seen with reference 
to a diagnosis, but in such circumstances, time has 
to/ 
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to be allowed before a reading can be made (probably 
18 to 24 hours), thus losing valuable time 
before 
passive immunisation may be induced, as well as exposing 
other members of the family to a needlessly prolonged 
risk of infection. 
The Schultz Charlton Reaction is moro expeditious, 
as quite a reliable reading can be taken within six 
to eight hours and the results are trustworthy in the 
vast majority of instances. Even before the rash is 
more than a blush, the test may be applied and it is 
the writer's opinion that it is best, in early cases, 
to make two injections, one on the trunk where the 
rash is already evident and one on a limb, where the 
rash has not yet appeared. When the necessary time 
has elapsed, any ambiguity in interpreting one of 
the reactions will undoubtedly be moved in one or 
other direction by the findings in the second experi- 
mental area. 
Where possible, both the Dick and Schultz Charlton 
tests should be applied in difficult cases with a rash 
and if both give no reaction, there is very strong 
presumptive evidence that the disease is not Scarlet 
Fever. In serious toxic cases with a poorly developed 
rash, the limited experience of the writer is that 
the Dick test is more often negative than positive, 
and this may be due to the patient being already 
overwhelmed/ 
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overwhelmed with toxin and quite unable to react 
further to any added dose. An analogy is seen in 
the case of Acute Miliary Tuberculosis, where the 
intracutaneous tuberculin test is often negative, 
In hospital, the repeated Dick Test is very 
useful, where a diagnosis is very doubtful. If a 
patient is definitely Dick -positive on admission and 
becomes Dick-negative during the course of the disease, 
with the proviso that no anti -serum has meantime been 
given, then a diagnosis of Scarlet Fever is perfectly 
justifiable, There is, however, a great advantage 
if definite information can be got from the Schultz_ 
Charlton reaction, because it makes early treatment 
possible for patients who are really ill, On the 
whole, the test is a very reliable one; so much so, 
that the writer was accustomed to apply it as a routine 
test in cases with a definite rash, at the same time 
as giving the therapeutic dose of Antiserum. After 
antiserum, the rash is not sufficiently quickly 
altered in intensity, as a rule, to render the Schultz_ 
Chariton test valueless, The relatively concentrated 
action of the serum used in the intracutaneous test 
produces changes far in advance of those instituted 
by the intramuscular therapeutic injection, so that, 
in cases where the patient is obviously ill, the 
simultaneous test and therapy occasion no loss of 
time, In this respect, I think its usefulness is even 
greater than the Dick test in suitable cases, for if 
serum/ 
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serum be administered with the latter, the rapid dif- 
fusion of immune bodies will prevent any reaction at 
all. 
When applying toxin or antitoxin tests or both 
in the diagnosis of Scarlet Fever, it must be kept 
in mind that neither is infallible. If, however, both 
point in one direction, the likelihood of error is 
small. If one only is used a certain proportion of 
cases will be found where no help is derived from the 
test and it is because of this that it is necessary 
to remember two points in particular. The first is 
that the reaction of the body to disease cannot be 
tabulated with precision. Immunity and susceptibility 
are not opposites with a great dividing space between 
them, but merge gradually into one another by a long 
chain of imperceptible gradations. This is simply 
another example of how nature works in gentle curves, 
or in other words, she has no water_tight compartments 
in her universe. The second point is that laboratory 
methods of diagnosis of Scarlet Fever are at present 
unable to replace the clinical interpretation of 
symptoms and signs. 
It is not intended to discuss the Differential 
Diagnosis of Scarlet Fever, from the clinical point 
of view, but a short summary of one or two difficult 
cases may be of interest. I have only seen one case 
of/ 
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of Scarlatina in a Negress. She is a nurse in one of 
our General Hospitals and a popular as well as capable 
member of the staff. She became ill, headache and sore 
throat being complained of. Her temperature was 102 °F. 
I was asked to see her with a view to making a diag_ 
nosis, as this was very important from the point of 
view of the rest of the staff, as well as of the 
children in the ward where she had been on duty. 
On examination, the tongue was not typical and natur- 
ally the skin was not very helpful, although on stand_ 
ing well back from the patient, there was a warm tint 
about it, suggesting a rash hidden by pigment. The 
skin had the typical pungent feeling. The pulse was 
not unduly accelerated. The throat was very congested, 
both tonsils were a little enlarged and were covered 
with soft exudate. The soft palate showed quite 
definite punctation, although the colour of the pun to 
was modified by the increase of pigmentation of the 
mucosa. The cervical glands lying under the angles 
of the jaws were enlarged and tender. On stretching 
the skin at the flexures of the joints, purplish lines 
were seen and considered to be "flexure_staining "e 
The chest was normal and the heart sounds closed and 
full; the cardiac rhythm was not toxic. A diagnosis 
of Scarlet Fever was made and the course of the 
disease confirmed this Here is an instance where 
the Dick Test and the Schultz_Charlton Reaction were 
quite/ 
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quite impotent to help. The appearance of the throat 
and mucous membranes, together with the burning sen_sa_ 
tion transmitted by the patient's skin and the presence 
of "flexure_staining" were the main diagnostic features. 
The second case is one which I saw recently in 
a General Hospital Ward, Prior to admission there, 
the patient _ a child of 8 years _ had been taken 
suddenly ill with headache and vomiting. There had 
been no sore throat. Convulsions had rapidly set in, 
followed by coma,and there had been and still was 
strabismus and slight rigidity of the neck. The 
abdominal, knee and plantar reflexes were normal. 
The breath smelt strongly of acetone and the urine 
contained acetone and diacetic acid, There was a 
uniform bright scarlatiniform rash with typical 
flexure staining. No paralysis other than the 
strabismus could be made out. Meantime, the patient 
had been treated with Chloral Hydrate and later, 
Morphia to control the convulsions and colon injections 
of glucose with gum had been given, along with intra_ 
muscular injections of insulin. Schuitz_Charlton and 
Dick Reactions were not carried out. I should have 
mentioned that the tongue was heavily furred and there 
was a suggestion of enlargement of the tongue papillae. 
The throat was normal. A diagnosis of Scarlet Fever 
was not made, but the case was removed to the Isola- 
tion Hospital. Eventually the disease was definitely 
found 
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found to be Polio_Encephalitis. The difficulties in 
this case were many. The administration of morphia 
and chloral hydrate causes scarlatiniform rashes in 
certain people. Continued vomiting gives acetonaemia, 
just as do Diabetes Mellitus and other diseases 
associated with acidosis. Coma is found commonly in 
children suffering from practically any acute disease. 
The strabismus and neck_rigidity suggested a condition 
having its origin in the central nervous system, but 
both may occur in gastrointestinal conditions as well 
as acidosis from any cause, in pneumonia and any acute 
illness where meningism is a symptom. The main points 
against a diagnosis of Scarlet Fever were (1) The 
normal throat and buccal mucosae, (2) The extra- 
ordinary uniformity of the rash. (3) The absence of 
the burning sensation felt on touching the skin of 
Scarlet Fever patients, (4) The predominance of 
Central Nervous System symptoms and signs, especially 
squint. 
The Schultz_Charlton and Dick Reactions would 
have been specially valuable here, but there were no 
facilities for carrying them out. In cases such as 
this, a previous record of the person's reaction to 
the Dick Test would be of supreme value, in so far 
that the definite knowledge of the patient's being 
Dick_negative would practically rule out Scarlet Fever 
as a possibility in many very difficult cases. One 
keeps/ 
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keeps in mind, of course, that occasionally the dose 
of the organism is so massive as to render the 
immunity _ all immunity is essentially relative to 
the dose and virulence of the infecting micro_ 
organism _ insufficient to deal successfully with 
the invader. There is the additional point too, 
that one sees cases from time to time at Centres for 
prophylaxis of Infectious Diseases, in whom the Dick 
Test is variable in the reaction it produces in the 
same person at different times. But, taken as a 
whole, the knowledge of the result of a recent test 
in children, would be invaluable in doubtful cases. 
Another case which was very interesting from 
the point of view of diagnosis, both for the patient's 
own welfare and that of other patients who might have 
been unduly exposed to infection, was one which was 
admitted to Hospital as Scarlet Fever and Laryngeal 
Diphtheria, The child looked extremely ill and was 
struggling for breath. The tongue was not typical 
of Scarlet never; the throat was clean; the buccal 
mucous membranes were congested; the conjunctivae 
were oedematous (Brownlee's Sign of Measles); there 
were symptoms of coryza and signs of bronchitis; a 
faint scarlatiniform rash was present on the upper 
part of the trunk; Koplik's spots were seen. 
A diagnosis of Measles with prodromal scarlatiniform 
rash and severe laryngeal signs was accordingly made 
and 
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and confirmed next morning by the appearance of a 
brilliant morbilliform eruption, During the patient's 
stay in Hospital, the Dick and Schick tests were 
carried out and were positive. These were done as 
a routine which was instituted so that (1) the re_ 
arrangement of patients was facilitated in the event 
of a case of Scarlet Fever or Diphtheria occurring 
in the ward; (2) passive immunisation against either 
or both diseases could be carried out if necessary; 
(3) active immunisation against Scarlet Fever could 
be induced during the patient's stay in Hospital and 
the parents advised, if necessary, to bring the child 
to the Centre for Prophylaxis to have the necessary 
Anti_Diphtheria: inoculations. 
The last case I wish to mention in respect of 
diagnosis is a very recent one. A child was brought 
to the School Clinic for Minor Ailments, suffering 
from a Boil on the arm, He looked rather ill and the 
mother said that there had been vomiting the previous 
day and the child had complained of headache but had 
no sore throat, Examination showed that the tongue 
was heavily furred and the papillae were a little 
enlarged, The fauces were congested; the tonsils were 
clean, The soft palate showed definite punctation of 
a bright scarlet colour, There was a faint blush with 
very indefinite characteristics of a scarlatiniform 
rash on the sides of the neck and the upper part of 
the chest, The temperature was 100 °F. and the pulse/ 
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pulse rate 130 per minute, The point of importance is 
that the case might very easily have been missed, for 
conditions such as boils are rather wearing and the 
headache and vomiting, in the absence of sore throat, 
might quite pardonably have been attributed to the 
general malaise of a staphylococci° infection. 
Second attacks of Scarlet Fever are not uncommon 
and naturally their occurrence lends support to the 
variations noted in the reactions to the Dick Test 
when applied to the same person at intervals, Goodall, 
in his text_book says that "It must be considered 
doubtful whether third or fourth attacks ever occur ". 
I have, in the records of the Infectious Diseases 
Hospital in Wakefield, one case in which typical 
Scarlet Fever occurred three times in one individual. 
The second attack commenced about one week after re_ 
covery from the first and was followed in about two 
and a half months by a third attack. The correctness 
of each diagnosis is, I think, unquestionable. We 
can only presume that such a person simply fails to 
acquire a permanent immunity, the reaction to the 
disease being somewhat analogous to the average person's 
behaviour to pneumonia; namely, there is the production 
of the necessary temporary immunity, but when the 
stimulus of the invading micro_organism is removed, 
there tends to be a return, in the biochemical com- 
position/ 
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composition of the blood and tissue fluids, to the pre_ 
existing normal. 
In closing this chapter, I should like to mention 
how valuable I have found Rumpel-- Leede's Sign, first 
taught me by Dr James of the City Fever Hospital, 
Edinburgh, in coming to a diagnosis of Scarlet Fever, 
when the case is not seen until the rash has completely 
disappeared. 
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OBSERVATIONS ON SCARLET FEVER AND 
ITS SPECIFIC THERAPY. 
IV. SELECTION OF DATA FOR ASSESSING THE VALUE OF 
SPECIFIC THERAPY IN SCARLET FEVER.- 
(27) 
Temperature:- Goodall states that the 
temperature usually reaches the normal at about the 
seventh to the tenth day. A critical fall is 
(38) 
occasionally, but not commonly, seen. Ker records 
that the fastigium may last from one to four days, 
but in most instances not more than three and the 
normal is gained by a rapid lysis, lasting from three 
(68) 
to five days. Savill notes that the temperature 
gradually subsides to normal in five or six days in 
(73) 
mild cases. Tidy describes the temperature as 
reaching the normal in five or six days and mentions 
that a fall by crisis is unusual. 
All of the above recorded opinions are unanimous 
that about a week is required for the normal temper- 
ature to be regained. This close correspondence 
signifies that the effect of any treatment on the 
temperature is a useful gauge of its efficacy in 
combating the toxaemia of Scarlet Fever. 
(27) 
Aspect of the Throat:- Goodall believes 
that/ 
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that the appearance of the throat varies much, even 
(36) 
in mild cases. Ker describes in detail the various 
appearances of the throat encountered in the disease 
but does not state whether they are liable to great 
variation in cases which might be considered almost 
identical, in the early stages of Scarlatina. 
In the writer's opinion, the variability of throat 
symptoms and signs is too great to be useful as a 
gauge of improvement in the general condition. Not 
uncommonly, throats which look extremely affected 
clear up very quickly, while, on the other hand, one 
or two crypts of the tonsils may continue infected 
for a considerable time, although the patient's 
general condition makes normal progress. In Toxic 
Scarlatina, the throat lesions are usually compara- 
tively mild and their improvement is entirely dis- 
sociated from any satisfactory general reaction to 
the disease. On the other hand, in Septic Scarlatina, 
the condition of the throat is a reliable indication 
of the direction of progress of the disease. 
Taken in wide survey, the aspect of the throat 
affords little guidance as to the course of the disease 
in ordinary cases. 
(27) 
Duration of Rash:- Goodall fixes the limits 
(36) 
as from twenty -four hours to nine or ten days. Ker 




Savill writes that the eruption has generally completely 
(73) 
disappeared by the seventh or eighth day. Tidy says 
the rash usually lasts two to three days and is 
(65) 
generally absent by the seventh or eighth day. Price 
records as follows: - 
"The rash may be quite transitory or may last a week 
or even longer. Generally speaking, it is more pro- 
nounced in severe attacks, but sometimes attacks 
"which are quite mild show rashes of considerable 
"intensity and persistence." 
There are such wide variations in the records of 
the duration of the rash in Scarlet Fever that the 
time of its disappearance appears to be of little help 
in assessing the progress of the patient. In this 
connection, I have seen many brilliant rashes disappear 
in just over twenty -four hours in patients not treated 
by Anti -Scarlatinal Serum, just as I have seen less 
pronounced rashes linger for about ten days. 
(27) 
Desquamation : - Goodall mentions that the 
commencement of desquamation may be delayed for some 
weeks. Ker6lays it down that the process begins about 
(65) 
the seventh day of the disease. Price notes that 
desquamation is a well known characteristic, but the 
degree to which it occurs is very variable. 
The writer is of the opinion that the texture of 
the/ 
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the patient's skin has a good deal to do with the time 
of commencement of desquamation. In young children, 
it starts very early as a rule, although the flakes 
are so delicate and powdery as to avoid ordinary notice. 
As a rule, there is nothing to be noted in the general 
condition of patients to account for speeding up or 
retarding the commencement of desquamation, nor is 
the early onset of desquamation in any way indicative 
that recovery from the disease will be hastened or 
that freedom from complications may be anticipated. 
So far, it would appear that the effect of any 
treatment on the temperature is the most reliable 
guide as to the antitoxic properties of that therapy. 
This has led me to disregard the effects on the rash, 
throat, and desquamation, generally recorded in papers 
dealing with the specific therapy of Scarlet Fever. 
The early toxaemia in Scarlet Fever is, unfortun- 
ately, only a comparatively minor consideration in 
endeavouring to evaluate the serum therapy of the 
disease. Septic complications are the dread of the 
clinician and their inhibition or amelioration by a 
serum of an "antitoxic" nature causes some division 
among the experts in the laboratory. Before summar- 
ising the records of text book authorities and others 
as to the incidence of complications, it will probably 
be wise to consider: - 
( 1)/ 
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(1) The association of the Streptococcus Scarlatinae 
with septic complications of Scarlet Fever. 
(2) The complete róle of the Streptococcus Scarlatinae 
in the disease. 
(3) Do local and general immunity exist in quantita- 
tive parallel? 
(63) 
(1) Pilot and Davis found that practically 
all apparently normal throats contain haemolytic 
streptococci in the crypts of the tonsils. But that 
does not mean that those organisms are serologically 
identical with the Streptococcus scarlatinae. Many 
workers have included experiments with antisera to 
such organisms in their investigation of the specificity 
of the Schultz Charlton Reaction and have found that 
such antisera do not give the blanching phenomenon. 
(57) 
O'Brien says: "With regard to septic complications, 
"there seems little doubt that the majority of the 
"organisms causing otitis, septic adenitis, etc., 
"belong to the Streptococcus scarlatinae group, for a 
"number of workers (Stevens and Dochez 1926; J. Smith 
"1926; etc.) have isolated strains from such complica- 
"tions, which agreed with the Dochez -.Dick strains in 
(19) 
every test which was applied ". Dochez and Bliss 
found that a haemolytic streptococcus identical with 
the Streptococcus scarlatinae could be isolated from 
all/ 
68. 
all the complications - e.g. suppurating glands, otitis, 
nephritis etc. - in all cases of Scarlet Fever. 
(58) 
Okell states that there is little doubt that both 
the toxigenic and the pyogenic activities of the 
scarlet fever coccus are responsible for most of the 
clinical manifestations of the disease and that the 
injection of sterile toxin alone can produce a syn- 
drome bearing the closest resemblance to scarlet 
fever. 
(2) Most authorities are agreed that the 
Streptococcus scarlatinae can be isolated from the 
vast majority of cases of septic complications of the 
disease. If such is the case, then there may be a 
state of bacteraemia at some stage in the disease, 
followed by localisation in various organs and tissues 
(58) 
which become the seat of complications. Okell 
believes that the streptococcus plays a dual reile in 
Scarlet Fever; it produces a toxin which diffuses 
through the body in the early stage of the disease; 
later, the micro-organism itself invades tissues like 
(58) 
any other pyogenic organism. He believes the pyo- 
genic function to be more or less separate immuno- 
logically from the toxaemia function. This does not 
necessarily mean that specific antitoxic therapy has 
no effect on septic complications of the disease, for 
(58) 
Okell himself states in the same contribution to the 
literature/ 
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literature on the subject that It is not clear to us 
if the preventive property of the "antitoxin" is purely 
an antitoxic effect ". Proceeding, he mentions that 
if there is the presence of an antibody other than 
antitoxin, the preparation of a serum rich in such 
antibody might be valuable in treating human beings 
in the pyogenic stages of the disease. Those pro- 
nouncements deal with animal experimental work, where- 
by injection of antitoxin, five hours before the 
intravenous administration of 5 c.cm. of young broth 
culture of the scarlet fever streptococcus, prevented 
the death of the experimental animal. The difficulty 
in interpreting the real significance of such experi- 
mental work in its application to the therapy of the 
naturally acquired disease, - Scarlet Fever - would 
seem to be that the induction of a primary "septic- 
aemia" is not really analogous to the pyogenic phase 
of a condition which commences as a toxaemia. The 
Streptococcus scarlatinae may and probably does re- 
quire to be preceded by the effect of its toxins, 
manufactured at the local seat of infection, before 
it is capable of attacking in its pyogenic capacity. 
(58) 
Okell subscribes to this theory when he says "The 
aggressive action of the toxin seems to be an important 
factor in the invasive power of the streptococcus." 
(3)/ 
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(3) Probably immunity of the body generally 
to the toxins of the Streptococcus scarlatinae in the 
later stages of the disease, implies some degree of 
local immunity of all the tissues. The essentially 
different functions of the organs and tissues of the 
body render some more likely to certain diseases, 
while others are apparently unaffected. Variations 
in tissue susceptibility are probably partly due to 
physico- chemical differences among themselves, but 
may they not also be due to actual quantitative dif- 
ferences in the supply of immune bodies reaching them? 
It is significant that most of the septic complica- 
tions of Scarlet fever affect mucous surfaces and 
secretory organs. Such tissues depend almost entirely 
on the diffusion of lymph for their nutrition and as 
antitoxic substances are contained in the globulins 
of the blood serum, these may not diffuse readily, 
thus causing a persistently low standard of immunity 
in tissues nourished in this way. Another factor 
which may operate in encouraging the involvement of 
certain tissues in the pyogenic activities of the 
streptococcus may be the "fixation" of toxins by 
them, thereby rendering toxin -antitoxin neutralisation 
difficult or impossible and as a result, they are 
infinitely more vulnerable when general invasion by 
the micro-organism occurs. 
The/ 
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The affinity between certain tissues and particu- 
lar toxins is well known as is also the selective 
tissue and organ invasion by micro-organisms. 
A parallel affinity probably exists with reference 
to antitoxin, not necessarily being exhibited by the 
same structures as the above. If these are facts, 
it is at once seen how irregularly distributed the 
toxins and antitoxins concerned in any disease may 
be. This may actually have some bearing on the 
incidence of complications in disease. The whole 
subject of local and general immunity is very in- 
volved and there are no very useful records of experi- 
mental work on it, but it seems to be beyond doubt 
that the specialisation of function necessary in the 
various tissues and organs of the human body, render 
them peculiarly vulnerable in varying degrees to the 
effects of certain toxins and the invasion of certain 
organisms, without necessarily being able to avail 
themselves correspondingly of the antitoxins circu- 
lating in the system generally. 
72. 
NOTES ON THE COMPLICATIONS OF SCARLET FEVER : - 
Albuminuria:- In the early stages of any acute 
infectious disease, albuminuria is common and does not 
(27) 
imply any injury to the renal tissue. Goodall states 
that actual nephritis occurs as a complication about 
the end of the third week, but may be much earlier 
(first week) or very late (twelfth week) . The occur- 
rence of nephritis has little to do with the severity 
of the disease, unless it occurs very early, when the 
type of case affected is the severe anginous variety. 
In 3,888 cases observed during the years 1904 -07, 
(27) 
Goodall found that albuminuria occurred in 8% of 
cases of Scarlet Fever. He distinguishes late 
(36) 
albuminuria from actual kidney involvement, but Ker 
finds it difficult to draw any definite line between 
them. The artificial distinction is probably based 
on degree of involvement of the kidney rather than 
the real pathological significance of the occurrence 
(36) 
of albumin. Ker states that patients between the 
ages of 5 years and 7 years are most liable to 
nephritis and he gives the percentage of total cases 
affected with either albuminuria or nephritis as 
(68) 
below 10%. Savill states that 7.9% of cases are 
affected with albuminuria and an addition of 4% with 
true nephritis. Tidy) considers the percentage 
incidence of kidney involvement to be only 5% and 
mentions/ 
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mentions that this complication is commoner in children. 
(36 ) 
Adenitis:- Ker records that about 13% of cases 
develop adenitis, which, of course, does not include 
the early enlargement of glands during the acute 
(27) 73) 
throat symptoms. Goodall and Tidy note the occur- 
rence of this complication commonly in conjunction 
with Nephritis. 
(27) 
Arthritis : - Goodall, in giving a record of 
3026 cases of Scarlet Fever in the South-Eastern 
Hospital, analysed by Hodges, states that this com- 
plication occurred in 3.8% of cases. He mentions 
that the most frequent age period is from 8 years 
to 25 years and that the condition seldom lasts 
longer than a week. Kor3gives the percentage 
incidence as 4% and the time of occurrence as be- 
tween the 6th day and 12th day. He is also of the 
opinion that arthritis seldom lasts more than a week. 
(68) 
Savill considers that this complication is seen in 
(73) 
6.7% of cases of Scarlet Fever. Tidy gives the 
period of onset as the end of the first week of the 
disease and believes the condition to be very fre- 
quent in adults, but uncommon in children. 
In connection with arthritis, the writer has 
been interested to note in nearly all of the cases 
developing this complication, that, during the 
eruptive period, the rash was very blotchy on the 
limbs/ 
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limbs with special localisation round joints. Indeed, 
in cases untreated by serum, an anticipatory diagnosis 
has frequently been made. No doubt others interested 
in infectious diseases have similarly noted this 
apparent connection between the character and dis- 
tribution of the rash on the limbs and the incidence 
of joint complications. 
Otitis : - Layton gives the percentage incidence 
(26) 
in a large series of cases as 8.61 %. Gibson states 
that 9% of Scarlet Fever patients developed Otitis. 
(76) 
Logan Turner deals with the findings of Gardiner, 
Consulting Otologist to the City Fever Hospital, 
Edinburgh, stating that Gardiner finds that from 65 
to 10% of Scarlet Fever patients suffer from purulent 
Otitis Media, which occurs most frequently in the 
first and second weeks of illness. About 50% of the 
cases are associated with adenoids and mucopurulent 
rhìnitis. In 300 cases of otorrhoea in Scarlet 
Fever, Gardiner found that 7% developed a mastoid 
complication and of these, ten required exposure of 
(68) 
the lateral sinus at the time of operation. Savill 
quotes Caiger's figure of 15% as the case- incidence 
rate of Otorrhoea and Otitis Media in Scarlet Fever. 
(73) 
Tidy says that ear complications are rare after the 
(27) 
age of 15 years. Goodall believes there is no 
comparatively fixed period when the ear complications 
of / 
75. 
of the disease may make their appearance and gives 
the percentage of cases exhibiting Otitis Media as 
(36) 
11% Ker records 10% as representing the prevalence 
of the complication and finds that it usually makes 
its appearance within three weeks of the onset of 
Scarlet Fever. It may last for several months, but 
as a rule the discharge ceases in a week or a fort- 
night. An interesting record of 1757 cases of 
Scarlet Fever, giving the percentage incidence of 
Otitis Media for the sexes separately is contained 
(52) 
in the Medical Officer, where it is shown that the 
occurrence in males (12%) is slightly higher than 
(40) 
in females (10%). Lamel minutely investigated a 
series of cases and found that 12.9% had had Otitis 
Media during the course of the disease. 
(36) 
Rhinitis : - Ker finds 8% of cases complicated 
by Rhinitis, including septic cases, where the con- 
dition exists from the commencement of the illness 
and probably should not therefore be counted as a 
true complication. He states that it is most fre- 
quently observed in young children. 
Heart Affections:- Dilatation and hypertrophy 
of the heart may occur as the result of Scarlatinal 
Nephritis. Endocarditis or pericarditis may accom- 
pany scarlatinal arthritis, there being a tendency 




mitral. Ker writes that endocarditis is by no means 
common and only occurred in 0.58% of 22,096 cases 
treated in the M.A.B. Hospitals. He believes that 
even this figure would be too high for the incidence 
of this complication in the Edinburgh City Fever 
Hospital. According to the same writer, pericarditis 
is still more rare and generally occurs in septic 
cases only. He mentions an interesting point in 
connection with the not uncommon variability of 
temperature during convalescence, when he notes that 
slight endocarditis may account for some otherwise 
(27) 
unexplained temperatures. Goodall agrees as to the 
rarity of heart complications in Scarlet Fever. 
(73) 
Tidy also comments on the extreme rarity of endo- 
carditis and states that the malignant variety, as 
well as purulent pericarditis, only occursin Septic 
Scarlet Fever. 
The rarer complications are not given in per- 
centages in the text books consulted and need only 
be mentioned in passing. Opinions appear to differ 
as to the frequency with which Bronchitis and Broncho - 
(27) 
pneumonia occur. Goodall states that Bronchitis is 
not uncommon in children and Broncho- pneumonia may 
supervene. Price) lays it down that neither Bronchitis 
not Broncho -Pneumonia is common, but that Aspiration 
(73) Bronoho- Pneumonia, may occur in septic cases. Tidy 
believes/ 
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believes that Bronchitis frequently complicates the 
(36) 
disease. Ker notes that Broncho- Pneumonia may play 
some part in causing death in septic cases and rarely 
is it seen during the desquamative period in ordinary 
cases. His experience is that this complication is 
usually trivial, comparing it to the type of lung 
complication found in Measles and Whooping Cough. 
Oedema of the lungsmay be seen during the course 
of acute nephritis. In this connection, it is inter- 
esting to remember that pilocarpine was at one time 
used very considerably in inducing increased action 
of the skin in cases of acute nephritis with a greatly 
diminished secretion of urine. Pyaemic infarction 
of the lung sometimes occurs in the rare condition of 
Lateral Sinus Pyaemia. Lobar Pneumonia is extremely 
rare and of correspondingly extreme gravity. 
All forms of paralysis as well as peripheral 
neuritis have been noted as complications of Scarlet 
Fever. Other nervous and psychical phenomena occur, 
among them being Chorea, Tetany and Manaic- ,Depressive 
Insanity. With reference to Chorea, the writer has 
several times noted the development of Chorea in 
young Scarlatinal patients who have some considerable 
time previously suffered from this toxic nervous 
disability, as ascertained by reference to their 
school medical cards. 
Diphtheria/ 
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Diphtheria is a not uncommon complication of 
Scarlet Fever, apart from the cases which at the 
outset are found to be a combination of the two 
(36) 
diseases. Ker writes, in this latter connection, 
that as many as from 10% to 15% of Scarlet Fever 
patients have been found in different years, in the 
Edinburgh City Fever Hospital, to give positive 
results when swabs have been examined, on admission, 
for the presence of Diphtheria Bacilli. When de- 
veloping in the convalescent stage, its incidence 
is probably closely bound up with the "carrier" 
question. Suppurative tonsillitis or secondary 
sore throat is not at all uncommon in children, pro - 
bably about 3.0% being so affected, although Goodall 
says it is rare. It may be very severe and accom- 
panied by rhinitis and even suppurative adenitis. 
Retropharyngeal abscess may co- exist. The mouths 
of convalescent children appear to be liable to 
ulceration of the mucosa, causing considerable general 
upset from difficulty in eating. 
(36) 
I am encouraged by Ker's submission of the not 
infrequent occurrence of Jaundice as a complication 
of Scarlet Fever. Quite a few writers do not mention 
this condition at all and most others simply include 
it in the list of very rare events in the course of 
the disease. In the introductory chapter of this 
thesis, the question of "ward epidemics" was mentioned 
and,/ 
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and, although I cannot account for it in any really 
satisfactory manner, I have had, on two occasions, 
"ward epidemics" of jaundice in connection with 
Scarlet Fever. The degree of pigmentation has always 
been comparatively slight but quite definite. 
Percentage of Total Complications:- Few of the 
authorities on Scarlet Fever give the incidence of 
total complications of the disease in the form of a 
percentage, but fairly accurate estimates can, of 
course, be obtained by adding together the figures 
quoted for individual complications. According to 
this method, it is found that Ker's total complica- 
tions (not complicated cases) would be just over 40%; 
Goodall, Price, Savill and Tidy are found to be in 
comparatively close agreement with this figure. 
Cushing) states that, previous to the introduction of 
antitoxin treatment, 45% of cases were complicated. 
(26) 
Gibson found only 26% of complications in his cases, 
but the number dealt with was comparatively small, so 
that no useful purpose is served by considering this 
figure. During an epidemic of the disease, which 
is apparently one of uniformly greater severity in 
(14) 
Warsaw than in our cities, Chodzko reported that 50% 
of cases were complicated. Probably the average 
text book figure of 40% is a reliable one. 
Septic Cases:- The occurrence of this type of 
Scarlet Fever would, at first sight, appear to negative 
the/ 
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the opinions of those authorities who lay it dorm 
that the toxic action of the Streptococcus scarlatinae 
is necessary to prepare the way for the later pyogenic 
invasion. But "septic" does not imply a condition 
of septicaemia, but simply an exaggeration of the 
local septic process in the throat and associated 
structures. The ordinary toxic symptoms and signs 
of Scarlatina are present, but with their abatement, 
there is no parallel improvement in the throat con- 
dition. Septic Scarlet Fever is seen in its most 
devastating form in children and especially in those 
about the age of five or six years. The case mort- 
ality is very high, and those who recover do so after 
a very protracted convalescence. In the older 
editions of his work on Infectious Diseases, Ker was 
of the opinion that Septic Scarlet Fever appeared 
to owe its clinical signs to a secondary infection 
with pyogenic organisms and that death, so frequent 
in this class of case, was the result of Septicaemia 
rather than of infection with scarlatinal germs. 
Now that a haemolytic streptococcus has, beyond all 
reasonable doubt, been identified as the causative 
organism of Scarlet Fever, it is no longer necessary 
to postulate secondary pyogenic invasion. 
(27) 
Toxic Cases : - Goodall's experience is that few 
sufferers from Toxic Scarlet Fever recover. This 
f orm/ 
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form of the disease is always fatal in children and 
(36) 
the duration seldom exceeds two days. Ker describes 
various types and is of the opinion that this form 
of Scarlet Fever practically never constitutes more 
than 1% of cases. He is in agreement with all other 
authorities that the condition is a very fatal one. 
Length of Stay in Hospital : - As early as 1911, 
Dr Lauder of Southampton considered 28 days to be a 
sufficient minimum period of detention in hospital 
for Scarlet Fever patients and in 1914 he reported 
that the average length of stay per patient was from 
32 to 36 days. Moore of Huddersfield appears to 
have had extraordinarily good fortune as the result 
of reducing the minimum period to 28 days, for he 
attained the highly commendable, if somewhat incred- 
ible, average duration of stay per patient of 29 days. 
(53) 
In a special article on Scarlet Fever and Diphtheria 
in Aberdeenshire, the figure of 37.7 days is quoted, 
the minimum period being again 28 days. 
Return Cases:- The elapse of a period of not 
more than 28 days is the one generally accepted in 
tabulating "return" cases, which are considered by 
some authorities to constitute some 3% or 4% of all 
Scarlatinal cases. Personally, I have never found 
more than 1.5% in which definite evidence of in- 
fection/ 
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infection from a previously discharged case could be 
established. In this connection, two interesting 
episodes occurred Quite recently. A maid was required 
in the Fever Hospital and one of the applicants, who 
was unsuccessful, was the sister of a patient admitted 
with Scarlet Fever seven days later. This is not, 
of course, an instance of what would have been a 
"return" case, but it is an example of co- incidence, 
for, if the above applicant had been successful in 
obtaining employment at the Hospital and had paid a 
visit to her home before her sister's admission with 
Scarlet Fever, it would have been difficult to con- 
vince the parents that the infection had not, in fact, 
been conveyed directly from the institution to their 
home. The second case is even more striking: 
A girl was discharged at 10 a.m. after an attack of 
Scarlet Fever and her sister was admitted with the 
same disease in the afternoon. Instances of this 
kind could be multiplied almost indefinitely and 
probably comprise a not inconsiderable proportion of 
"return" cases. 
The length of the period of isolation in Scarlet 
Fever and the percentage incidence of "return cases" 
do not vary in inverse ratio. Indeed, many observers 
are of the opinion that the shortening of the minimum 
detention in Hospital to 28 days has had the effect 
of/ 
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of lowering the percentage of "return" cases. But, 
nevertheless, one cannot help feeling a little un- 
comfortable when a "return case" is admitted, for, 
although to the initiated, there is really no re- 
flection on the persons concerned in the discharge 
of the infecting case, yet the general public form 
strong opinions on the subject. There seems to be 
little doubt that the persistence of catarrh of 
mucous membranes is the most important factor in 
such infections and in winter particularly, patients, 
who are apparently incapable of conveying infection 
at the time of discharge, do harbour the Streptococcus 
scarlatinae, whose virulence may be suddenly increased 
by a recurrence of catarrh after discharge. 
Cameron carried out investigations on behalf of 
the M.A.B. and found that about 4% of discharged 
Scarlet Fever patients were still infectious and the 
percentage was much higher in those affected with 
enlarged tonsils and adenoids. Stevens and Dochez 
examined a large number of throats of Scarlet Fever 
patients who had been in hospital for one month and 
they found the Streptococcus scarlatinae in 47.3 %. 
The majority of cases examined had inflamed tonsils. 
The presence of residual desquamation in dis- 
charged cases has been considered by some authorities 
as a contributory cause of "return" cases, but there 
appears/ 
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appears to be little ground for continuing to regard 
this matter seriously. Moore of Huddersfield has 
pointed out that, instead of there having been an 
increase in the number of "return" cases following the 
discharge of incompletely desquarnated scarlatinal 
patients, the number has actually decreased. 
If the matters discussed in this chapter are 
materially bound up with the efficiency of any therapy 
in the disease, as the writer most assuredly believes 
they are and if the Antitoxic Serum Therapy of Scarlet 
Fever is specific, then there should be, - other de- 
tails such as dosage, day of disease on administration 
of serum, potency and properties of the serum being 
carefully considered, - undeniable evidence that real 
benefit accrues in the disease in all its varied 
manifestations and implications. It is now the 
writer's intention to analyse minutely the effect 
of Antitoxic Serum Therapy on 106 definitely diagnosed 
cases of Scarlet Fever and compare them with the 
foregoing and with the findings of various workers. 
85. 
OBSERVATIONS ON SCARLET FEVER AND 
ITS SPECIFIC THERAPY. 
V. THE ANTITOXIC SERUM TREATMENT OF SCARLET FEVER:- 
PRELIMINARY. 
Before commencing the analytical study 
of this form of therapy, certain preliminary details 
are worthy of some consideration, namely: - 
(1) The uniformity in potency of the serum used. 
(2) Dosage. Should all cases be treated with serum? 
(3) Method of administration: 
(a) In normal patients. 
(b) In sensitised patients. 
(4) Day of disease on which the therapy is instituted. 
(5) Serum rashes and Anaphylaxis. 
(6) The dangers of sensitisation. A means of recog- 
nising serum -treated patients. 
(1) Potency: -- The preparation of an anti- 
serum for Scarlet Fever has been carried out in 
(66) 
different ways by different workers. Dochez may be 
considered the pioneer in the production of a specific 
antitoxic serum, which he carried out by the actual 
inoculation of the Streptococcus scarlatinae into 
agar media, which had previously been introduced 
aseptically into the cellular tissues of a horse's 
neck/ 
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neck. Drs George and Gladys Dick used increasing 
doses of sterile filtrate obtained from the Strepto- 
coccus scarlatinae. Both of those sera were entirely 
antitoxic in character. In 1925, Messrs Parke Davis 
& Company attempted to produce and claimed to have 
produced an antibacterial and antitoxic serum. Other 
reputable firms and notably Messrs Burroughs Wellcome 
and Company quickly took up the study of this new 
therapy and set about preparing specific antiserum. 
Whether any serum prepared from the bacterial antigen 
of the Streptococcus scarlatinae is really antibacterial 
is a matter for grave doubt. But as the initial symp- 
toms of Scarlet Fever are those of toxaemia, it is 
the antitoxic content of a given serum which is 
important in early treatment. 
At first, Scarlet Fever Antitoxin was unconcen- 
trated and this probably accounted for the large 
number of cases of serum rash recorded by early 
observers. Previous experience with concentration 
methods for Diphtheria Antitoxin soon pointed the 
way to a suitable technique for similar elimination 
of the major protein fraction in the new antitoxin. 
Pick and Atkinson had shown that antitoxins were 
present in the globulin fraction of an immune serum. 
Later, Gibson and Banzhaf showed that it was the 
pseudoglobulins with which the antitoxin was closely 
associated and they described a method of fractioning 
blood/ 
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blood serum to obtain increased antitoxic properties 
in a smaller volume. Banzhaf further modified the 
technique, so that an antitoxic serum containing from 
four to six times the original quantity of antitoxin 
in a given volume was obtained. Such a serum only 
contained about half the quantity of protein found 
in the same volume of unconcentrated serum. 
So far, the procedure in the preparation of 
Scarlet Fever Antitoxin presents no great difficulties, 
but when the question of standardisation is approached, 
th(rre)are barriers which have not yet been surmounted. 
Robb of Belfast says "The fact that the ordinary 
laboratory animals cannot be made use of to measure 
the antitoxic value of the serum is a great handicap ". 
He goes on to say that because human beings have to 
be used in testing and because even with this test 
there is such a great margin of error in estimating 
potency, he is afraid that serum of low antitoxic 
value may find its way on to the market. In this con - 
(58) 
nection, Okell points out that probably comparatively 
few people, especially in the older age groups, can 
be taken as being virgin soil so far as scarlet fever 
infection is concerned. 
Two principal methods have generally been utilised 
in estimating the potency of Scarlet Fever Antitoxin 
(a) The Schultz Charlton Test (b) Neutralisation of 
a known toxin. 
In/ 
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In the case of the Schultz Charlton test, it is 
estimated that even where definite and apparently com- 
parable results are obtained, the error is much too 
great to allow any reliance to be placed on it in 
estimating the antitoxic content of curative serum. 
In addition, the Schultz Charlton test is not positive 
in 100% of cases. This may be due, as Smith says 
in an article in the Journal of Hygiene, to the 
division of the Scarlet Fever group of Streptococci 
into several sub-groups, as is found in carrying out 
(60) 
agglutination tests. Park has also pointed out that 
there may be groups of Scarlet Fever Streptococci which 
produce toxins, not identical but having an antigenic 
overlap. 
(b) Neutralisation of a known toxin: - 
Drs McCoy and Dyer of Washington prepared an antiserum 
of high antitoxic content in 1926 and this is issued 
as a provisional standard serum, pending the finding 
of some really satisfactory method of evaluating anti - 
(78) 
toxin. Prior to this, Wadsworth, Kirkbride and Wheeler 
suggested an antitoxin unit, namely the amount of anti- 
toxic serum which will neutralise 100 skin -test doses 
of toxin. This is analogous to the unit for other 
antitoxins, substituting skin -test doses in human 
beings for minimum lethal doses in the standard guinea - 
pig. This unit is quite unsatisfactory, because of 
the great variability of the reaction obtained in 
susceptible individuals on injecting a skin -test dose 
of/ 
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of toxin. The latter itself is only an empirical 
quantity, being 0.1 c.cm. of a 1 -1,000 dilution of 
Dick toxin. Even when the same individual is used for 
repeated experiment, it is found that the minute doses 
of tóxin produce, in time, refractory phenomena. 
In the same article, the three workers mentioned above 
state that white goats may be used very satisfactorily 
(59) 
for skin tests) but Parish and Okell do not agree that 
any reliance may be laid on the results in those 
animals. 
The potency of Scarlet Fever Antitoxin is there- 
fore to be regarded as quite empirical and reliance 
has to be placed on its therapeutic effects in the 
disease itself as a gauge of its antitoxic content. 
This is highly unsatisfactory but inevitable at 
present. For this reason, it is important to procure 
the serum from firms of high standing, in order to 
ensure a more or less constant level of therapeutic 
value. My own observations lead me to prefer Messrs 
Burroughs, Wellcome and Company's serum, because of 
the much less evident disagreeable sequelae of the 
therapy using their preparation. I do not know whether 
this firm succeeds in reducing the protein content to 
a lower level than do Messrs Parke, Davis & Company 
but my experience, in using antitoxins prepared by 
the last mentioned firm, both for Diphtheria and 
Scarlet Fever, convinces me that serum reactions are 
much/ 
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much more common than when the English firm's prepara- 
tions are employed. 
In dealing with a new batch of Scarlet Fever 
Antitoxin, I always test it against the remnant of a 
previous batch, comparing the Schultz- Charlton re- 
actions carefully. I know that this method is not 
at all scientific, but I am bound to admit that the 
apparent constancy of antitoxin content is quite 
remarkable. The difference in the percentages of 
serum reactions produced by the sera of the two firms 
mentioned does not seem to me to be accounted for by 
any difference in therapeutic worth. 
(2) Dosage:- Before the advent of Anti- 
toxic Serum prepared by actively immunising the horse 
against Scarlet Fever, Reiss and Jungman recommended 
the intravenous injection of 50 cc. to 100 cc. of 
pooled convalescent serum. Zingher advocated even 
larger doses, up to 200 cc., intramuscularly. 
Parkl)observes that fresh normal blood injected intra- 
venously in doses of 120 cc. to 240 cc. and repeated, 
if necessary, in three or four days has shown very 
beneficial effects in some desperately ill cases. 
The original Dochez.Serum was unconcentrated and 
in sending a supply to Robb) of Belfast, a dose of 
30 cc. to 40 cc. was recommended. This antitoxin 
was later produced in a concentrated form and the 
dose/ 
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dose now advocated was 20 cc. Still later, the dose 
was reduced to 10 cc. Peters2and Allison used from 
10 cc. to 40 cc. of the concentrated antitoxin, 
according to the severity and duration of the disease. 
(3) 
Banks used a uniform dose of 10 cc. during an epidemic 
in a Public School, but every case was treated intra- 
venously, instead of by the usual intramuscular method. 
(2) 
Later, he modified the dose, but not the method of 
administration, giving children from 5 cc. to 10 cc. 
of the Parke Davis Serum, and adults from 10 cc. to 
(50) 
20 cc. McGarrity recommends doses of 10 cc. to 20 cc. 
of concentrated antitoxin or 40 cc. of the unconcentra- 
(15) 
ted type. Craig treated Scarlatina Simplex with 
10 cc. of specific antitoxin; toxic cases were given 
20 cc. and septic cases had a mixed serum therapy, 
consisting of 10 cc. of Scarlet Fever Antitoxic Serum 
and 50 cc. to 100 cc. of Polyvalent Antistreptococcic 
Serum. Harriès3considered 12 cc. of the usual con- 
centrated antitoxin an adequate dose. Where he had 
employed the earlier unconcentrated variety, he gave 
25 cc. Cushinglrecords the clinical course of the 
disease in 500 patients treated by intramuscular 
injection of a uniform dose of 10 cc. 
(27) 
Goodall says that the exact dose of Scarlet Fever 
Antitoxin is far from being settled, but that up to 
the present, doses of from 10 cc. in moderately severe 




employed. Ker mentions the same ratio in dosage and 
states that a second or third dose should rarely be 
necessary, if the first dose is an adequate one. 
(65) 
Price defines the limits of dosage very narrowly, 
recommending the early administration of 10 cc. to 
15 cc. 
Messrs Burroughs, Wellcome & Company suggest 
10 cc. in mild cases and from 20 cc. to 50 cc. in 
severe forms of the disease. 
In my earlier acquaintance with the specific 
therapy of Scarlet Fever, I used fairly large doses, 
up to 30 cc. or 40 cc., but I have formed the opinion 
that there is nothing to be gained by giving the 
ordinary case more than 10 cc. and rarely is it neces- 
sary in any case to increase the dose above 20 cc. 
in severe attacks of Scarlatina. But, as has already 
been xention 4 in an earlier chapter of this treatise, 
t oft- >n the greatest difficulty in prognosing 
in So ar ! e' `r ;7,- r . Cases are seen which appear 
ielentioa -,. t their initial clinical manifestations, 
yet ono r to antitoxin in a very satisfactory 
way while , %Mor appears little improved, even after 
an intorvai of §eventy -two hours. The theory of 
uni on iaa ; toxins is a fascinating one in such in- 
etAnce §, but I havo seen a number of cases of this 
typo an4 i in lie one in the series under review - 
whore/ 
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where a second dose of antitoxin from the same batch 
produced quite a dramatic change for the better. 
In my opinion it is unnecessary, as a rule, to 
make any great modification in the dose of antitoxin 
for children as compared with adults. If the body 
weight is less, the intensity of the toxaemia seems 
to warrant a greater antitoxin content per kilogramme. 
Doses of less than 10 cc., given intramuscularly, 
seem quite inadequate. One of the cases included 
for discussion was apparently a very mild one and was 
given 5 cc. Scarlet Fever Antitoxin, only to require 
an additional 10 cc. next day, because there was no 
observable improvement in the patient's condition. 
I am inclined to agree with Craig, that certain 
septic cases are much benefited by a combined therapy 
of Scarlet Fever Antitoxin and Polyvalent Antistrepto- 
coccic Serum. Indeed, where the throat symptoms and 
signs have predominated out of all proportion to the 
general toxaemia after 48 hours or so, I have repeated 
the polyvalent serum with very encouraging ameliora- 
tion of the septic process. 
The co- existence of Diphtheria and Scarlet Fever 
is probably less of a rarity than is sometimes stated 
and where the clinical picture has left some doubt 
as to the presence of diphtheria, I have not hesitated 
to give Diphtheria Antitoxin along with Scarlet Fever 
Antiserum. The reliability of the bacteriological 
diagnosis/ 
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diagnosis of Diphtheria when combined with Scarlet 
Fever leaves something to be desired. On not a few 
occasions I have given Diphtheria Antitoxin in sus- 
picious cases, only to receive a negative laboratory 
report from both the direct swab and the examination 
of cultures. In a large percentage of these, however, 
I have had the accuracy of the clinical diagnosis 
strongly supported by what I believe to be a very 
important sign of the disease, namely the slowing of 
the pulse to 60 or even 50, exhibited between the 
seventh and tenth days of disease. This bradycardia 
may be due to an actual stimulation of the vague nerve 
by the diphtheria toxin or it may be a relative vagal 
preponderance due to the intoxication of the sympa- 
thetic innervation of the heart. 
The inclusion of polyvalent antistreptococcic 
serum and Diphtheria antitoxin in the treatment of 
patients does not vitiate the conclusions to be drawn 
from the specific therapy of the disease itself. 
The co- existence - it might well be called accidental 
co- existence - of the pathological results of some 
other organism or organisms cannot possibly be affected 
by any therapy which is specific for one particular 
invader. If Scarlet Fever Antitoxin is to be given 
an even chance of proving its worth, conditions which 
are not due to the Streptococcus scarlatinae must be 
eradicated by intelligent therapy. 
The/ 
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The mildness of many cases of Scarlet Fever has 
caused the question to be asked:- Should Scarlet Fever 
(67) 
Antitoxin be used in all cases? Dr J.D. kolleston, 
addressing the Nottingham Medico- Chirurgical Society 
on 4th January 1928, gave it as his opinion that the 
antitoxin treatment of Scarlet Fever was of great 
value, but need not be employed except in cases of 
(51) 
some severity. McLachlan and Hunter mention in 
their tabulated study of the effects of specific 
therapy in Scarlet Fever that "chiefly for reasons 
of economy, it has been restricted to the severe and 
complicated cases." This seems to imply that those 
two observers considered the routine serum treatment 
(57) 
of Scarlet Fever desirable. O'Brien subscribes to 
the view that all cases should receive antitoxin when 
he says "The large amount of evidence available has 
convinced practically all observers that Scarlet Fever 
Antitoxin is a specific curative serum, and that, 
given early in the disease, its beneficent action 
approaches that of the specific antitoxin used in 
diphtheria." Dr O'Brien further points out that it 
is the antitoxin content of the serum which is im- 
portant and that there is no evidence of any useful 
therapeutic purpose having been served by sera reputed 
to be antibacterial. Banks of Leicester is a strong 
advocate for the universal adoption of specific 




says that in cases in which serum is administered 
early - as it should be - and the disease runs a mild 
course, it cannot be determined whether the illness 
was originally of a mild type or whether the serum 
modified its severity. This comment is quite scien- 
tific, but it is equally true that many mild cases 
develop complications if not treated with antitoxin, 
so that a uniform absence of septic sequelae in early 
serum -treated mild cases would argue in favour of the 
administration of Scarlet Fever Antitoxin to all 
(24) 
patients suffering from the disease. Flusser has 
treated all Scarlet Fever patients with antitoxin 
since 1926 and he says that if the administration of 
the therapy is sufficiently early and is adequate, 
every case reacts satisfactorily to this form of 
treatment. Brookerr states that the real value of 
serum in Scarlet Fever is in treating the early toxic 
stage of the disease. Scott °used Scarlatinal Anti- 
toxin for the most severe cases of the disease only. 
(55) 
Meyerdierks concluded from his observation of specific 
therapy that antitoxic serum should be given in every 
case of Scarlet Fever in the febrile stage. 
Harries)records the clinical course of 1071 cases 
treated with Scarlet Fever Antitoxin in 1926 and 
gives it as his formed opinion that convalescence in 
Scarlet Fever is definitely shorter when specific 
therapy/ 
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therapy is employed. Attempts have been made to 
tabulate clinically the type of case which should be 
(43) 
treated with Antitoxin., and Lenthe mentions that 
temperatures exceeding 102 °F. in adults and reaching 
101.4 °F. in children are indications for the admin- 
istration of serum. In the same treatise, this 
observer notes that the resultant feeling of well- 
being was a marked feature, as expressed by the patients 
(43) 
treated. Lenthe does not find that every case reacts 
objectively in an entirely satisfactory manner. 
(34) 
Husler used Scarlet Fever Antitoxin on 34 cases of 
moderate severity and is emphatic in stating that the 
serum had a remarkable effect on the toxaemia of the 
disease. He does not consider that mild attacks 
(6) 
need be treated with Antitoxin. Benson and 1iiaciver 
state that septic cases did not appear to benefit from 
s) 
specific antitoxin. Banks and Mackenzie give a 
report on 404 cases treated, intravenously for the 
most part, and are eulogistic in their praise of this 
special method of employing the antitoxin. They 
describe the beneficial results as being quite dramatic. 
(75) 
Toomey and Dolch are inclined to the opinion that 
when given intramuscularly there is very little real 
benefit to be gained from the antitoxin, although the 
period of toxicity appears to be slightly reduced 




records that twice as many multiple complications 
occurred in untreated, as compared with treated cases. 
His series of cases included ten Septic and two Toxic, 
all of which recovered. As mentioned previously, 
Craig included polyvalent anti- streptococcic serum 
in the treatment of Septic Scarlet Fever. Friedemann 
and Deicher at first reserved Antitoxin treatment 
for severe cases, but later observations convinced 
them that all definite cases of Scarlet Fever should 
be given the benefit of serum, for, although the 
initial signs and symptoms might suggest a mild attack, 
such cases might become quite serious later, if un- 
(79) 
treated. Yoannovitch supports the routine treatment 
of all cases of Scarlet Fever by means of Antitoxin 
when he says that in nearly all the cases so treated 
there was a resulting decrease of the temperature and 
a notable improvement in the patients' general con - 
(83) 
dition. Zoeller, on the other hand, enlarges on 
the dangers of serum sickness and the undesirability 
of sensitisation to horse serum of patients in whom 
the disease is mild. 
From the foregoing, it may be said quite justly 
that the majority of the workers quoted are definitely 
in favour of the universal administration of Scarlet 
Fever Antitoxin in all definite cases of the disease. 
If I could, by my own observations, convince myself 
that/ 
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that a case which begins mildly will remain true to 
its colours, I think I should agree that specific 
therapy should be withheld in such, but I am repeat- 
edly reminded by hard facts that prognosis in Scarlet 
Fever is one of the most difficult things in Medicine; 
indeed, to give anything approaching a definite 
prognostic opinion involves taking a "long chance ". 
Entirely on scientific grounds, in spite of seeming 
inconsistencies in the results of this form of treat- 
ment, a definite position in favour of universal 
specific therapy must be taken up, for if, as has 
been generally agreed by eminent scientists, the 
toxin of the Streptococcus scarlatinae is a specific 
toxin and is responsible for the toxic stage of the 
disease, nothing but benefit for the patient can 
accrue from the neutralisation of that toxin by its 
specific antitoxin. 
(3) Method of Administration:- 
For ordinary cases of Scarlet Fever, especially in 
children, there appears to be little to be gained by 
using any other than the intramuscular route in 
giving Antitoxin. Intravenous injection in young 
subjects is a difficult procedure and however expert 
the operator, restlessness of the patient may be 
difficult to control. The strain on the child is 
much greater in employing intravenous therapy and 
apprehension/ 
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apprehension is increased. By this method, antitoxin 
must be given more slowly than when intramuscular 
injection is used and there is a much greater likeli- 
(3 & 4) 
hood of severe serum reaction. But Banks is def- 
initely of the opinion that the intravenous admin- 
istration is the method par excellence in all cases 
and it must be admitted that his results are striking. 
In using serum intramuscularly, I have always 
employed the rapid "stab" method which is largely 
used by Syphilologists in administering mercurial 
preparations and I have repeatedly succeeded in 
having finished the operation without the patient 
(27) 
being aware that anything had taken place. Goodall 
dislikes this route, because of the risk of abscess 
formation. I have yet to see an abscess from giving 
antitoxin into the gluteal muscles and I attribute 
my apparent good fortune to two ordinary precautions. 
First, the serum must be given into the actual 
muscles and not into the thick gluteal pads of fat; 
and second, gentle massage of the superficial 
structures on the deep ones by means of a firm pad 
causes rapid diffusion of the antitoxin as well as 
expediting its absorption. 
The subcutaneous method, preferred by Goodall, 
must be a little tedious, and it is difficult to 
understand why the great tension of the very super- 
ficial tissues into which he chooses to introduce 
the serum is not more likely to lead to abscess 
formation,/ 
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formation, because of the very slow absorption, than 
is any temporary and rapidly diminished disturbance 
in the deep and well supported muscular strata. 
(36) 
her takes a very sane view in recommending the intra- 
muscular route as the one of choice except in toxic 
cases, when the intravenous administration should be 
(75) 
practised. Toomey and Dolch describe the much 
accelerated action of the serum when given intra- 
venously. 
Various workers describe their own particular 
methods of dealing with cases already sensitised to 
horse serum. One which I have found to be admirably 
suitable is to give 0.1 cc. subcutaneously first and 
then 1.0 cc. intramuscularly, repeated at hourly 
intervals for two injections. At the end of three 
hours, I gave the remainder of the dose of antitoxin 
and there has never been any untoward result. It is 
interesting that I have on record about a dozen cases 
where, because of the inaccuracy of the previous 
history of the patients, it was unknown to me that 
Diphtheria Antitoxin had been required in the past. 
All of these were treated with Scarlet Fever Anti- 
toxin, without desensitisation and in only one case 
were there any anaphylactic phenomena observable. 
The case which did react certainly caused considerable 




All the series of cases collected for this 
treatise have been given antitoxin by the intra- 
muscular method. 
(4) Day of Disease on which Serum Therapy is institute:- _____________ 
The early symptoms and signs of Scarlet 
Fever are those of a toxaemia, which must necessarily 
increase in intensity until the antitoxins of the 
tissue -fluids and the blood are sufficiently mobilised 
to deal effectively with the condition. This active 
immunity may be greatly assisted in the early phase 
of its production by inducing a co- existent passive 
immunity. It is therefore reasonable to presume 
that the earlier the administration of specific 
antiserum, the greater is the help afforded in over- 
coming the general intoxication. 
The greatest drawback to the really efficient 
antitoxin treatment of Scarlet Fever is the fact 
that the average day of disease on admission to 




Average Day of Disease on Admission. 
Age Group. ¡ 
1 - 5 yrs. 
Sex. 
F 
5 - 10 " 
F 
10 - 15 " 
F 
15 - 25 " 
25 - 35 " 
F 















Average for all, patients 3.0 
Some authorities consider that the clinical 
course of the disease is directly related, so far 
as the incidence of complications is concerned, to 
the promptness of the administration of Antitoxin. 
Such a statement must be qualified by adding that 
after the first five days of illness, the results of 
antitoxin treatment are so negligible that the time 
of giving becomes unimportant. By the fifth day, 
many patients give a negative reaction to the Dick 
Test/ 
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Test, from which it may be deduced that they now have 
a sufficiency of antitoxin in their blood and tissues 
fluids and are unlikely to benefit from further add- 
itions to their store of antibodies. In this con - 
(6:) 
nection, Peters and Allison found, in Dick -Testing 
131 Scarlet Fever patients on the third day of disease, 
that 67 were already negative, i.e. 51 %. Their work 
suggests that the first two days of illness constitute 
the most important period in the administration of 
specific antitoxin, if favourable results are to be 
anticipated. This view is strongly supported by 
(51) 
McLachlan and Hunter, who found that in 13 cases 
treated on the first day of disease, only 1 was com- 
plicated. Of those treated on the second day of 
disease, nearly 15% showed complications; thereafter, 
the percentage of complicated cases was approximately 
20% for cases where it had not been possible to give 
serum until the 3rd or 4th day of disease. 
On the other hand, because a case of Scarlet 
Fever is not seen, with a view to specific therapy, 
until the 3rd or 4th day of disease, there is no reason 
for withholding the therapy and almost certainly some 
benefit is derived from it. McGarrity notes that 
particularly in toxic cases, he has noticed a great 
change for the better after intramuscular injections 
on the third day of illness. 
The/ 
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The prevention of complications cannot be said 
to be the immediate effect of Antitoxin Therapy, which 
is primarily concerned with the toxic manifestations 
of the disease. The effect on the temperature may 
be regarded as a gauge of the efficacy of the treatment 
and it is definitely found that the rate of subsidence 
of the patient's temperature is, broadly speaking, in 
direct ratio to the day of administration of Scarlet 
(66) 
Fever Antiserum. Robb of Belfast goes so far as to 
say that, given early, antitoxin had completely aborted 
(81) 
cases of the disease. Zikowsky records a very favour- 
able impression gained during the use of Scarlet Fever 
Antitoxin, stating that in over half the number of 
cases treated, the temperature was normal or nearly 
(7) 
so in less than twenty -four hours. Bipoli concluded 
from his observations that when given within three 
days of onset, the most constant effect was a markedly 
beneficial one, especially in severe and toxic forms 
(-17) 
of the disease. Drs George and Gladys Dick note that 
in early treated cases, the temperature falls and there 
is general improvement within twenty -four hours. They 
further mention that only in one of sixty -four cases 
of Scarlet Fever, where antitoxin was given on the 
first day of disease, did any complication arise. 
In the same series of cases, five developed ear com- 




day of disease. Cushing upholds the definite relation 
of the time of giving antitoxin to the observed effects, 
saying that if given early, there is a marked fall in 
the temperature and a definite reduction in the pulse 
(24) 
rate in 12-36 hours. Flusser, although he found that 
cases receiving treatment late in the course of disease 
were not benefited, states quite definitely that no 
single case failed to react satisfactorily if adequate 
early treatment was given; even severe attacks showed 
a fall of temperature and a lessening of the toxicity. 
(6) 
Benson and Maciver show that a much larger percentage 
of patients have a rapid reduction in temperature if 
treated on the first or second day of illness than is 
noted in those who have had serum given on the third 
(25) 
day. Friedemann and Deicher appear to incline to the 
belief that as many as 60% of patients, treated so late 
as the fifth day of disease, derive definite benefit 
from the therapy, with regard to temperature. It is 
difficult to give an opinion on the value of such an 
observation, since a very large proportion of Scarlet 
Fever cases have approximately normal temperatures by 
the evening of the fifth day. 
Many other workers have given valuable analyses 
of the results of Specific Therapy in Scarlet Fever and 
have concluded that the treatment should be commenced 
early, but a number of them do not detail any stat- 
istical synopsis of their findings, arranged according 
to the day of administering serum. The following 
tables/ 
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tables show the writer's findings with reference to 
differences in the course of disease, as a result of 
specific treatment, instituted on various days of 
disease. 
(1) Day of Disease on which Scarlet Fever Antitoxin 
was given. The numbers signify cases, and the 
table is arranged for each Age and Sex Group:- 
Age Group. Sex. 
Day of Disease. 
1st 2nd 3rd f Later than 3rd 
1 - 5 
M 2 6 4 5 
F 3 2 3 6 
5 - 10 
M 1 5 2 
F 2 5 7 3 
10 - 15 
M - - 2 - 
F 1 3 - 2 
15 - 25 
M - 1 4 4 
F 1 4 7 10 
25 -35 
M - - 2 1 
F - 3 - 3 
35 - 45 
M - - _ 
F - 1 _ - 
108. 
This tabular representation shows that only 
10 cases out of 106 cases were treated with antitoxin 
on the first day of the disease, but 40 cases actually 
had specific therapy no later than the second day. 
In passing, it may be noted again that the number of 
female cases exceeds that of males in all the age 
groups above 1 -5 years. 
(2) Periods and Average Periods elapsing between 
the administration of Scarlet Fever Antitoxin 
,for (a) Total Cases (b) Total Males (c) Total 
Females) and the return of the temperature to 
normal, when the antitoxin was given on the 
first day of disease. 
Cases. period ela s n:. 
verage Period 
elapsing. 
1 2 3 4 5 6+ 
Description No. Day Days Days Days Days Days 
Total 
Cases 10 2 4 3 - 1 - 2.4 Days 
Total 
Males 3 1 2 - - - - 1.7 Days 
Total 
Females 7 1 2 3 - 1 - 2.7 Days 
It is seen that 9 cases out of ten (i.e. 90%) 
had a normal temperature by the evening of the fourth 
day. This must be considered to be due to the treat- 
ment, for though various observers have said that they 
have/ 
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have yet to see a series of antitoxin treated cases 
which could not be matched by results in untreated 
cases, 
it is usually agreed by text book authorities and all 
who have an intimate knowledge of Scarlet Fever that 
from five to seven days are commonly required for the 
subsidence of the temperature. 
(3) Periods and Average Periods elapsing between the 
administration of Scarlet Fever Antitoxin 
(for (a) Total Cases (b) Total Males (c) Total 
Females) and the return of the temperature to 
normal, when the antitoxin was given on the 
second day of disease. 
















Cases 30 4 10 10 4 - 2 2.8 Days 
Total 
Males 12 2 6 4 0 - - 2.2 Days 
Total 




- 2 3.2 Days 
When antitoxin was given on the second day of 
disease, 24 cases out of 30 cases (i.e. 80%) had normal 
temperatures by the end of the fifth day, a result 
which is certainly unusual in untreated cases of 
Scarlet Fever. What is more significant is that 
whereas/ 
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whereas 90% of those treated on the first day of dis- 
ease had normal temperatures by the evening of the 
fourth day, only 47% of cases receiving antitoxin on 
the second day succeeded in establishing normal temper- 
atures by the end of the same time- limit. 
(4) Periods and Avorage Periods elapsing between the 
administration of Scarlet Fever Antitoxin 
(for (a) Total Cases (b) Total Males (c) Total 
Females) and the return of the temperature to 
normal when the antitoxin was given on the third 
day of disease. 

















Cases 31 8 14 3 3 1 2 
Total 
Males 14 4 5 1 1 1 2 2.9 Days 
Total 
Females 17 4 9 2 2 - - 2.1 Days 
In this series, 22 cases out of 31 cases (i.e. 
71%) had normal temperatures by the end of the fifth 
day. There is thus a percentage decrease when com- 
pared with cases treated on the second day of disease 
(i.e. 80%) . The difficulty in influencing the fall 
of temperature by means of serum given on the third 
day/ 
day of disease is made even more evident by the further 
rapid diminution in the percentage of cases having 
normal temperatures at the end of the fourth day of 
disease. As is seen, only 8 cases (27%) reacted 
sufficiently to make this possible. So far, the 
tables go to show that each day of delay in diagnosing 
Scarlet Fever which is to be treated specifically, 
reduces the likelihood of the temperature being normal 
by the end of the fourth day by 50%; in other words, 
cases treated on the second day of disease give approx- 
imately only half the number of normal temperatures 
exhibited by cases treated on the first day of disease 
when these are compared at the end of 96 hours' illness; 
and similarly, third day cases only show half the 
number of normal temperatures compared with second 
day ones. The actual percentages in the above groups 
are 90¡x, 47%, and 27% respectively. 
On examining the temperature charts of cases in 
the 106 under special consideration in this treatise, 
I fail to discover that any benefit accrues, so far 
as influence on pyrexia is concerned, when antitoxin 
is given later than 72 hours after the onset of Scarlet 
Fever. A table of such cases is here appended but it 
gives no information which could be interpreted as 
different from the course of the toxaemia of Scarlatina 
in untreated cases. 
Periods/ 
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(5) Periods and Average Periods elapsing between the 
administration of Scarlet Fever Antitoxin 
(for (a) Total Cases (b) Total Males (c) Total 
Females) and the return of the temperature to 
normal, when the antitoxin was given later than 
the third day of disease. 





































It may be noted that, with one exception, the 
average period elapsing, as detailed in the above 
tables, is considerably longer in the case of females 
than males. 
(5) Serum Rashes and Anaphylaxis: - 
The two conditions have little in common, except that 
they both arise from the introduction of foreign pro- 
tein into the system by a parenteral route. No sensi- 
tising dose is required to cause the production of a 
serum rash; while, in the case of true anaphylaxis, 
the/ 
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the patient must have become sensitised to the particu- 
lar protein. But occasionally after the first in- 
jection of serum, a patient may develop alarming 
symptoms, closely resembling those of anaphylaxis and 
these may be followed by death. Children are usually 
the victims and the class of case exhibiting such 
unfortunate sequelae generally belongs to the "lymph- 
atic" type. It has been estimated that death as a 
direct result of a primary injection of serum may be 
expected to take place in 1 out of 70,000 cases treated. 
Apparently, the dose has little to do with the onset 
of fatal symptoms; for example, Kerley found that 
although death did not actually supervene, extra- 
ordinarily urgent symptoms of collapse occurred after 
a subcutaneous injection of four minims of serum. 
It is impossible to recognise, beforehand, the 
cases which will react either generally or externally 
to the injection of serum. Several authorities have 
recommended the intracutaneous injection of a small 
quantity of the serum as a test of sensitiveness to 
serum, but there is now very convincing evidence that 
a positive skin reaction may be obtained (i.e. the 
appearance of an urticarial wheal at the seat of intra- 
cutaneous injection) in persons who exhibit no general 
serum rash when given the therapeutic dose. The 
contrary is also true. 
With regard to anaphylaxis, it is unwise to take 
a/ 
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a risk in treating any patient who has already had 
serum therapy at some period previously, unless the 
interval elapsing between two injections is less than 
ten days. It appears quite a simple rule, to remember 
to desensitise such patients, but in actual practice, 
while the greatest vigilance is exercised with refer- 
ence to new cases coming into hospital, unnecessary 
risks are occasionally run during the convalescence of 
patients in wards where mixed infection has been 
accidentally introduced. For instance, the inclusion 
of a case of combined Diphtheria and Scarlet Fever in 
a Diphtheria Ward may occur. It becomes necessary to 
give a temporary passive immunity to Scarlet Fever to 
Dick -positive patients and for this purpose, 5 cc. of 
Scarlet Fever Antitoxin may be used per patient. 
Patients whose residence in hospital is less than ten 
days do not require desensitisation, but all the 
remainder must be so treated, if risks are not to be 
run. The amount of serum used as a desensitising 
dose is important, as even very small injections of 
the foreign protein to which a patient is already 
sensitised may cause anaphylactic shock instead of 
preventing it. Some persons are exquisitely hyper- 
sensitive to the parenteral administration of foreign 
proteins. Fortunately, the number of cases reacting 
severely to second injections of horse serum, after an 
interval/ 
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interval of two weeks or longer, is very small and 
while it is the clinician's duty to avoid risks, it 
is also necessary for him to avoid alarm, if something 
untoward does occur at some time. It is a poor phil- 
osophy to neglect the relief of thousands because the 
therapy was, in spite of reasonable precautions, 
followed by an unfortunate result in one or two cases. 
Care beyond ordinary limits is only necessary in 
patients with a history of hay Fever, Asthma, Urticarial 
eruptions and allied recognisable phenomena of hyper- 
sensitiveness to foreign proteins. Such persons should 
only be treated intravenously with the greatest 
reluctance and where urgency is extreme. 
It is impossible to discover any moderate agree- 
ment among observers as to the incidence of serum 
rashes in the specific treatment of Scarlet Fever. 
This may be because of differences in the protein 
content of various sera. It is certainly partly be- 
cause of great differences in the sensitiveness of 
different groups of individuals. I should like to 
reiterate here that in treating Diphtheria and Scarlet 
Fever with antitoxin, I have found the percentage of 
serum rashes to be consistently much lower when 
Messrs Burroughs Wellcome and Company's Serum was 
used than when employing preparations by Messrs Parke, 




I propose to give a resume of the experiences of 
various observers with reference to serum rashes and 
anaphylaxis and finally to quote my own findings in 
(66) 
respect of 106 cases of Scarlet Fever. Robb used whole 
serum (unconcentrated) on 14 cases in 1925, with only 
(J7' 
215 (3 cases) serum reactions. Kirkhope'treated 101 
contacts by injecting 2.0 cc. of Scarlet Fever Antitoxin 
intramuscularly and 20 of these exhibited serum 
(49) 
phenomena. MacFarlane gives details of the treatment 
of more than 800 cases of indubitable Scarlet Fever in 
the City Hospital, Birmingham, and states that 28.6% 
suffered from serum reactions, most of which were 
slight. In about one- quarter of the reacting cases, 
there was intense rash and about one-ninth of those 
(15) 
affected had severe multiple symptoms. Craig describes 
the results of treatment in 512 cases of Scarlet Fever; 
in his series 415 had reactions to the serum, but he 
(6) 
notes that there were no alarming symptoms. Benson and 
Maciver found symptoms and signs of serum sickness in 
(43) 
34% of cases treated. Lenthe was fortunate enough to 
discover only 2 cases of serum reaction in 44 cases 
injected. Harries) had 17 cases (20%) out of a total 
of 84 patients. Bröckè0)records the details of treat- 
ment in 50 cases of Scarlet Fever by means of Specific 
Antitoxin at the Municipal Hospital, Aachen, and his 
experience was that only 6% (3 cases) had signs 
attributable to the serum proteins. In his earlier 
experiences/ 
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experiences with Serum Therapy, using unconcentrated 
(J2) 
Antitoxin, Harries mentions that practically every 
(16) 
case developed serum sickness. Cushing's cases ín- 
(29) 
eluded 13% showing hypersensitive symptoms. Gordon 
and his co- workers have made an interesting comparison 
between Polyvalent Antistreptococcic Serum and Scarlet 
Fever Antitoxin with regard to the incidence of serum 
reactions. The percentages of cases reacting were 
33% and 31% respectively. This lends support to the 
views of various authorities, including Park, that 
the immune bodies which constitute the antitoxic and 
antibacterial content of sera play little or probably 
no part in promoting reactions to horse serum. 
(45) 
Lunin analyses the results of antitoxin treatment in 
100 children under 12 years in the Rauchfuss Children's 
Hospital and states that 31 cases developed serum rash. 
He distinguishes three types of eruption; the urticarial, 
the morbilliform and also a multiform erythema. There 
seems to be little purpose served by typing serum 
rashes and it is the writer's opinion that if watched 
closely, eruptions will be found to change their 
general appearance within a few hours in a large 
majority of cases. It must be very rare for a serum 
rash not to exhibit urticarial wheals either as an 
evanescent or comparatively lasting characteristic at 
some period of its existence. 
Banks, who, as already stated, is a strong advocate 
of/ 
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of intravenous therapy, found that when patients were 
treated in this way, 60% had immediate reactions, as 
evidenced by rigors, pyrexia and rapid pulse. The 
symptoms generally passed off in about half an hour, 
but there was one death in 404 cases treated. A death 
as the direct result of therapy militates against a 
certain treatment finding public favour and few cases 
of Scarlet Fever at the present time have initial toxic 
symptoms sufficiently urgent to warrant universal 
intravenous treatment of the disease. But Banks men- 
tions that only 2.8% of the cases showed any evidence 
of serum rash after the subsidence of the early dis- 
agreeable symptoms. Toomey) and Dolch treated 283 cases 
in one of the Cleveland Hospitals with resulting serum 
reactions in 109 (38.5 %) . 
My series of 106 cases gave a percentage incidence 
of serum rash of 9.4% (10 cases) . It is of interest 
that only 7.5% of the male patients developed this 
sequela, as against 10.6% of females. An observation 
was made above with reference to the time elapsing 
between the administration of antitoxin and the return 
of the temperature to normal, it being noted in that 
connection that males reacted, on the whole, more 
favourably than females. 
(6)/ 
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(6) The dangers of sensitisation. x 
of recognising serum treated patients. Once a patient 
has had an injection of a therapeutic or immunising 
serum prepared by actively immunising an animal, there 
is set up in that person a "sensitised" state to that 
particular serum. It is important to note that the 
presence of immune bodies does not in any way modify 
the hypersensitiveness induced, the reaction being 
excited by the normal protein fraction in the serum. 
Neither can any future modification of the dosage 
prevent sensitisation, unless the whole of the protein 
can be removed from the therapeutic agent. It seems 
that such a triumph of the laboratory, even if possible 
eventually, will be long delayed, since the immunity 
conferred by an antitoxic serum is due to "substances" 
closely associated with the pseudo -globulin fraction 
of the protein content. The actual amount of serum, 
administered parenterally, required to sensitise a 
person to the contained protein is infinitessimal. 
Rosenau and his co- workers found that an experimental 
guinea pig could be sensitised to horse serum by the 
injection of 0.000001 cc. 
There are no outward signs of hypersensitiveness 
after injection of a serum, and it is not until a second 
dose has been given after an interval of, say, two or 
three/ 
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three weeks, that it becomes evident in a percentage 
of cases that a previous injection of an identical 
protein has taken place. The occurrence of serious 
anaphylactic phenomena is rare, but that is no reason 
why everything possible should not be done in an attempt 
to obviate urgent serum sequelae altogether. 
In Fever Hospital Practice, it is by no means 
easy to get accurate histories of the patients admitted. 
Children constitute a large proportion of the hospital 
population and they cannot be expected to have any 
detailed knowledge of previous illnesses. Moreover, 
parents are frequently so distressed by the acuteness 
of their child's illness and by the necessity for 
removal to hospital that only scant attention is given 
to queries which seem for the moment of very secondary 
importance. A very useful purpose would be served, 
if some international method could be devised, whereby 
cases previously treated with serum could be unmistake- 
ably recognised. There is an alternative, which has 
already been on trial for some time and about which, 
opinions differ very materially. This comprises the 
utilisation of different animals for the preparation 
of immunising and curative sera. For example, Messrs 
Parke, Davis and Co. have made use of goats in con- 
nection with active immunisation against Diphtheria. 
But even in such an arrangement, unless there be 
universal agreement as to the animal to be used in 
each/ 
each specific instance, there can only be eventual con- 
fusion, with a result no less undesirable than the 
difficulties at present experienced in using prepara- 
tions of horse serum. 
I have given this problem very considerable 
thought and I have concluded that the following scheme 
is practicable and might be useful. International 
agreement with regard to distinctive skin colours as 
evidence of previous treatment of a particular disease 
seems quite feasible. Such is not absolutely essential, 
as the factor of prime importance is the recognition 
of previous serum treatment, but there would be some 
value in an agreed colour scheme instead of one con- 
stant colour, in so far that definite information of 
second and third attacks of the same disease would 
thus be afforded. Having concurred in the desirability 
of "skin recognition of previous serum- treated dis- 
eases", it would only be necessary to include in each 
package of antitoxin a wafer, resembling an ophthalmic 
"lamella ", enclosed after sterilisation in a parchment 
envelope and having on it a small quantity of some 
indelible harmless dye. After preparing the patient's 
skin, the wafer would be applied to the site of in- 
jection and the antitoxin needle would enter the skin 
after traversing the dyed surface, carrying with it a 
small quantity of the pigment into the superficial 
tissues/ 
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tissues and in this way ensuring a permanent stain. 
It might be necessary to stipulate certain areas as 
those to be used for the administration of antitoxin, 
such as (1) The Gluteal Regions (2) Either Thigh 
(3) Either Flank (4) Either Deltoid (5) Either Cubital 
Fossa (6) The Lumbar Spinous Area (7) The Base of 
the Skull (8) The Anterior Fontanelle. 
Clinicians could survey those areas very rapidly 
and students would learn to consider an "antitoxin 
mark" a routine observation in the examination of a 
patient, just as they learn at present to examine for 
evidence of vaccination in the differential diagnosis 
of Varicella. 
Precautions against anaphylaxis would in nowise 
affect the immediate reactions seen from time to time 
after an initial intravenous injection of antitoxin, 
which method appears to be to me unreasonable as a 
routine practice in the treatment of a disease whose 
antitoxic therapy is not, as a rule, a matter of 
extreme urgency. 
123. 
OBSERVATIONS ON SCARLET FEVER AsaD 
ITS SPECIFIC THERAPY. 
VI. THE ANTITOXIC SERUM TREATMENT OF SCARLET FEVER. 
DISCUSSION: - 
The headings proposed in the introductory 
chapter of this treatise were: - 
(1) Effect of Scarlet Fever Antitoxin on the Toxicity 
of the disease. 
(2) Effect of Scarlet Fever Antitoxin on the Incidence 
of Complications. 
(3) Effect of Scarlet Fever Antitoxin on the Length 
of Stay in Hospital. 
(4) Effect of Scarlet Fever Antitoxin on the Percentage 
of Return Cases. 
(5) The Prophylactic Use of Scarlet Fever Antitoxin. 
(1) The effect on the Toxicity of Scarlet 
Fever has already received detailed attention in con- 
nection with the arguments advanced for the earliest 
possible specific treatment of the disease. It has 
already been seen that the majority of workers are 
agreed that early administration has a definitely 
beneficial effect on the toxaemia, though there are 
differences in the conceptions of what constitutes 
hastened decline of the toxic phase and at what time 
limit/ 
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limit antitoxin may be said to be of relatively little 
importance in the treatment of the initial stages of 
(17) 
Scarlatina. The Dicks, for example, consider the 
effect on the rash to be the best indication of the 
benefit derived from early injection of antitoxin. 
Others have laid emphasis on the subjective state of 
the patient - the feeling of well -being and the relief 
of symptoms - and it must be allowed that practically 
all my patients capable of analytic thought have pro- 
nounced themselves as being much better, about twenty - 
four hours after antitoxin treatment. But the subject- 
ive improvement almost certainly runs in parallel with 
the diminution in temperature and I see no reason to 
accept a patient's statement as evidence, rather than 
the mechanical record of a clinical thermometer. The 
writer's opinion, as has been previously stated, is 
that the temperature chart is the best guide to the 
(66) 
antitoxic effect of serum. It is true, as Robb points 
out, that the administration of a non -specific serum 
may cause quite a dramatic fall in temperature; but in 
such a case the temperature does not remain at the low 
level reached as a result of the protein injection. 
It rapidly regains its former register, whereas after 
adequate early specific therapy, although the fall 
may not be in any way critical, the new level is 




(2) The consideration of the effects of 
Scarlet Fever Antitoxin on the incidence of complica- 
tions bristles with difficulties. Three distinct 
opinions may be said to require discussion. The first 
is that there is undoubted benefit from the specific 
therapy. The second contends a direct negative to the 
foregoing assertion. Lastly, an intermediate position 
is taken up by many workers with an intimate and vast 
experience; their observations have been that the 
beneficial results following early treatment are dis- 
tinctly convincing, but that the administration of 
serum after the second or third day of disease appears 
to have little influence on the incidence of complica- 
tions. 
To prevent undue involvement, it will be most con- 
venient to deal with the several points of view in 
relation to (a) Total Complications (b) Individual 
Complications. 
(a) Total Complications:- There is comparatively close 
agreement in the text books that 40% of cases, untreated 
by serum, may be expected to develop complications. 
The figure is naturally subject to considerable quali- 
fication, depending on the characteristics of any 
given epidemic, the previous physiological condition 
of the persons affected and all the other factors dis- 
cussed/ 
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discussed in an earlier chapter. The main point at 
issue here is, that if the antitoxin is specific and 
if complications are definitely the handiwork of the 
Streptococcus scarlatin_ae, one of two things must 
follow; viz.- (I) The Incidence of Complications should 
be markedly diminished (II) A scientific explanation 
of the failure of antitoxin to reduce the complication - 
rate appreciably is required. 
Dealing with the findings of workers who confid- 
ently assert the beneficial action of Scarlet Fever 
Antitoxin in the prevention of complications, the 
(62) 
following records are notable. Peters and Allison 
treated 114 of the worst cases of 860 admissions to 
hospital and they found that the incidence of septic 
complications was low. No classification of the cases 
is made with regard to the day of disease when the 
antitoxin was given, but they state that even when 
administered so late as the fifth day, there was 
definite benefit derived from its use in septic cases. 
(58) 
Okell states that experience has been uniformly in 
favor of the view that, if it is given sufficiently 
early, antitoxin tends to prevent the septic complica- 
tions of Scarlet Fever. He also notes that once 
pyogenic complications have become established, serum 
treatment does not have any modifying effect on them. 
It may be well to say at once that the actual treatment 
of/ 
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of pyogenic manifestations of the late stages of the 
disease will not be considered in this treatise. 
Although some authorities - and among them Okell himself 
- incline to the belief that Scarlet Fever Antitoxin 
may possess antibacterial, as well as antitoxic, 
qualities, there seems to be little doubt that the 
invasion of the tissues by the actual micro- organisms 
follows and is indeed made possible by the antecedent 
crippling effects of the diffusible toxin. 
(51) 
McLachlan and Hunter had only 27% complicated 
cases in 230 patients suffering from severe attacks 
of the disease. I have already mentioned that marked 
initial signs and symptoms do not necessarily imply 
a complicated or even protracted convalescence. 
(49) 
Mair MacFarlane was fortunate enough to have only 
19.2% of complicated cases when antitoxin had been 
(3) 
given. Banks has no doubt whatever that antitoxin is 
of paramount importance in preventing the pyogenic 
invasions of the Streptococcus scarlatinae. As already 
mentioned elsewhere, he treated all his cases intra- 
venously. In the Medical Officer, 1927. V 38, p.147, 
a review of the antitoxic treatment of all cases of 
Scarlet Fever admitted to the Borough Fever Hospital, 
Wolverhampton is given and very favourable results 
are reported. It is stated that "Apart from its effects 
in cutting short the disease, this serum has been of 
particular therapeutic value in the treatment of 
severe/ 
123. 
severe cases of Scarlet Fever ". Complications were 
(11) 
inhibited in such cases. In his Annual deport, Burton 
definitely opines that serum prevents complications. 
(1) 
Dr Thomas Archibald found that in nearly 1400 cases 
treated, complications rarely occurred. 
(70) 
Scott treated with serum only those patients whose 
initial clinical manifestations were severe and yet 
(74) 
only 30% developed any complication. Toomey agrees 
that septic sequelae are less evident in treated than 
in untreated cases. Birkhaug early formed the con- 
clusion that, given in adequate dosage, Scarlet Fever 
Antitoxin brings about a rapid recovery without septic 
(2b) 
complications. Gordon appears to have been particu- 
larly unfortunate in the clinical course of untreated 
severe cases of Scarlet Fever, for he states that none 
of these escaped complication, whereas 35% of treated 
severe cases were uncomplicated. The difficulty of 
matching cases has already been referred to. Some 
patients react tremendously in the matter of heat 
regulation to any infection; which in turn gives a 
very high pulse rate and an abnormal peripheral dila- 
tation of capillaries, seen as a brilliant rash. 
Yet they may prove by the sequence of events during 
convalescence that they were not seriously ill during 
the acute stage. This naturally applies to both 
treated and untreated cases, but whether or not it 
applies equally in a limited number of cases is 
difficult/ 
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difficult to answer. No reference is made to the ages 
of the patients in the two groups, but presumably they 
corresponded closely. In ordinary cases of Scarlet 
(28) 
Fever, Gordon records that 66% were uncomplicated when 
treated with serum. 
(69) 
Schottmüllor found very definite evidence of the 
decrease of septic complications on the institution of 
(56) 
specific therapy in Scarlet Fever. Nankwell notes 
that no serum -treated case in his recorded series 
suffered from any severe complication, but some of 
the untreated cases had serious complications and many 
had minor septic sequelae. He makes an interesting 
observation that two of the controls nearly died during 
the septic stage, but after treatment with antitoxin 
they made complete and quite remarkable recoveries. 
(39) 
Kolmer is insistent on the value of serum in the treat- 
ment of the disease and the prevention of complications. 
(44) 
Lindsay, Rice and Sellinger are convinced that the 
administration of antitoxin reduces the incidence of 
(33) 
complications. Harries says that more cases can be 
discharged by the thirtieth day of disease and com- 
plications are markedly reduced in number, when anti- 
serum is used in the treatment of the toxic phase. 
(32) 
In an earlier communication, the same observer notes 
that "Septic complications in their early stage are 
"lessened. A decrease is noted in Rhinitis and early 
"Adenitis,/ 
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"Adenitis, which may be due to the decrease in the 
"congestion of the mucous membranes. In regard to the 
"septic conditions, the author agrees with the opinion 
"of the Dicks that by removing toxaemia, not only is 
"the true extent of septic involvement made evident, 
"but the patient is better enabled to tackle it." 
Cushing)found that, whereas previous to the institution 
of antitoxin treatment, 45% of cases of Scarlet Fever 
were complicated, only 25$ of serum treated cases 
(23) 
developed a septic phase. Eley asserts that the number 
of complications is definitely reduced as a result of 
(7) 
specific therapy. Bipoli experimented in the Isolation 
Hospital, Pudna and formed the opinion that complica- 
tions were, in a measure, prevented, but not influenced 
after they had become established. 
The findings of the foregoing careful observers 
would seem to permit of no doubt of the value of 
Scarlet Fever Antitoxin in preventing complications. 
But the case has still to be stated for the directly 
(20) 
opposite point of view. Doolittle says "I myself have 
yet to see the data of a series treated with intra- 
muscular injections of Scarlet Fever Antitoxin which 
I could not, without much discredit, match with a 
series of my own untreated cases ". Friedeman and 
Deicher are emphatic that, while the toxic stage of 
scarlatina reacted favourably to antitoxin, the late 
septic/ 
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septic complications were neither prevented nor in- 
fluenced after they had manifested themselves. Hus er 
states that he failed to find any beneficial effect 
(5) 
of serum on the incidence of complications. Baxter 
is slightly more indulgent in his pronouncements on 
the effects of specific therapy, for he allows that, 
while the numbers of complicated cases in treated and 
untreated cases showed close correspondence, the 
(77) 
septic processes were mitigated by serum. von Borman 
records that his experience. with Scarlet Fever Anti- 
toxin was that the incidence of complications was not 
(12) 
influenced by the treatment. Busobmann praises the 
effects on the toxic type of Scarlatina in the early 
stages, but he found no reliable evidence of lessened 
(41) 
incidence of complications. Lautier and Dreyfus, 
(S2) (54) 
Zingher, Meyer all agree that the percentage occur- 
rence of septic sequelae is not lowered by antitoxin 
(30) 
treatment of the toxic phase. Gottsche takes the same 
view as Baxter; that the seriousness of complications 
is dinstinctly lessened, but their incidence is quite 
(43) 
uninfluenced. Lenthe does not conclude from his 
observations in the Bremen Municipal Hospital that any 
benefit accrues, so far as the lessened frequency of 
septic phases of the disease is concerned, from the 
use of specific treatment. A special committee, of 
which Lunin was president, reported on the treatment 
of/ 
132. 
of 714 cases of Scarlet Fever in five Children's 
Hospitals in Leningrad in 1926. Their considered 
opinion was that antitoxin had no effect on Septic 
Scarlet Fever or on the incidence or course of septic 
complications of the ordinary forms of the disease. 
(75) 
Toomey and Dolch are quite uncomplimentary to the 
treatment, in its relation both to the toxic phenomena 
of scarlatina and the septic processes resulting from 
the bacterial invasion of the tissues. In connection 
with the latter, they note that there were actually 
more complicated cases per cent in the treated than 
in the untreated control series. 
So far, the extreme views have been presented and 
it is difficult to reconcile them. Certainly the 
reports referred to are not lacking in conviction and 
it requires more than a passing thought to discover 
some reasons why both may be perfectly correct findings 
and yet diametrically opposed to each other. 
The third class of record to be dealt with, as 
setting forth the influence of antitoxin on the 
incidence of septic manifestations in Scarlet Fever, 
is one in which the observers choose a middle path. 
They are agreed that the early administration of anti- 
toxin lessens the percentage occurrence of complications, 
but that, given later in the toxic phase, no such 
(27) 
useful purpose is served by the therapy. Goodall makes 
the/ 
133. 
the general statement that, the earlier the serum is 
given, the less likely are complications to occur. 
(17) 
The Dicks note that in a series of cases treated with 
antitoxin on the first day of disease, only 1 out of a 
total of 64 was complicated. The sane workers treated 
59 cases on the second day of disease, with a very 
great relative increase in the percentage incidence 
of septic sequelae. The complete prevention of 
Scarlatinal nephritis is noted as having followed 
(14) 
specific therapy. Chodzko puts forward a strong 
argument for the power of antitoxin to diminish the 
number of complications, if given early. He records 
that his experience in Warsaw was that all cases, 
injected on the first or second days of disease, made 
an uneventful recovery. Where serum had been admin- 
istered on the third day of illness, 25% of cases 
showed complications. Those treated later than the 
third day ran a much less favourable clinical course, 
there being 40% of the patients exhibiting septic 
(15) 
sequelae. Craig is definitely of the opinion that 
the percentage of complicated cases shows an additional 
increase for each day of delay in treating the disease 
U 
specifically. Benson and Maciver note a considerable 
diminution of complicated cases if serum is given 
during the first three days of disease. They conclude 




are not noticeably inhibited. Robb records that in 
100 cases of Scarlet Fever receiving early treatment 
with antitoxin only 3 per cent were complicated. 
Of the three cases, one developed arthritis and two 
had mild otorrhoea. The patient who had arthritis had 
(57) 
had Rheumatic Fever two years previously. O'Brien 
makes a general statement that there is considerable 
evidence to suggest that the early administration of 
antitoxin decreases the liability to complications. 
The findings in my own series of cases agree with 
those recorded by workers who failed to find that any 
favourable influence was exerted by antitoxin on the 
incidence of complications. The real test of whether 
specific antiserum prevents complications is undoubt- 
edly the comparison of the percentage incidence of 
these in groups of cases treated on different days of 
disease. It is reasonable to expect that cases 
treated on the first day of illness should show fewer 
complications per cent than cases treated on the 
second day. Similarly second day treatment should 
ensure greater freedom from septic manifestations than 
third day treatment. Yet I have failed to demonstrate 
any inhibitory influence, for, although the percentages 
in the table include Serum Rashes, of which about 10% 
occurred, the close correspondence in the percentage 
numbers on the various days quoted, leaves little 
argument in favour of antitoxin being useful in pro- 
moting an uneventful convalescence. 
135. 
Numbers and percentage numbers of Complicated Cases occurring in 
(a) Total Males, (b) Total Females, (c) Total Cases, when Scarlet 
Fever Antitoxin was given on (1) 1st Day of Disease (2) 2nd Day 
of Disease, (3) 3rd Day of Disease (4) After 3rd Day of Disease. 
Day of Disease on 
which Scarlet Fever 












Cases 3 7 10 
Number of 
Complicated 
Cases 1 3 4 
Percentage No. 
of Complicated 
Cases. 33.3% 42.9% 40% 
2nd Day 
umer of 
Cases 12 18 30 
Number of 
Complicated 
Cases 5 7 12 
Percentage Io. 
of Complicated 
Cases 41.6% 38.8% 40% 
3rd Day 
Number of 
Cases 14 17 31 
Number of 
Complicated 
Cases 5 5 10 
Percentage No. 
of Complicated 
Cases 35.7% 29.4% 32.3% 
After 3rd Day 
Dumber of 
Cases 11 24 35 
umer o 
Complicated 
Cases 5 9 14 
Percentage o. 
of Complicated 
Cases 45.5% 37.5% 40% 
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(b) Coming now to the question of the effect 
on Scarlet Fever Antitoxin on the incidence of individ- 
ual complications, it will be convenient to discuss 
each of the common sequelae under a separate heading. 
Observations by various workers will be grouped accord- 
ing to their implications, in the order adopted with 
regard to the study of total complications. It may be 
imagined, at first sight, that no useful purpose can 
be served by dealing with the late manifestations 
under clinical headings, since it has already been 
shown that opinions are divided on the question of 
the effect of specific therapy on the occurrence of 
complications generally. But such is not necessarily 
the case, for modifications may result from specific 
therapy to inhibit or reduce the number of certain 
complications, although others may be completely un- 
affected. For example, as will be detailed during 
the study, some observers note that nephritis was 
entirely absent from the clinical course of serum= 
treated cases. Nephritis is one of the most dreaded 
of the sequelae of Scarlet Fever and if it can be 
altogether eradicated from the Scarlet Fever Wards 
by the use of Antitoxin, a very useful purpose will 




Late Albuminuria and Nephritis:- In Scarlet 
Fever, the incidence in untreated cases is about 8% 
on the average, but there is great variation. Some 
epidemics show the percentage of these sequelae to be 
as low as 2% or even less; other outbreaks have a very 
high nephritis complication -rate. Further, it varies 
considerably in different countries, according to 
whether Scarlet Fever is a mild or serious disease 
(40) 
there. For example, Lamel notes that in a series of 
cases in the Infectious Diseases Hospital at Berndorf, 
30.6ó had late albuminuria and 19.3% actually had 
(26) 
haematuria. On the other hand, Gibson had no case of 
kidney involvement in cases untreated by antitoxin. 
Using antitoxin intravenously, in contra -distinction 
to the other workers to be quoted, Banks and Mackenzie 
show that no case of nephritis occurred in the 404 
(32) 
cases treated. Harries was similarly fortunate in his 
experiences with Scarlet Fever Antitoxin in one series, 
(33) 
although he had two cases of this complication in 
(56) another series of 1071 cases. Nankúell reports his 
findings in the treatment of thirty severe cases of 
the disease; there were no cases of damage to the 
kidney tissues. Gordon )was favourably impressed by 
the action of antitoxin in lowering the incidence of 
nephritis and states that the number of cases occurring 
was reduced by one half. He notes, however, that the 
percentage occurrence of late albuminuria did not appear 
to be influenced. 
The / 
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The opinions of the above workers are sufficient 
to demonstrate that quite a strong case may be stated 
for the beneficial effect of antitoxin in inhibiting 
or at least reducing the incidence of kidney mischief 
in Scarlet Fever. 
Selections will now be made from the records of 
workers whose formed opinion it is that no diminution 
of the percentage occurrence of nephritis results from 
(16) 
the specific therapy of scarlatina. Cushing reports, 
after a careful survey of 500 treated cases, that no 
benefit, so far as the protection of the kidneys is 
concerned, resulted from antitoxin. A like statement 
(75) 
is made by Toomey and Dolch. The special Committee in 
Moscow, referred to earlier, could find no reason to 
believe that nephritis was less common in treated than 
(31) 
in untreated cases. Gottsche studied 622 cases closely 
in the Municipal Hospital, Bremen, but he could not 
discover any real reduction in the number of cases of 
nephritis among Scarlet Fever patients, although he 
concedes that the cases occurring were probably less 
severe. Meyèr4fecords the findings of a special 
Congress on Scarlet Fever, held at Königsberg; the 
Congress agreed that nephritis, as one of the complica- 
tions of Scarlet Fever, was not by the 
administration of antitoxin. Buschma Wsees no reason 
to believe that the cases he treated enjoyed any special 
(77) 




to a similar conclusion. Busier, Friedemann and Deicher, 
(20) 
and Doolittle all agree that from their careful re- 
spective studies of the results of Scarlet Fever Anti- 
toxin in the treatment of Scarlet Fever, they are un- 
able to produce data to show that an enhanced protection 
was afforded to the renal glomeruli by the use of 
specific serum. 
The most detailed reports are given by several 
observers with regard to the relation between the per- 
centage incidence of nephritis and the day of disease 
on which antitoxin was administered. The following 
(8) 
general conclusions are noteworthy. Birkhaug states 
that when antitoxin was given in adequate dosage during 
the first four days of disease, convalescence was un- 
(6) 
eventful. Benson and Maciver note that if serum is 
given after the third day of disease, the incidence of 
15) 
nephritis is not favourably influenced. Craig details 
the clinical course of 512 cases, practically all of 
which were treated during the first three days of 
disease and in his series there was only one case of 
(14) 
nephritis. Chodzko shows that, taken in complete 
survey, kidney complications were reduced to less than 
half their previous case -rate by antitoxin, but he 
further asserts that the frequency of occurrence varied 
according to the day of disease on which serum was 
administered. Robb6reviews a hundred cases treated 
very/ 
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very early in the course of the disease; there was no 
(51) 
case of late nephritis. McLachlan and Hunter give an 
interesting analytical study with reference to com- 
plications, including Nephritis. They found that no 
case of real nephritis (they distinguish albuminuria 
from nephritis) occurred in any case treated on or 
before the fourth day of disease. No case of either 
of the two kidney conditions occurred if antitoxin was 
given on the first day of illness; three cases of 
albuminuria were found among 72 cases of Scarlet Fever 
treated on the second day; two out of 43 cases treated 
on the third day and four of the 49 cases having anti- 
toxin on the fourth day developed albuminuria. Three 
cases of nephritis and one of albuminuria were noted 
among 53 patients undergoing serum treatment on the 
fifth day of disease. 
In my own series of 106 cases, there was only one 
case of nephritis (i.e. 0.94%). It developed in one 
of the 40 male patients treated. All of the 66 females 
escaped kidney disorder. The complication occurred in 
a patient treated after the third day of disease. 
I therefore feel disposed to argue, that although the 
total complications occurring in Scarlet Fever show 
little modification in number as a result of antitoxin 
treatment, there is a definite limitation of the 
incidence of nephritis and that probably if all cases 
could have serum treatment by the second or third day 
of/ 
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of disease, this complication would become very rare 
indeed. 
Adenitis:- In Scarlet Fever cases untreated by 
antitoxin, from 10% to 15% develop adenitis. The 
figures quoted take no account of the early enlargement 
of cervical glands, particularly the tonsillar, which 
is commonly seen in the early stage of the disease. 
Banks(3) 
describes the complication as having occurred in 
seven out of nine cases of the semi- septic type, which 
may be regarded as complicated from the beginning of 
the clinical syndrome. But even in Scarlatina simplex, 
the incidence of adenitis is very variable and as was 
mentioned in another chapter, there tends to be small 
concentrated outbreaks of the condition from time to 
( 51) 
time in hospital wards. McLachlin and Hunter record 
less than 5% as the case -incidence of late enlargement 
of cervical glands. This complication is not a serious 
one, only a very minor proportion of cases requiring 
(26) 
any surgical treatment. Gibson is either unusually 
fortunate or he considers adenitis of extremely little 
importance for he does not mention it among the com- 
fy (40) 
plications arising in his cases. Lamel analyses in 
detail the clinical characteristics and complications 
of 62 cases and states that over 30% developed adenitis. 
It should be noted that the Case Mortality was 8% which 




Some observers appear to include all enlargements 
of cervical glands, independent of the time of occur- 
rence, i.e. whether initial or subsequent to the acute 
stage, as a complication. This is probably entirely 
wrong, for it is impossible to conceive that no reaction 
occurs in healthy cervical glands during the local 
attack of the Streptococcus scarlatinae on the tissues 
of the fauuces. 
8) 
Gordòn states a convincing case for the usefulness 
of Scarlet Fever Antitoxin in minimising the incidence 
of Adenitis. He found that this sequela occurred in 
only one-third of the number of cases hitherto affected 
and he notes that the duration of the inflammatory 
It (69) 
process was reduced. Schottmuller singles out adenitis 
particularly as being very noticeably reduced in its 
incidence, although, even in treated cases, 22% were 
(33) 
thus complicated. Harries investigated the clinical 
course of 100 treated cases and found only three 
instances of adenitis. Banks) and Lackenzie note that 
the percentage incidence of enlargement of glands was 
very low (1.5% : 6 cases) in 404 patients who had anti- 
toxin administered intravenously. 
Evidence pointing to failure of specific therapy 
to influence the development of glandular enlargement 
(10) may now be reviewed briefly. Bröcker says that the 
occurrence of adenitis seems to be little modified 
by/ 
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by serum; at the same time he quotes figures which give 
the benefit to serum- treated cases. But the percentage 
incidence is certainly comparatively great, 38% being 
the complication-rate in this particular instance. 
Friedema g5ánd Deicher could find no diminution in 
the occurrence of adenitis as a result of giving anti - 
(34) (5) (77) (12) (41 
toxin. Husler, Baxter, von Borman, Buschmann, Lautier 
and Dreyfus, all observe that in their carefully 
critical investigations of cases treated serologically, 
there was no definite evidence to show that adenitis 
was less common in patients receiving antitoxin than 
(29) 
in those treated by expectant methods. Gordon, 
Bernbaum and Sheffield record that in their experimental 
work with Scarlet Fever Antitoxin, Convalescent Serum 
and Polyvalent Antistreptococcic Serum, they found that 
18.2% of patients receiving specific therapy developed 
adenitis as against 10.2% treated with a polyvalent 
serum. Cushing) reports an almost negligible reduction 
in the incidence of this particular sequela; he found 
that before the introduction of antitoxin, about 15% 
of cases had adenitis as a complication; treated cases 
gave a complication-rate of 12% for adenitis. 
As the theme develops, it becomes more and more 
apparent that little agreement is reached by competent 
observers with reference to any beneficial effects 
exhibited by antitoxin so far as the incidence of 
adenitis/ 
144. 
adenitis in cases of Scarlet Fever is concerned. There 
are yet to be considered, the opinions of those circum- 
spect observers who are unwilling to range themselves 
either in support of an unqualified affirmative or of 
(66) 
a complete negative. Robb writes that only one case 
(7%) of slight enlargement of the cervical glands 
occurred in 14 cases of the disease receiving early 
antitoxin treatment. But there were three cases of 
mild adenitis among 7 cases receiving their serum on 
the third day of disease. Such an incidence, (43 %) 
would be very large in untreated cases. Reviewing 100 
(66) 
cases in the same article, Robb states that all were 
treated very early in the course of the disease and 
(14) 
there was no case of glandular enlargement. Chodzko 
agrees that cervical adenitis is much less evident if 
(8) 
cases receive antitoxin very early. Birkhaug had no 
evidence of adenitis in the series reported, when 
antitoxin had been given on or before the fourth day 
(51) 
of disease. McLachlan and hunter compile a table 
showing the incidence of various complications, accord- 
ing to the day on which Scarlet Fever Antitoxin was 
administered. Investigation by them showed that no 
case treated on the first day of disease developed 
adenitis. Two cases out of a total of 72 having 
antitoxin on the second day developed the complication. 
Of the third day series, numbering 43, only 1 had 
glandular/ 
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glandular enlargement. So far, their evidence seems to 
suggest that injection of antitoxin on the first day 
of disease obviates adenitis and that the incidence of 
this complication is approximately the same for cases 
treated on the second and third days of illness. 
But the argument breaks down at this point, for in 102 
patients undergoing specific therapy on the fourth and 
fifth days of disease, there was not a single instance 
of infection of the cervical glands. 
My series of 106 cases of Scarlet Fever treated 
with antitoxin include311 instances of adenitis (10.4%). 
Three cases occurred in 40 males and eight in 66 females. 
Those developing in male patients had the following 
distribution, : - one case in the 1 -5 years age -group; 
two cases in the 5 -10 years age -group. Adenitis in 
the female patients were distributed more widely, so 
far as age groups are concerned,:- two cases developed 
in the 1 -5 years age- group; a similar number was found 
among patients between five and ten years; the 10 -15 
years age -group afforded one case; three cases occurred 
in the 15 -25 years age-group. 
As regards the relation between the percentage 
incidence of the complication and the day of disease 
on which antitoxin was administered, my experience does 
not strengthen the argument that the earlier the treat- 
ment by means of Scarlet Fever Antitoxin, the less 
likely is adenitis to be found complicating Scarlet 
Fever./ 
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Fever. Out of a total of 10 patients treated on the 
first day of disease, three developed infection of the 
cervical glands. A like number, out of 30 patients 
treated on the second day of disease were affected. 
Thirty -one cases were treated on the third day of 
disease and of their number, three developed adenitis. 
The complication was also seen in two cases out of a 
total of 35 patients receiving their antitoxin after 
the third day of disease. 
I am not convinced that adenitis is in any way 
minimised by the antitoxin treatment of Scarlet Fever 
and I see no reason to believe that, even if its 
incidence varies in different epidemics and different 
countries, the question of co- incidence can entirely be 
ruled out of the favourable reports given by some 
observers. 
Arthritis:- Pain in various joints is a not un- 
common occurrence during the course of Scarlet Fever. 
Some 4% to 6% of patients suffer from this complication, 
which generally appears about the end of the first week 
of illness or in the earlier part of the second week. 
It is important to remember that joint pains are some- 
times very marked as a manifestation of serum sickness. 
It is not suggested that patients suffering from serum 
rash and joint pains would be diagnosed as suffering 
from Scarlatinal Arthritis, but eruptions caused by 
the/ 
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the injection of antitoxin are not always true to text- 
book limits of duration. No other skin condition, 
unless it be Urticaria itself, is so volatile and de- 
ceptive as serum rash. A brilliant rash may be noted 
by a nurse during the early morning, but when it is 
hoped to show it to the Sister or Medical Officer, no 
abnormality of the skin can be found. In this con- 
nection, the writer remembers a case where the Sister 
of a ward was very anxious to show him a perfect 
morbilliform serum rash, which she has noted about two 
hours previously. Not a blemish could be found on the 
patient's skin. Some confusion followed, but definite 
proof that no mistake had been made as to the identity 
of the patient was soon forthcoming. The point has 
been laboured perhaps, but only to show that great care 
is necessary not to include serum sequelae among true 
cases of arthritis. The difficulty is increased by 
the fact that approximately the same period elapses 
after giving serum, before the joints become painful, 
as is required for the development of arthritis after 
the onset of Scarlet Fever. Occasionally, joint pains 




ks and Mackenzie quote no case of Arthritis 
among the complications which occurred in 404 cases of 
Scarlet Fever treated intravenously. HarriéPhad 2 
cases/ 
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cases in 100 patients treated intramuscularly, which 
is the method to be inferred throughout, unless other - 
(28) wise stated. Gordon says that serum treatment greatly 
reduced the incidence of arthritis, only about one -third 
of the number of cases occurring, as compared with 
(51) 
the normal percentage. McLachlan and Hunter record 
that the complication was completely inhibited in 230 
(16) 
cases undergoing specific therapy. Cushing notes that 
only 2% of 500 serum- treated patients complained of 
n (10) 
joint pains from Scarlatina) Arthritis. Brooker had 
no case of arthritis in his series. 
(75) 
Toomey expresses the opinion that antitoxin does 
not lessen the number of cases of arthritis occurring. 
Similarly, there was no noticeable reduction in the 
percentage incidence of joint complications in the 
investigation of 714 cases of Scarlet Fever treated 
specifically in five Children's Hospitals in Leningrad. 
Gordon 0and his cc- workers found that in treating 1021 
cases, the percentage occurrence of arthritis was 
7.4 %. This was less than the figure for cases treated 
with convalescent serum (11 %) but considerably greater 
than the incidence in patients having polyvalent anti- 
(77) 
streptococcic serum (4.7 %). von Borman could find 
no disparity, with a bias favourable to antitoxin - 
treated cases, between the percentages of joint com- 




Craig notes that only slightly over 15 of his 
cases developed the complication, the actual number 
being seven in 512 patients treated with antitoxin. 
(14) 
Chodzko believes that the percentage incidence of the 
complication depends on the day of giving antitoxin. 
He had no case of arthritis in patients treated on the 
first day of disease. Thereafter the number increased 
for each day of delay in instituting specific therapy, 
until, when antitoxin was injected on or after the 
fourth day, no appreciable reduction in the percentage 
(17) 
occurrence of arthritis was noted. The Dicks support 
(66) 
this opinion in their record of cases. Robb had only 
one case of Arthritis, occurring in a patient who had 
had Rheumatic Fever two years previously, among 100 
cases receiving very early specific therapy. 
Only two cases in my series of 106 treated with 
antitoxin, developed Scarlatinal Arthritis. No case 
occurred in patients having serum on the first or 
second day of disease. Of the 31 patients to whom 
antitoxin was administered on the third day, one had 
arthritis. The other case was one in 35 patients 
injected with serum after the third day of disease. 
Both occurred in females. 
The possibility of including joint disorders due 
to serum was mentioned above, but it must also be 
allowed that instances of real Scarlatinal Arthritis 
may be missed because of the co- existence of a serum 
rash. There seems to be no valid reason why a serum 
sequela/ 
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sequela consisting chiefly of a skin eruption should 
not appear simultaneously with real Scarlatina) 
Arthritis. Because of the great difficulty in dis- 
tinguishing whether joint pains are in fact really 
arthritic, consequent on the toxaemia of Scarlet Fever 
or whether they form part of a reaction to serum 
therapy, it is not easy to assess the value of anti- 
toxin in preventing joint complications. It is also 
true that the percentage incidence of this complication 
is variable, comparative freedom from it being enjoyed 
for perhaps some weeks in Hospital Practice, only to 
be followed by a closely grouped series of cases. 
I am inclined to believe that no entirely satisfactory 
case has yet been stated to show a consistently bene- 
ficial effect exerted by Scarlet Fever Antitoxin so 
far as the incidence of arthritis is concerned. If I 
must take up a definite position, I should agree that 
very early treatment probably tends to minimise the 
number of cases occurring, but treatment with serum 
after the second day of disease is impotent in inhibit- 
ing joint involvement. Benefit from early treatment 
is quite a rational thesis, since arthritis is not a 
septic complication due to the invasion of the tissues 
of the joints by the Streptococcus scarlatinae, but 
entirely due to the toxaemia of the disease, the toxin 
being in comparatively great concentration because of 
the/ 
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the liberal distribution of blood vessels around the 
articulations of the body. 
Otitis Media : - The percentage incidence of Otitis 
is from about 8% to 12% and it becomes evident, as a 
rule, during the latter portion of the third week of 
disease. mention has already been made of the fact 
that valuable information might be forthcoming, with 
regard to the previous health of patients developing 
septic complications in Scarlet Fever, if it were 
possible to have the closest co- operation between 
Infectious Diseases Hospitals and the School Medical 
Service. My own observations lead me to conclude that 
a large percentage of patients who develop otitis, 
already have abnormalities of the throat and naso- 
pharynx. 
(7) 
Bipoli analyses a series of cases treated specif- 
ically in the Isolation Hospital, Pudna and records 
that there was a decrease in the number of instances 
of otitis media. Brocker)obtained very encouraging 
results during his investigation at Aachen, for he 
notes that antitoxin treatment reduced the incidence 
of ear complications to one-third of the usual per- 
centage in untreated cases. But even with this dimin- 
ution, this particular septic sequela was still found 
in 8% of cases. In 500 cases, Cusi RA also had a 
complication/ 
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complication rate of 8% for otitis, but he mentions 
that prior to the introduction of antitoxin treatment, 
the usual figure for cases exhibiting ear infections 
(16) 
was 14% Gushing makes a further very interesting 
observation, namely, that whereas about 18% of the 
cases of otitis media, occurring during the course of 
Scarlet Fever, used to develop mastoiditis necessit- 
ating mastoidectomy, the use of specific anti-serum 
had reduced the percentage by more than half; in fact, 
to 8%. Other workers infer this, in some instances, 
when they remark that not only are the complications 
(1) 
reduced in number, but also in severity. Archibald 
affords unstinted praise to the value of antitoxin in 
preventing otitis, among other complications. He also 
believes that serum benefits the actual established 
complication, for he says "Their progress was in all 
instances arrested and in many, definitely improved at 
an early period. The effect on rhinitis and otorrhoea 
would appear to suggest an antibacterial action on 
the part of the serum, as well as an antitoxic one ". 
(28) 
Gordon found very definite reduction in the 
number of cases of otitis occurring. The percentage 
incidence was roughly only half as great in serum - 
(33) 
treated patients. Harries had only 2 cases of dis- 
charging ears in 100 cases treated. Banks) and Mackenzie 
can apparently well afford to brave the criticism of 
those whose opinion it is that universal intravenous 
injection/ 
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injection of serum in Scarlet Fever is unnecessarily 
drastic, for again their record shows that no case, 
out of 404 treated, developed otitis media. 
It seems almost a pity to have to temper the 
zealous enthusiasm of the above protagonists by intro- 
ducing arguments for the negative, but the fact that 
the balance has still to be held suggests that many 
modifying factors are at work. In the future it may 
be necessary to look much wider than the laboratory 
and the disease and their inter -relation; the vast 
importance of a knowledge of the previous physiology 
and pathology of Scarlet Fever patients will, almost 
undoubtedly, be increasingly realised. 
.(34) 
Hustler is definitely of the opinion that the 
percentage number of cases of otitis was not any less 
as a result of the introduction of specific therapy. 
(77) 
von Borman was equally unable to demonstrate, in 
his series of 102 cases, that any inhibition of otitis 
(12) 
media followed the use of antitoxin. Buschmann argues 
in the same strain as the two foregoing observers. 
In an article on the proceedings of the Congress on 
(54) 
Scarlet Fever at Konigsberg, Meyer states that the 
unanimous opinion expressed by the members was that 
septic sequoias (which necessarily includes otitis 
media) were not at all reduced in relative incidence 




during the early stage of the disease. Gordon has 
already been quoted as finding that polyvalent anti - 
streptococcic serum had a more beneficial effect on the 
incidence of complications than had Scarlet Fever Anti- 
toxin. Once again he records the same conclusion with 
regard to ear involvement in the septic stage. In his 
series of 1021 patients, he found that 11.5% of serum - 
treated cases developed otitis media. Patients treated 
with polyvalent anti- streptococcic serum were much more 
satisfactory, only 6.6% having purulent discharge from 
(45) 
the middle ear. Luni.n carried out careful clinical 
observations at the hauchfuss Children's Hospital, but 
he failed to discover that ear complications were less 
common in treated, than in untreated, cases. 
(66) 
Qualified findings: - Robb states that only 2 cases 
of mild otorrhoea occurred in a series of 100 patients. 
(17) 
All his cases were treated very early. The Dicks found 
that the fundamental requirement in the prevention of 
septic complications was the early administration of the 
antitoxin. Of 64 cases treated on the first day of 
disease, only 1 case developed otitis media; this was 
actually the only complication found in the whole series. 
Oases treated on the second day of disease had a much 
less favourable clinical course; of their number (59), 
five developed middle ear infection and one of those 
affected developed mastoiditis. CraigSalso notes that 
there/ 
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there was a smaller percentage of cases of otitis media 
in Scarlet Fever patients receiving antitoxin on the 
first and second days of disease than in those treated 
(6) 
at a later period. Benson and Maciver found that if 
antitoxin were given after the third day of disease, 
the incidence was comparable to that in untreated cases. 
Birkhaug says that he had no case of otitis in cases 
of Scarlet Fever receiving adequate antitoxin treatment 
on or before the fourth day of disease. 
My experience is that otitis media is infinitely 
more common in children under five years than in any 
other age -group. To state a percentage occurrence for 
a large series of cases is sometimes misleading. The 
best method is to give the number of cases for each 
age group as well as for the total cases treated on 
the various days of disease. In the series of 106 
cases treated at King's Cross Hospital, Dundee, there 
were 4 instances of suppurative otitis media. All 
occurred in the 1 -5 years age-group which comprised 
32 cases of Scarlet Fever. There was thus a percentage 
incidence of 12.5% for the age- group, although only 
3.8% for the total cases under review. One patient was 
a male and the other three were females. No case of 
otitis media was found among the patients receiving 
antitoxin on the first day of disease; 1 occurred in 
the series treated on the second day; 1 also among 
third -day cases. The other two instances were in 
patients/ 
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patients not undergoing specific therapy until after 
the third day of disease. No case of mastoiditis 
occurred in the series. 
The age -group 1 -5 years, in which the complication 
developed, comprised 17 males and 15 females. Seven 
males were treated with serum on the second day of 
disease without the occurrence of any case of otitis, 
whereas in the females, numbering only two, treated on 
the same day, one case of otorrhoea developed. The 
only case of purulent discharge from the ears in male 
patients was one where antitoxin was administered on 
the third day. In this age- group, eleven patients 
(5 males and 6 females) had antitoxin after the third 
day of illness, yet no case of otitis occurred in the 
male portion, whereas two cases were found among the 
six females. 
Admittedly, the numbers are too small to allow of 
any definite conclusion, but from observations previous 
to and consequent on the period when the cases under 
discussion were selected, I am unwilling to agree that 
there is any real decrease in the incidence of otorrhoea 
as a result of serum therapy. The early admission to 
hospital, permitting of expert nursing in the toxic 
phase, may have as much to do with limiting the number 
of discharging ears as has the administration of 
Scarlet Fever Antitoxin. I think that attention ought 
to/ 
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to be concentrated on the age-group or age-groups in 
which otitis most commonly occurs in attempting to 
assess the virtues of antitoxin in preventing this 
complication. There must be considerable variability 
in the ages of patients per cent of hospital populations, 
resulting in widely divergent records of the complica- 
tion -rate in Scarlet Fever. Statistical surveys of 
experimental work anent a new therapy should certainly 
take account of the individual age-groups most con - 
corned, when dealing with the several complications, 
rather than emphasising the variation per cent of total 
cases treated. 
Rhinitis : - Sepsis of the nasal mucosa and acces- 
sory sinuses occurs in about 8% of Scarlet Fever 
patients. It is a late complication and is chiefly 
seen in children under ten years, but the age dis- 
tribution is not at all limited, As in otitis, the 
type of patient most likely to develop rhinorrhoea is 
the one having pre-existing throat or nasal abnormal- 
ities. The whole of the statistics with reference to 
rhinitis may be made or marred by the competence of 
the nursing staff. The condition certainly spreads 
at a great rate unless the strictest vigilance is 
observed. 
Banks and Mackenzie were not completely successful 
in ousting this complication by means of the intra- 
venous/ 
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intravenous injection of antitoxin, but they present a 
very creditable record, having had three instances of 
rhinitis in over four hundred cases of Scarlet Fever. 
(33) 
Harries quotes no case of nasal sepsis in 100 cases; 
a really remarkable record, if the majority of the 
(56) 
patients were children. Nankivell came to the con- 
clusion, after careful observation of thirty cases of 
severe Scarlet Fever, that rhinitis was very much 
(28) 
reduced in frequency by antitoxin. Gordon had only 
5 cases of rhinitis in 317 patients treated. He notes, 
in addition, that the condition cleared up more 
quickly in serum -treated patients than in others. 
(1) 
Archibald makes an observation with regard to rhinitis 
similar to the one quoted in the discussion on otitis 
media. He therefore agrees with Gordon's opinion, 
that antitoxin hastens the disappearance of purulent 
(16) 
nasal discharge. Cushing was extremely favourably 
impressed with the action of antitoxin in inhibiting 
(10) 
rhinitis. Bröcker reports that no case of rhinitis 
occurred during the course of disease in 50 patients 
treated specifically. 
The findings of the above workers are by no means 
the unanimous verdict of all careful observers. 
(29) 
Gordon and his co- workers had actually more cases of 
rhinitis in treated than in untreated cases of Scarlet 
(31) 
Fever. Gottsche sees no reason to believe that any 




concerned, results from specific therapy. von Borman 
says that his experience was that the percentage 
incidence of rhinitis was about the same for treated 
(51) 
and untreated cases. McLachlan and Hunter had one 
case of rhinitis in 13 patients treated with antitoxin 
on the first day of disease; 4 instances in 72 patients 
treated on the second day; 3 in 43 third day cases; 
a Similar number in 49 undergoing antitoxic therapy 
on the 4th day. There is no possible ground for 
asserting that their statistics show that any beneficial 
inhibitory influence on the incidence of rhinitis is 
exerted by Scarlet Fever Antitoxin. 
But, just as in discussing the other complications, 
it is necessary to consider the findings of those 
workers who qualify their findings by relating them 
to the day of disease when antitoxin was administered 
and concluding that early treatment means a lowered 
(14) 
percentage of complicated cases. Chodzko found that 
no case of rhinitis occurred in patients having anti- 
toxin on the first day of disease. Thereafter, the 
numbers showed progressive increase, until,when the 
patients were not subjected to specific treatment until 
after the fourth day of disease, there was no notice - 
(66) 
able decrease in the occurrence of rhinitis. kobb 
states a strong case for the early institution of 
antitoxin treatment in cases of Scarlet Fever. In his 
detailed/ 
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detailed record of 100 cases treated early, it is noted 
that no case of rhinitis occurred. 
I can find no evidence in my series of cases to 
suggest that antitoxin plays any useful part in sup- 
pressing rhinitis in the late stage of Scarlet Fever. 
The community served by the hospital, where the cases 
were collected, was a working -class one, veering to- 
wards pauperism. Rickets and Congenital Syphilis were, 
in my opinions more than usually evident and they may 
account for the relatively large percentage incidence 
of Rhinitis . Certainly 1 am unable to incriminate 
the hospital staff in any way, for in one ward which 
was particularly affected by the complication at one 
period (it had been receiving patients for several days 
from a very undesirable quarter in the city) was super- 
vised by one of the most competent and energetic 
Hospital Sisters I have over known. 
Of 32 patients in the Age-group 1 -5 years, 22% 
had rhinitis. Patients in the next age-group numbered 
26 and of these 23% had the complication. A consider- 
able fall in the incidence is noted in the age-group 
10-15 years, although a percentage of 12.5% cannot be 
regarded as a satisfactory indication of benefit 
derived from antitoxin. In the 15 -25 age-group, there 
were 31 patients and rhinitis only occurred in 3.2%. 
The complication is not common in this age -group in 
ordinary records of the disease and the low figure 
recorded/ 
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recorded is of no value at all. The sexes were affected 
about equally throughout. 
With regard to the relative incidence in cases 
treated on various days of disease, it will be seen 
from the analytical tables given at the end of the 
thesis, that 10% of cases treated on the first day of 
disease had rhinitis; 23% of second day cases were 
affected; only 9.7% developed rhinitis, when antitoxin 
had been administered on the third day and 11.4% of 
those undergoing specific therapy later than the third 
day. 
It was mentioned when discussing Otitis that 
prolonged concentration by competent observers on the 
age -groups most affected was required. The statement 
may be reiterated here. The decrease of the gross 
percentage of complications is of far less importance 
than (a) the definitely beneficial effect in the age- 
groups seriously affected and (b) the demonstration 
that any particular therapy is enhanced in its action, 
in proportion to the day of disease on which it is 
administered. 
Cardiac Complications:- These are very rare in 
actual practice. When they do occur, they are usually 
seen in conjunction with arthritis, but that does not 
signify that they are a sequel to the joint complica- 
tion, but rather a further manifestation of the 
toxicity/ 
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toxicity of the disease which makes arthritis possible. 
It is not proposed to deal with affections of the 
individual coats of the heart separately. The total 
incidence of any cardiac involvement will be suf- 
ficient to demonstrate whether or not antitoxic therapy 
is distinctly beneficial in this connection. Ordinarily, 
from 1 case in 200 to 1 in 500 may be expected to 
develop signs of the local effects of Scarlet Fever 
Toxin on the heart. No account will be taken of 
the temporary cardiac abnormalities which occur in the 
early phase of the disease. In two of his records, 
32 & 33) 
Harries makes a special note that no case of cardiac 
complication occurred in the case treated with anti- 
toxin, whereas untreated cases showed the usual in- 
(4) 
cidence of carditis. Banks and Lackenzie report 
that all of their 404 patients, treated intravenously, 
(29) 
escaped cardiac mischief. Gordon, Bernbaum and 
Sheffield found that 3.5% of 285 serious cases of 
Scarlet Fever had carditis, although specific therapy 
had been used; the percentage was roughly comparable 
to that in 120 severe cases treated by the injection 
(51) 
of convalescent serum. McLachlan and Hunter note 
one case of cardiac irregularity among 230 patients 
treated and that particular patient had not received 
antitoxin until the fifth day of disease. Cardiac 
irregularity is a disappointing classification in a 
statistical survey. In dealing with children, nothing 
is/ 
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is more common in the cardiac action than irregularity 
- apart from sinus arrhythmia - and the only one of 
grave import, in my opinion, is the presence of extra 
(66) 
systoles. Robb details no case of impairment of the 
heart's action in 100 cases of Scarlet Fever having 
Lund early antitoxin treatment. Craig found that cardiac 
complications were completely inhibited in 512 cases 
treated with serum. 
The writer's series of cases shows an unfortunately 
high incidence of sequelae affecting the heart. Out 
of 106 cases of Scarlet Fever, one had Endocarditis 
and another Liyocarditis. The case of Endocarditis 
occurred in a patient treated on the third day of 
disease and the caso developing myocarditic signs was 
treated after the third day of illness. The former was 
a malo patient in the 5 -10 years age-group; the latter 
a female in the 1 -5 years age group. The Scarlet Fever 
patient exhibiting myocarditis was suffering from the 
septic form of the disease. Heart signs developed on 
the seventh day of illness. The patient developing 
endocarditis, did so on the nineteenth day and was an 
ordinary case of Scarlatina Simplex on admission. 
The writer is of the opinion that antitoxin is 
impotent to inhibit cardiac complications. It is true 
that no involvement of the heart occurred in patients 
receiving specific therapy on the first two days of 
illness, but an incidence of 2 cases out of a total 
of/ 
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of 106 patients treated, is above the average incidence 
when expectant methods of therapy are utilised. 
Other Complications: - Little, if any value, can 
be placed on the percentage incidence of rare com- 
plications, comparing treated with untreated cases. 
The only complications coming under this heading, in 
the writer's series of cases, were:- 2 cases of Peri- 
tonsillar Abscess and 1 case of Conjunctivitis. 
One of the patients developing Peritcn_sillar Abscess 
was a female in the 10 -15 years age-group. She had 
had antitoxin on the first day of disease. Cervical 
adenitis became evident on the fourteenth day of illness 
and seven days later the classical signs of quinsy 
made their appearance. The second instance of the 
complication was in a male patient in the 15 -25 years 
age -group. He had undergone specific therapy on the 
fourth day of disease and had no other septic sequela 
during the course of the illness; there was enlarge- 
ment of the lymph glands draining the affected peri - 
tonsillar region. 
The case of Conjunctivitis occurred in a male 
patient in the 10 -15 years age -group and the condition 
was particularly refractory to treatment, thereby 
necessitating an extension of stay in hospital of 
three weeks. There is a possibility in cases of this 
kind that involvement of the eyes may be determined 
b y/ 
165. 
by refractive error. In ophthalmological practice, 
the writer finds almost without exception that where 
stye or blepharitis or conjunctivitis or keratitis 
selects one eye for its inflammatory activities, that 
eye is defective in its refraction. If both eyes have 
refractive errors and only one is the seat of a patho- 
logical process, the affected eye has invariably the 
greater refractive error. This observation is pro- 
bably not beside the point and it strengthens the 
argument that the previous health of patients should 
be known in detail, in order to assess accurately the 
part played by a specific disease in causing complica- 
tions and the degree to which various organs and 
tissues are already predisposed to complicatións by 
reason of inherent defects. 
Septic and Toxic uses : - These may be dealt with 
here, for they are, in fact, complicated cases for 
the time of onset. It is to be expected, theoretically, 
that toxic cases will benefit very materially from 
antitoxic serum, whereas septic cases will be less 
obviously influenced. Both types are relatively un- 
common, but nevertheless contribute considerably to 
the number of deaths from Scarlet Fever, the case - 
mortality being high and particularly so in the toxic 
(33) 
variety. Of five deaths in Scarlatina, Harries states 
that two were due to the septic form of the disease and 
one / 
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one to the toxic variety. 
(69) 
Schottmuller records that of six hypertoxic and 
apparently hopeless cases of the disease, three re- 
(80) 
covered as a result of antitoxin treatment. Zikowsky 
states that in 60 cases of severe Scarlatina, largely 
made up of septic and toxic cases, the case mortality 
was reduced to the very satisfactory figure of 5% by 
adequate serum therapy. In another treatise, the same 
(81) 
observer notes that in four septic cases included in 
a series of 73 cases, antitoxin had no observable 
effect and all proceeded to a fatal termination. 
(41) 
Lautier and Dreyfus say that marked benefit was de- 
rived from serum in the treatment of toxic cases, 
improvement rapidly following the administration. 
(12) 
Buschmann similarly praises the action of antitoxic 
therapy in toxic forms of the disease. 
Baxter) found that the results of specific anti- 
toxin treatment of septic cases gave disappointing 
results. 
(7) 
Bipoli concludes from his observations that, when 
given within three days of onset, antitoxin has a 
particularly beneficial effect on the hypertoxic forms 
of Scarlet Fever. He also records that septic cases, 
(15) 
if treated early, undoubtedly benefit. Craig's series 
of 512 treated cases included ten septic and two toxic 
cases, all of which recovered. All were treated early 




O'Brien says that septic cases are not, in his 
opinion, favourably influenced by antitoxin. Benson 
and Liaciver remark that their critical observation of 
cases did not lead them to conclude that septic cases 
reacted favourably to antitoxine 
There is absolute agreement that toxic cases of 
Scarlet Fever derive marked benefit from specific 
therapy. The writer's series of cases does not in- 
clude any toxic cases, but the fact is immaterial, 
for controversy on the effects of Scarlet Fever Anti- 
toxin on such appears to be non- existent. 
The same cannot be said with regard to septic 
cases. Some observers are satisfied that these are 
favourably influenced by antitoxin and others are 
either uncertain that mitigation of the septic process 
follows the administration of serum or are quite un- 
complimentary to the treatment as it applies to Scarla- 
tina Maligna. 
Three cases of the septic variety of Scarlet Fever 
are included in the writer's series. One was a female, 
aged 3 years, admitted on the 10th day of disease and 
given antitoxin on the same day. The temperature did 
not regain the normal until the nineteenth day. The 
patient made a very slow convalescence and was not fit 
for discharge until the 108th day of disease. A very 
persistent and wearing Otitis Media was the cause of 
such a prolonged sojourn in hospital. 
The/ 
168. 
The second case was that of a boy of four and a 
half years, admitted on the fifth day of disease and 
treated on the same day. The temperature only became 
normal on the 17th day and convalescence was very 
tedious. General debility necessitated his stay in 
hospital for a considerable period and a very late 
rhinitis (61st day) then appeared, resulting in the 
postponement of discharge until the ninety- second day 
of disease. 
The other septic case was a girl of four years, 
who was admitted on the fourth day of disease and 
whose temperature subsided after eight days. The 
length of stay in hospital was 51 days in this instance. 
I can find no evidence from the clinical course 
of the septic cases referred to above, or from observa- 
tions of a number of other septic cases treated with 
antitoxin, that any definite curative influence is 
exerted by Scarlet Fever Antitoxin on this particular 
variety of scarlatina. 
Deaths : - The case mortality is very variable, 
but probably the limits are roughly from 1% to 4% in 
untreated cases. If specific therapy is really effect- 
ive, antitoxin- treated cases in this country should 
show a very low percentage death -rate. It has been 
demonstrated fairly conclusively in the foregoing 
portion of this chapter that the initial toxaemia of 
Scarlet Fever is very definitely reduced and particu- 
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particularly are toxic cases benefited. Deaths occur- 
ring should therefore be found to be chiefly from 
Septic Cases, Septic Complications, or cases treated 
late in the disease. 
No deaths occurred in the writer's cases. 
Archibald) says that although all the cases treated 
were of the severe type, the case - mortality was only 
a fraction of 1%, whereas the usual case mortality in 
(56) 
untreated cases was 1.6%. Nankivell had no deaths in 
30 severe cases, while an equal number of untreated 
cases included two patients who nearly died from serious 
complications and whose lives were apparently saved 
by the late administration of antitoxin. Baxter 
(5) 
had 
two deaths in 100 cases treated. He qualifies this 
comparatively high case -mortality by detailing the 
causes of death. One was a Septic case and the other 
fatality was probably determined by a co- existent 
(43) 
Gastro -Enteritis and Broncho- Pneumonia. Lenthe re- 
cords one death in 44 cases; the victim of the disease 
was not treated with serum until the ninth day of 
(45) 
illness. Lunin experienced a moderately high case- 
mortality in his series of cases treated in the Rauch - 
fuss Children's Hospital. Six children out of a total 
of a hundred died. But all of the deaths except one 
were due to Septic complications; the sixth was due to 
Broncho -Pneumonia following Measles. 
(75) 
Toomey not only finds that serum treated cases 
had/ 
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had a higher percentage incidence of complications than 
untreated cases, but also that four deaths in 283 
patients treated, were directly attributable to anti- 
toxin. All four died of anaphylactic shock. Such 
findings are not reassuring. 
(81) 
Zikowsky states that he had four fatal cases in 
73 severe attacks. All the deaths occurred in septic 
(17) 
cases. The Dicks had no fatalities among patients 
who had had antitoxin before the sixth day after the 
(15) 
disappearance of the eruption. Craig records only one 
death in 512 patients and he notes that there was 
tuberculous peritonitis present. 
The above extracts from the literature substantiate 
the thesis postulated with regard to the type of case, 
which, in spite of antitoxin treatment, may progress 
to a fatal termination. 
Now to hark back to the beginning of this section 
of the treatise and to deal with the two alternatives 
stated there. The first of these was:- "The Incidence 
of Complications should be markedly diminished as a 
result of specific therapy ". Critical analysis of the 
findings of other observers, combined with deductions 
from the statistical record of the writer's own cases 
allow certain conclusions to be formed. (1) That the 
incidence of nephritis is definitely lessened by anti- 
toxin treatment of the toxaemia of Scarlet Fever. 
Given/ 
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Given early, it renders the possibility of this com- 
plication very remote. (2) Adenitis, Otitis, hh.initis 
and comparable septic sequelae generally, are not 
favourably influenced by serum treatment of the toxic 
phase of Scarlatina. (3) Cardiac complications are 
as common when serum has been administered as when 
non -specific methods are employed. (4) Arthritis is 
probably minimised in its percentage occurrence by 
very early serum treatment. 
Having taken up an indeterminate position in this 
aspect of the antitoxin treatment of Scarlet Fever, 
the second alternative requires to be faced: - 
"A scientific explanation of the failure of antitoxin 
to reduce the complication -rate appreciably is required ". 
The theory of unidentical toxins readily presents 
itself as a possible solution to the anomalies in the 
findings of different observers. If a number of sub- 
groups of Streptococcus scarlatinae exists, producing 
unidentical but closely related toxins, it is possible 
that only a percentage of cases of Scarlet Fever cases 
treated by means of serum are, in fact, specifically 
treated. Such would explain with a fair measure of 
satisfaction the praiseworthy effects of antitoxin 
recorded by many observers, without invalidating the 
disappointing results obtained by others. But the 
consistently good results on the toxaemia of Scarlet 
Fever could hardly be attributed to a serum which was 
other 
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other than specifically antitoxic. 
The empirical standardisation of antitoxin must 
be kept in mind, but it is probably less important than 
appears on the surface. No commercial firm of repute 
can afford to give anything less than its best to 
experimental medicine and almost certainly no such 
laboratory falls short of the true realisation of its 
responsibility in the matter. Even if a definite 
standardisation were possible, as it is in Diphtheria, 
there is no means of standardising the disease in the 
same way. The number of Streptococci scarlatinae 
cannot be gauged within thousands of millions; neither 
can the rate of the production of toxins in vivo be 
measured, for each individual attacked reacts at a 
different rate in the matter of phagocytosing bacteria, 
neutralising their toxins, eliminating toxins, fixing 
toxins and actively preventing or passively allowing 
the inroad of pathogenic micro -organisms. Some scient- 
ists are almost too exact; a sprinkling of philosophy 
might, on occasion, modify their outlook. For instance, 
having carefully standardised Diphtheria Antitoxin 
and decided the most serviceable scale of contents of 
ampoules of the remedy, hardly any two experts are 
agreed as to actual dosage in the disease itself. 
This is entirely because Diphtheria cannot be standard- 
ised and its special treatment must remain a qualified 
empirical/ 
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empirical one as regards the amount of antitoxin used, 
the qualification being that the unit, in terms of 
Minimum Lethal Doses of Diphtheria Toxin for a guinea - 
pig of 250 grammes, is known and moderately constant. 
The early fixation of toxin by certain tissues 
offers scope for deductions, with reference to the 
inability of antitoxin to prevent septic complications. 
Earlier in this work, quotations were made from eminent 
authorities who are of the opinion that the destructive 
action of the toxin of the causative organism makes 
the later bacterial invasion possible. This hypothesis 
is interesting and is, in the writer's opinion, a com- 
paratively satisfactory explanation of the relative 
escape of joints and kidneys in antitoxin -treated cases. 
Fixation of toxin is probably integrally bound up with 
the rate of tissue fluid exchange. Because of their 
function, the kidneys must permit of rapid interchange 
of fluids as well as actively excreting harmful sub- 
stances. The continuous bathing of the renal tissues 
- and particularly the glomeruli - with fluid of a 
rising antitoxic titre, cannot fail to give the 
maximum "unfixing" result. Similarly, the joints are 
richly supplied with blood and the secretion of 
synovial fluid, along with extensive lymph drainage, 
must hasten fluid interchange around articulations. 
This, in turn, speeds up the local increase in con- 
centration of antitoxin, thus enhancing the protection 
of the structures concerned. 
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Structures which are prone to septic infection in 
Scarlet Fever are such as have a relatively slow ex- 
change of fluids, in the sense that their nutrition is 
by means of very gentle diffusion. Toxins are much 
more readily diffusible than antitoxins and accordingly, 
a moderately concentrated and prolonged toxic action 
precedes the neutralisation process. The result is 
probably an intimate distribution of toxin, which so 
cripples the involved tissues that recovery is very 
slow; too slow to have been substantially established 
before the micro-organisms themselves attack. 
EFFECT OF SCARLET FEVER ANTITOXIN ON THE LENGTH. OF STAY 
IN HOSPITAL. 
The normal period of detention in Hospital for 
uncomplicated cases is 28 days. But the average length 
of stay is much greater than this, because the septic 
processes which are mainly responsible for lengthening 
convalescence are usually slow in clearing up. 
It may be assumed almost at once that, since 
complications regarded "en bloc" are not materially 
reduced in incidence or shortened in duration, anti- 
toxin can have little effect on the average length 
of stay. There is naturally as little concurrence of 
opinion/ 
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opinion in this aspect of the therapy as has already 
been noted when discussing the complications of Scarlet 
Fever. 
(15) 
Craig records a considerable reduction in the 
average detention in hospital as a direct result of 
antitoxin treatment. Baxter) states that, of 100 
patients treated, only two had to remain in hospital 
(28) 
beyond a period of six weeks. Gordon concludes that 
serum treatment lessened the average stay in hospital 
by at least a week; in fact, he says from seven to ten 
(56) 
days. Nankivell observed a similar reduction of 
7 
hospital detention in his series of cases. harries 
says that from his observations, more patients could 
be discharged by the thirtieth day of disease, when 
antitoxin had been used in treating Scarlet Fever. 
3 ( 
Banks discharged sixteen patients, who had been 
treated intravenously, after about a fortnight's 
residence in Hospital. All had been treated within 
the first four days of disease. The patients in this 
series were all boys between 12 years and 18 years of 
age. Speaking at the Annual Meeting of the Fever 
Hospital Medical Service Group of the Society of 
Medical Officers of Health in 1929, the same observer 
said that in 300 cases, extending over a period of 
seven months, the average stay in hospital had been 
sixteen days. Continuing, he said that adults did 
so well that they were discharged, as a rule, after 
eight/ 
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eight or nine days. 
(66) 
Robb notes that discharge from hospital had been 
possible earlier, since the introduction of antitoxin 
treatment. In the later period of his experimental 
clinical work with antitoxin, he had released a number 
of patients after a period of isolation varying from 
seventeen to twenty -four days from the date of onset 
of the disease. The statement has a qualification, 
that all such releases were cases which had undergone 
specific therapy very early in the disease. 
The question of the effect of Scarlet Fever Anti- 
toxin on the Length of Stay in Hospital, of cases of 
Scarlet Fever, resolves itself into (1) The effect of 
antitoxin in the prevention of complications. 
(2) Can a definite prognosis be given? (3) Do cases 
treated early have a shorter average stay than cases 
treated late in the disease? 
The first of these has already been dealt with 
in full on another page and it was definitely concluded 
that, with the exception of nephritis and probably 
arthritis, the early treatment of patients with anti- 
toxin was no adequate safeguard against complications. 
Banks appears to take an unreasonable risk in dis- 
charging patients so early as the sixteenth day, for 
a large proportion of septic complications do not make 
their appearance by that time. A few quotations from 
my/ 
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my series of cases may be instructive in this respect. 
A female patient in the 1 -5 years age-group, treated 
with antitoxin on the first day of disease, developed 
Adenitis on the 24th day and Khinitis on the 37th day. 
Another female patient in the 10 -15 years age-group, 
treated on the first day of disease, commenced symptoms 
of peritonsillar abscess on the 21st day of disease. 
Numerous examples of late septic complications could 
be quoted from the records of patients treated on the 
second and third days of disease. 
The second point: Can a definite prognosis be 
given, when antitoxin has been employed in the treat- 
ment of Scarlet Fever? My own cases convince me that 
it is foolish to attempt to try to select patients who 
will make an uneventful recovery. I have to admit that 
it may be entirely different when cases are treated 
intravenously, but as I believe few clinicians would 
feel justified in applying this drastic method of 
therapy to ordinary cases of Scarlet Fever, the excel- 
lent results obtained by Banks can hardly be taken to 
represent the general findings in the matter. biy own 
observations leave me satisfied that there is no royal 
road to uneventful convalescence through the agency of 
intramuscular injections of Scarlet Fever Antitoxin. 
Comingto the third point: Do cases treated early 
have a shorter average stay in hospital than cases 
treated late in the disease? In my series, the average 
detention/ 
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detention in Hospital for cases treated on the first 
day of disease was 41 days; for cases treated on the 
second day, 34 days; third day cases remained 31.5 
days on an average and 33 days represents the period 
for cases treated later than the third day. The average 
length of stay in Hospital for all cases treated was 
34 days. The average Day of Disease on discharge was 
the 37th. It may be noted that clean cases were dis- 
charged on the 28th day of disease and not after 28 
days? Stay in Hospital. 
I am unable to discover that antitoxin exerted 
any favourable influence on the length of stay in 
Hospital. The figures quoted for my cases correspond 
very closely with those given for untreated cases in 
Aberdeenshire, as reported in the Medical Officer, 
1926, V.36, p.213. The average duration of Stay in 
Hospital is stated as 37.7 days, when the minimum 
detention was 28 days (not until the 28th day of disease 
as was my custom). 
THE EFFECT OF SCARLET FEVER ANTITOXIN ON TEE 
PERCENTAGE OF "RETURN" CASES. 
If a case of Scarlet Fever is admitted to Hospital 
and the patient found to have been in association with 
a patient discharged from Hospital after an attack of 
the / 
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the disease, it is called a "return" case, provided 
that not more than the arbitrary period of 28 days has 
elapsed since the release from Hospital of the "infect- 
ing" case. The type of patient chiefly responsible for 
"return" cases is the one who has suffered from one of 
the septic complications of the disease, notably 
rhinitis. The percentage of "return" cases varies, 
depending partly, at least, on the assiduity with which 
investigations of the possible source of infection are 
carried out. Co- incidence has also to be kept in mind, 
as was mentioned in an earlier chapter. 
Various investigators have given widely divergent 
percentages for "return" cases of scarlatina. From 
just over V, to nearly 5% are found in the literature. 
(51) 
McLachlan and Hunter give a report on the con- 
dition of patients after discharge from hospital and 
this tends to show that although there are no obvious 
complications at the time of discharge from hospital, 
it does not necessarily follow that the patients have 
ceased to be infected with the Streptococcus scarlatinae. 
Of 230 patients treated in Hospital, McLachlan and 
Hunter state that 63 were complicated. The usual 
standard was required for discharge, yet when home 
visits were made, 37 were found to have septic sequelae. 
Of these, 16 cases were due to recurrence of complica- 
tions after leaving Hospital, while 21 cases developed 
complications for the first time at home. A large 
percentage/ 
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percentage of the total complications found, was due 
to rhinitis. 
The above is a strong argument against the limita- 
tion of "return" cases as a direct result of serum 
therapy. It is also very suggestive of the existence 
of numerous carriers of the Streptotoccus scarlatinae 
among patients discharged as "clean" cases. The 
tonsils, the adenoid tissue in the naso- pharynx, the 
nasal spaces and their adjacent sinuses offer excellent 
protection for the micro- organisms and it must be very 
difficult indeed to be certain that the invader has 
not only been forced to recede but has also been com- 
pletely ousted from the tissues of the host. Until 
some relatively rapid bacteriological test can be 
applied to convalescents, as is now applicable in 
Diphtheria, there must continue to be a risk consequent 
on the release from.Hospital of every convalescent 
patient. Some workers have found nearly 50% of throats 
harbouring the Streptococcus scarlatinae at the end of 
thirty days from the onset of disease; this implies 
that probably several months are required before all 
discharged patients are completely free from infection. 
It has already been noted that the incidence of 
septic complications is not reduced by antitoxin and 
it follows that the number of "return" cases is un- 
likely to be limited by the use of specific therapy. 
If an anti bacterial serum were available, there would 
almost/ 
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almost certainly be a very different opinion formed, 
but at present no such serum has been satisfactorily 
demonstrated in the therapeutics of Scarlet Fever, 
(49) 
Fair MacFarlane had only 1.7% of "return" cases, 
although he discharged patients very early - adults 
had an average stay in hospital of eight or nine days - 
but the result does not necessarily imply a beneficial 
influence on the incidence of "return" cases. 
Apparently, MacFarlane intends to convey this favour- 
able impression. All the cases were clean on discharge, 
because the period for the onset of septic processes 
had not then arrived. If and when sepsis did manifest 
itself, there would tend to be more rapid recovery than 
occurs in hospital, where it is the massive infection 
in wards that undoubtedly contributes largely to the 
lingering of septic processes. If each patient with 
a septic sequela could be completely isolated, I feel 
sure the complication would disappear much more rapidly 
than is the case in the average Scarlet Fever Ward. 
Incidentally, rhinitis is not really common in adults 
and it is pre -eminently the cause of "return" cases. 
(66) 
Robb prefers a period of 42 days as the time- 
limit for calculating the percentage of "return" cases. 
Even then, the figure he quotes is only 2.7%. This 
seems to point in the direction of discounting the 
time elapsing between the discharge of a patient and 
the/ 
182. 
the admission of a "return" case. And such an argument 
is perfectly logical, for it is the definite relation 
which is of primary importance and which must remain 
so until Hospital Staffs are able to give a clean bill 
of health, based on laboratory findings, to persons 
leaving Fever Hospitals after an attack of Scarlatina. 
My series of 106 cases includes only one "return" 
case (0.94 %), which was admitted 15 days after the 
discharge of the "infecting" case, but this low apparent 
incidence does not convince me that antitoxin was neces- 
sarily responsible for such a satisfactory percentage. 
Very careful enquiry by medical practitioners might 
have modified the percentage considerably. Moreover, 
the type of home to which a patient is discharged is 
certainly important. If a discharged patient is the 
only child in a household, very ordinary precautions 
will obviate further cases, for the adults are probably 
already immune and child relatives will be discouraged 
from visiting for the time- being. Similarly, because 
in the submerged tenth of the population, the percentage 
of immunes is very high among children, there is little 
chance of "return" cases occurring. The state of 
overcrowding and insanitary conditions generally would 
very probably cause all the susceptibles to be in- 
fected at the time of the development of the disease 
in the first, instance. 
On/ 
On the other hand, the well -to-do working -class 
and the middle -class homeswith families of two or three 
children are likely to provide more "return" cases. 
The young inmates have been sheltered during their early 
years and probably, as a result, have not acquired an 
immunity to the disease. They readily become infected 
if the discharged sister or brother should still harbour 
virulent Streptococci scarlatinae. 
THE PROPHYLACTIC USE OF SCARLET FEVER. ANTITOXIN. 
Cross -infections are the dread of those in clinical 
charge of Hospitals for Infectious Diseases. Yet they 
are not uncommon, in spite of the utmost vigilance and 
therefore any measure which is likely to minimise 
their incidence is welcomed whole -heartedly. Whatever 
may be said for or against the antitoxic therapy of 
the disease itself, one thing, I think, is conclusively 
proved and that is, the great value of Scarlet Fever 
Antitoxin as a prophylactic. 
Everyone is agreed that the best prophylactic 
against Scarlet Fever is the development of an active 
immunity. This is possible either as a result of sub- 
infective doses of the Streptococcus scarlatinae un- 
known to the individual or by the injection of in- 
creasing doses of Scarlet Fever toxin. But the 
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acquisition of an active immunity is a useless pro- 
position when it is desired to protect patients who 
have already been exposed to the disease and who are 
positive Dick- reactors. The only method then available 
is to provide patients with a temporary security 
against the development of the disease. 
It is very advantageous to test all admissions - 
other than Scarlet Fever patients, of course - for 
susceptibility to Scarlatina and to have the result of 
the test charted. If a case of Scarlet Fever is then 
found at any time in the ward, there is no loss of 
time in taking steps to prevent the spread of the 
disease. All Fever Hospitals do not have a sufficiency 
of Side-Wards to permit of dividing susceptible contacts 
into small groups, but much can be done, even in the 
absence of ideal facilities. There is usually a con- 
siderable percentage of Dick- negative patients in a 
ward, if several age-groups are represented. Advantage 
should be taken of this by alternating "negative" and 
"positive" patients' beds during the rearrangement 
which becomes necessary. I have usually endeavoured 
to obtain an even more liberal spacing, in dealing with 
the susceptible contacts who had been in immediate 
proximity to the case of Scarlet Fever; two "negatives" 




Immediately after the removal of the case from 
the ward, all susceptibles should be given at least 
5.0 cc. of Scarlet Fever Antitoxin. If their Dick - 
heactions are noted as being markedly positive, a dose 
of 10.0 cc. is probably required. I have, unfortunately 
had occasion to use Scarlet Fever Antitoxin prophy- 
lactically on a considerable number of occasions in 
Hospital practice and I have been entirely satisfied 
with its action. 
In my earlier application of the preventive 
qualities of antitoxin, I was a little disappointed., 
but it was the dosage which was at fault. At that time, 
2.5 cc. were given and. I am bound to confess that such 
a dose is, for the most part, useless. But since 
giving 5.0 cc. to 10.0 cc., according to the age of 
the patient and the degree of the Dick heaction, I 
have had no second case in any ward which became 
"infected ". The sense of security is a great relief 
and especially so where patients' relatives have to be 
interviewed. There is also the additional cause for 
satisfaction that patients about to be discharged may 
be released as if no untoward incident had occurred. 
At least fourteen days immunity is ensured by prophy- 
lactic doses of antitoxin. I have Dick- tested quite 
a number of passively immunised patients at the end 
of three weeks and found them still "negative ". 
(35) 
Dr Joe's observations lend weight to my own. 
He/ 
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He states that the ordinary dose of 2.5 cc. to 5.0 cc. 
of antitoxin, used prophylactically, is not always 
sufficient. Continuing, he lays it down that if a 
Dick- positive reaction of under 20 millimetres is 
obtained, 5.0 cc. should be given. If the reaction 
exceeds that in extent, then 10.0 cc. are indicated. 
His final comment is that 5.0 cc. is only given with 
safety, if carefully decided on after examining the 
Dick teaction in patients. If no such control is 
carried out, Dr Joe considers that the routine dose 
should be 10.0 cc. 
(37) 
Kirkhope gives a detailed analytical study on 
the prophylactic use of antitoxin. He, first of all, 
tried 2.0 cc. doses of unconcentrated serum intra- 
muscularly as a prophylactic in fourteen contacts. 
One of the persons so treated, developed Scarlet Fever 
the following day. Similarly treating a second series 
of 101 contacts, he found that 10 developed Scarlet 
Fever. At this point he makes an interesting observa- 
tion as to the time elapsing between the inoculation 
and the development of the disease. In one case it 
was so long as twelve days. It has to be understood 
that the actual patients with which contacts were 
associated, were being treated at home. 
His next contacts were only three in number and 
each was given 5.0 cc. of unconcentrated Scarlet Fever 
Antitoxin. Two of the three escaped Scarlet Fever, 
while/ 
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while the other developed the disease on the same day 
as the serum was given. Such a result does not 
necessarily mean that 5.0 cc. of antitoxin were useless, 
but simply that the prophylaxis was applied too late 
in the incubation period. 
Thirty -four more contacts were given 10.0 cc. 
unconcentrated antitoxin and of their number, three 
developed Scarlet Fever. 
Experimenting now with concentrated antitoxin, 
(37) 
Kirkhope carried out prophylactic passive immunity in 
140 children, who were contacts of cases of Scarlet 
Fever. Doses varying from 2.5 cc. to 5.0 cc. were 
given and the only child who developed Scarlet Fever 
was one receiving 3.0 cc. of serum. Incidentally, 
the attack of Scarlatina did not develop until fourteen 
days after inoculation. This appears to demonstrate 
that the duration of passive immunity is probably more 
dependent on the dose of antitoxin than is the actual 
immediate protection afforded. Such a conclusion is 
a perfectly reasonable one, for destruction of the 
"foreign" immune bodies is a gradual process and the 
initial supply must have a fairly definite relationship 
to the period required for their complete removal from 
the system. 
(37) 
Kirkhope's experimental work gives strong support 
to the hypothesis that 5.0 cc. is a suitable average 
dose/ 
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dose of antitoxin in the case of a child- contact of 
(50) 
Scarlet Fever. IaicGarrity recommends the same limits 
of dosage in prophylaxis as does Dr Joe of the Metro- 
politan Asylums Board Hospital Service, namely, from 
5.0 cc. to 10.0 cc. 
In the case of very young children, say, under 
six months, the disease is so rare that prophylaxis 
by means of injecting antitoxin seems hardly justifiable. 
The apparent "natural" or "inherited" immunity to 
certain infectious diseases is an interesting one and 
has taxed the ingenuity of many eminent epidemiologists. 
Cases are on record where the infants of scarlet fever 
patients have escaped infection and yet an "inherited" 
immunity could not be offered as an explanation in such 
a case. One explanation which I have not found offered 
by any authority I have consulted is, that the escape 
from infection may be due to a simple failure to react, 
on the part of the immature organism. When it is re- 
membered that a disease is the specific reaction of 
the organism to the invasion of micro- organisms or 
other causative factor, the failure of the infant to 
produce a specific response is feasible. It is well 
known that certain parts of the nervous system, for 
instance, are very immature at birth and there is no 
reason why other organs and tissues should not be 
graded in their development. Those structures, whose 
highly specialised development at birth is essential 
to life, will naturally be completely capable of full 
function/ 
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function when extra- uterine life begins. Others, whose 
development is not so urgent, or the inhibition of 
whose complete function is actually beneficial, will 
proceed to maturity at a later period. Immature 
structures and tissues will probably be incapable of 
reacting specifically to disease. The occurrence of 
Whooping Cough in early infancy and the relative rarity 
of Measles may depend on such factors as are mentioned 
above. The trachea is certainly highly developed in 
the early months of life and its rapid and thorough 
response to adverse local conditions is of vital 
importance to the child. 
The above remarks may be entirely unscientific, 
but I am inclined to think that the immunity in early 
infancy, followed as it often is by later susceptibility, 
is of a different character from the immunity of later 
life and is probably a simple failure to react specif- 
ically to the causative agents of certain diseases. 
In the above connection, it is of interest that 
the blood of very young children has not acquired the 
group characteristics which are to be constant in the 
later period of life. It is really undifferentiated. 
This strongly suggests that a comparable state may 
exist in some of the infantile tissues, thus rendering 
recognisable specific reactions to certain invaders 
quite impossible. 
190. 
OBSERVATIONS ON SCARLET FEVER AND 
ITS SPECIFIC THERAPY. 
VII. SUMMARY AND CONCLUSIONS. 
SUMMARY - INTRODUCTORY. 
The diagnosis of Scarlet Fever may be very easy 
or very difficult. The help made possible as a result 
of laboratory research should not be ignored, although, 
as a rule, cases which are clinically indefinite are 
the ones in which serological methods of diagnosis 
render little assistance. 
Experimental therapy with specific antisera 
should demonstrate clearly that such treatment is 
uniformly valuable, before the administration of 
Scarlet Fever Antitoxin becomes a routine measure in 
Hospitals for Infectious Diseases. 
Streptococci have been consistently found assoc- 
iated with the throat lesions in Scarlet Fever since 
1885, but the struggle for the establishment of a 
definite causative relationship between streptococci 
and Scarlatina continues even up to the present. 
Many authorities have now concluded that it has been 
shown, beyond reasonable doubt, that the disease is 
the clinical syndrome of a specific reaction of the 
body to a special streptococcus, which is toxigenically 
constant/ 
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constant and which has been designated Streptococcus 
scarlatinae. 
Controls are essential in exact scientific work. 
In this respect, researches dealing with susceptibility 
to Scarlet Fever can be perfectly controlled, the same 
person being used for both test and control. But in 
the investigation of specific therapy, deductions from 
observations are seriously handicapped, because separ- 
ate individuals must be made use of as "clinical 
controls ". Before such a method can be at all re- 
liable, the previous physiological and pathological 
condition of both "treated" and "control" cases must 
be known. Close co- operation between School Medical 
Departments and Infectious Diseases Hospitals would 
do much to enhance the scientific accuracy of clinical 
therapeutics in Experimental Medicine. The difficulty 
in prognosing in Scarlet Fever must also be kept in 
mind in controlling specific therapy, the initial 
symptoms and signs not uncommonly giving an impression 
which requires considerable modification as the disease 
runs its course. In addition, the complement of 
patients per ward has some bearing on the percentage 
of complicated cases in "treated ", as well as 
"untreated" Scarlet Fever and what I have termed 
"Ward Epidemics" of various sequelae, due to relative 
overcrowding, play a part in determining the course 
of the disease in individual cases. 
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If Scarlet Fever is a clinical entity due to the 
Streptococcus scarlatinae and if the therapeutic serum 
used is specific for the disease, the results of therapy 
should compare very favourably with the text -book re- 
cords of the disease, whatever the antecedent history 
of the patients may be. The serum is probably only 
antitoxic, although some workers believe it to be anti- 
bacterial too. If it is simply an antidote to the 
toxic manifestations, it is unreasonable to expect it 
to prevent or mitigate septic complications, unless 
these are made possible by the previous crippling of 
the tissues by toxins fixed in them. The dependence 
on the aggressive action of its toxins has been postu- 
lated as a requirement before the Streptococcus scarla- 
tinae can itself invade the organs and tissues of the 
body. 
Arguing against the desirability of employing 
Scarlet Fever Antitoxin, the expedient must be weighed 
against the ultimate. Passive immunity may prevent 
the development of an adequate active immunity and thus 
increase the percentage of second attacks. Or, the 
type of disease may become modified as a result of the 
increased antagonism experienced by the causative micro - 
organism. 
The ideal method of ensuring the disappearance of 
Scarlet Fever is the universal adoption of methods 
bestowing an active immunity. The best treatment for 
any/ 
any disease is prevention. 
The spread of Scarlet Fever is probably much more 
commonly due to carriers than is at present recognised 
and the importance of carriers must, eventually take 
its rightful place in the epidemiology of the disease, 
now that the identity of the cause is regarded as 
established. Difficulties in the rapid identification 
of the organism in the laboratory still require 
solution, but, it is to be hoped, are not unsurmountable. 
Recrudescence of septic complications after discharge 
has also been shown conclusively to contribute mater- 
ially to the spread of infection, not necessarily 
confined to a period justifying the new case being 
categorised as a "return" case. Missed cases are 
certainly of moment as links in the chain during an 
epidemic. Fomites, cutlery, milk, are all capable of 
spreading Scarlet Fever. Desquamated scales have been 
incriminated, but evidence of the spread of infection 
by this means can only be justified when the possibility 
of the existence of any focus of sepsis in the desquam- 
ating patient has been ruled out. 
HISTORICAL:- 
It is more than two and a half centuries 
since Sydenham differentiated Scarlet Fever from 
Measles, but two hundred years elapsed before bacterio- 
logical method made it possible to demonstrate the 
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presence of haemolytic streptococci in the throats of 
patients suffering from early Scarlet Fever. Some time 
later, attempts were made to prepare an antitoxic serum; 
.íarmorek actually treated cases with such a preparation 
and several other notable workers took up the study. 
The laboratory pendulum has swung "for" and 
"against" the streptococcal origin of Scarlet Fever 
ever since the discovery of the consistent presence of 
a streptococcus haemolyticus in the throats of persons 
affected; an oscillation of great amplitude in one 
direction being followed, as soon as experimental 
evidence would permit, by an equally pronounced devia- 
tion in the opposite direction. Not only have extreme 
views been put forward, but intermediate positions have 
also been taken up; some recording that the finding 
of the streptococcus was not the whole story; some 
putting forward symbiotic theories; some regarding the 
Streptococcus scarlatinae as being implicated in the 
toxic phase of the disease but not in the septic 
sequelae and so on. The elusiveness of the compara- 
tively recently discovered ultra-microscopic viruses 
has only intensified the search by other workers to 
discover a particular one responsible for Scarlet 
Fever. 
Each sect of laboratory research workers has had 
a following, the duration of the impression made 
depending on the degree of repute attained either 
previous/ 
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previous to or during the experimental investigations. 
Long and painstaking reviews of the bacteriological 
literature were undertaken and the evidence interpreted 
critically, in order to establish or refute a particular 
thesis. 
It was in 1917, that the epoch -making experiments 
of Schultz and Charlton were carried out, when they 
demonstrated that the blood of convalescent Scarlet 
Fever patients contained an antitoxin which specifically 
counteracted the toxic effects of Scarlet Fever on the 
skin. They also showed that many persons, who, appar- 
ently had not suffered from Scarlet Fever at any time, 
had this same specific antibody in their blood. 
Comparatively little interest was manifested in this 
wonderful work at the time of publishing a report of 
it. 
During the next few years, a great deal of work 
(18) 
was done by Dochez and his co- workers to establish the 
toxigenic specificity of the various groups of haemo- 
lytic streptococci. Gordon investigated the agglutina- 
tion characteristics of streptococci from the throats 
of Scarlet Fever patients and decided that 80% of them 
(61) 
were identical in this respect. Park strongly opposed 
this view, backing up his arguments by careful labor- 
atory researches. In 1923, the well -known experimental 
work of Drs. George and Gladys Dick was carried out, 
and in the following year, the same workers established 
the/ 
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the Dick Reaction as an accurate scientific test for 
susceptibility to Scarlet Fever. 
Since then, there has been a renaissance in the 
laboratory interest respecting Scarlet Fever. A tremen- 
dous amount of experimental work has been carried out 
and correlated. The true value of the serological 
diagnostic tests of Schultz and Charlton has been 
recognised and pioneers in Experimental Therapy, notable 
among whom are Zingher, Dochez and Behring have done 
much to establish the specific antitoxic treatment of 
the disease. Favourable records of the use of Scarlet 
Fever Antitoxin necessarily raised the question of its 
productionon a commercial scale and firms such as 
Messrs Parke, Davis and Company and Messrs Burroughs 
Wellcome and Company entered wholeheartedly into the 
immunological struggle against the Streptococcus 
scarlatinae. 
The overcoming of the toxic effects of the invasion 
of the human organism by the Streptococcus is not the 
whole story of any form of serum therapy in Scarlet 
Fever. The septic complications are the dread of 
those in clinical charge of the cases, and the dif- 
ficulties requiring solution, before these can be 
effectively dealt with, have not been overlooked. 
Some reputable observers have formed the opinion that 
the Streptococcus scarlatina° can be isolated from all 





Okell, supporting the view that the complications are 
due to the bacterial invasion of the tissues by the 
causative organism, lays it down that the Streptococcus 
plays a dual r8le, the toxic and pyogenic activities 
being separate phases of the invasion. He rules that 
the toxic effects on the tissues are necessary fore- 
runners of the actual bacterial attack. 
The history of the clinical elucidation of the 
various atypical forms of Scarlet Fever is interesting. 
(22) 
So long ago as 1838, Eiselt described Scarlet Fever 
(72) 
without a rash and a little later Taupin described two 
similar cases, where the rash could not have been 
missed, because the observer had been keenly observant 
and exceptional circumstances made it possible to 
follow the course of the disease from the very moment 
of invasion. Scarlet Fever without pyrexia is des- 
cribed in the British Medical Journal of 1896 and 
probably a proportion of cases of Erythema Scarlatina - 
forme seen in Dermatological Clinics belong to this 
form of the disease. 
All possible modifications of Scarlet Fever have 
been noted in the historical clinical records; the 
variations and effective disguises tax the acumen of 
trained diagnosticians and are almost certain pitfalls 
for the beginner. The Streptococcus scarlatinae, half 
secluded in the mass of streptococci generally, appears 
unwilling to proclaim its identity and is all the time 
side -tracking/ 
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side-tracking scientific experiment by wanton sallies 
from the beaten track. It is easy to understand that 
the protean character of Scarlet Fever and the great 
difficulties in the way of the ultimate positive 
establishment of the causative organism make serum 
therapy difficult to evaluate. If severe initial 
symptoms were always followed by the clinical manifesta- 
tions of a severe attack of the disease, results of 
treatment could be detailed with mathematical pre- 
cision. 
Progressive sanitation, increased hospital accom- 
modation, disinfection of houses and clothing and all 
the other measures introduced by virtue of various 
Acts of Parliament, have not lessened the incidence of 
Scarlet Fever. Active Immunisation would minimise 
the number of cases, but until such becomes a routine 
procedure, the treatment of Scarlatina by the intro- 
duction of immune serum is worthy of the fullest 
investigation. 
Aetiology and Diagnosis:- The strictly literal 
interpretation of the classification of diseases into 
"epidemic ", "endemic" and "sporadic" has gradually 
become more difficult to defend, as increasing know- 
ledge has afforded scientific workers a more compre- 
hensive view of the workings of natural processes. 
Epidemic curves are themselves made up of smaller 
curves,/ 
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curves, which in turn are undulated; endemic and spor- 
adic cases link up and complete the graphic representa- 
tion of the major and minor periods of incidence of a 
particular disease. 
The "Epidemic Constitution" theory is an apt one 
in relation to Scarlet Fever. A large percentage 
number of susceptible persons permits of rapid spread 
and ideal conditions for enhancing the virulence of 
the invader, The fact that the case mortality is lowest 
when the disease is most prevalent may be due to an 
inherited attenuation of virulence by the micro-organisms, 
as the direct result of their ancestors' struggle for 
existence in the face of circumstances which are 
constantly becoming more antagonistic, as each new 
host commences to develop an active immunity. 
Scarlet Fever is less prevalent in rainy weather; 
this might possibly be due to an increased peripheral 
blood -supply resulting from lowered barometric pressure. 
If such does actually occur, the supply of polymorpho- 
nuclear leucocytes will be increased in the mucous 
membranes and adenoid tissues of the throat. 
Conditions predisposing to Scarlet Fever are 
(1) Local (2) General (3) Environmental; the second 
of which may be of a temporary or chronic nature. 
The spread of Scarlet Fever is probably quite 
often a direct one, but until it is possible to make 
use of the laboratory in determining the freedom of 
convalescents/ 
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convalescents from infection, convincing evidence will 
be difficult to obtain. Chronic immune carriers are 
also worthy of note. Clothes, toys, books, bedding 
and many other classes of common articles have all 
subscribed their quota to the spread of the disease, 
although it seems likely that now that Scarlet Fever 
is less mysterious than hitherto in its bacteriology, 
the human carrier question will require more emphasis 
and the fomitic transmission will dwindle in importance. 
In this respect, it is instructive to note that Chapin 
of Liichigan does not carry out disinfection after 
removal of cases of Scarlet Fever. 
Domestic animals, vermin, milk, have all received 
attention in connection with the spread of infection. 
Of these, milk alone has been definitely incriminated, 
but it is important to remember the close and prolonged 
association of human beings with this product during 
the various dairy processes. 
Auto -infection after the removal of enlarged 
tonsils and adenoids and after extensive burning, is 
quite definite. 
The age and sex distribution of Scarlet Fever 
requires little comment, except that the writer's 
4 
cases agree with the findings of Pope in that, after 
the first quinquennial age period, the disease is 
vastly more common in females than in males. 
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In the diagnosis of Scarlet Fever, clinical and 
laboratory methods are complementary, not antagonistic. 
The former must remain, for the moment, the more 
important in difficult cases, where the results of 
intradermal tests are often of very little help. 
The repeated Dick heaction is an important exception 
to the above statement, unless in very toxic cases, 
where a failure to react in the early stage of the 
disease - comparable to the negative tuberculin test 
in Acute iiliary Tuberculosis - may be noted. The 
Schultz Charlton test may be applied at the same time 
as the administration of a therapeutic dose of Scarlet 
Fever Antitoxin and the result is quite reliable. 
This saves time in instituting remedial measures in 
patients who are obviously ill. In the interpretation 
of the results of intradermal tests, it has to be 
remembered that all immunities are relative and that 
persons with definite records of negative reactions 
may be overcome by massive doses of the infecting 
micro -organism and its toxin. 
Several difficult clinical cases have been detailed 
in the text, one of them exhibiting a prodromal scarla- 
tiniform rash of Measles. 
In dealing with Infectious Diseases among School 
Children, great help could be afforded in diagnosis if 
each child were Dick and Schick tested on being exam- 
ined as an Entrant at Routine School Medical Inspection. 
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Better still, if active immunisation against Diphtheria 
and Scarlet Fever could be carried out in the Child 
Welfare Centres, those diseases would rapidly cease to 
be a drain on Hospital accommodation and public re- 
sources. 
Second, and even third, attacks of Scarlet Fever 
may be more common than is generally admitted. These 
are probably the result of an inherent inability, on 
the part of the individual, to develop a permanent 
active immunity (c.f. Pneumonia). 
SELECTION OF DATA FOxt EVALUATING SPECIFIC Tt E itAPY : - 
Of the toxic symptoms, the temperature is the 
only one which is sufficiently consistent in its 
duration and character to show definite modification 
as the direct result of specific therapy. Various 
observers have recorded the effect of antitoxin on 
the throat, the duration of the rash, the commencement 
and character of desquamation; but the writer is of 
the opinion that the normal limits of variation in 
these are too great.to allow of any deduction which 
could be considered rational. 
The effect of specific therapy on the complications 
of Scarlet Fever is of paramount importance, as these 
account for all the cases of chronic ill -health 
following/ 
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following the disease and for the vast majority of 
protracted periods of convalescence. It is to be 
remembered that the anti -serum is anti -toxic and not 
antibacterial, but that the aggressive action of the 
toxins of the Streptococcus scarlatinae is probably a 
necessary precursor of the invasion of the tissues by 
(53) 
the micro -organisms themselves. Okell is definitely 
of this opinion. The fact that some careful observers 
have failed to demonstrate any favourable effect on 
the incidence of complications, does not necessarily 
mean that antitoxin does not help materially in re- 
ducing complications if it can gain the injured tissue 
or organ early enough and in sufficient concentration. 
Fixation of toxins by certain tissues is given as one 
reason for the localisation of pyogenic activities 
during the late stages of Scarlet Fever, but the 
difference in diffusibility of toxins and antitoxins 
may be fundamentally important and this in turn may 
be accentuated or made less apparent, according to 
the manner in which individual tissues are nourished. 
In other words, the rate of tissue-fluid exchange may 
be vitally important in determining the antitoxin 
content of individual tissues. Since antibodies are 
closely identified with pseudo -globulins, they are 
necessarily less rapidly diffusible than toxins. 
The complications of Scarlet Fever have been 
detailed, giving the average percentage incidence of 
each/ 
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each in cases of the disease untreated by antitoxin. 
A note is made of the very blotchy character of the 
rash on the limbs, often observed in patients who 
develop arthritis. Mild degrees of jaundice are not 
uncommon in Scarlet Fever and, in the writer's experi- 
ence, this complication has usually occurred in small 
outbreaks - another argument in support of Ward 
Epidemics. The percentage of total complications in 
Scarlatina is about 40% in cases which are not treated 
specifically. 
Further data, which are important from the point 
of view of their possible modification by the antitoxin 
treatment of patients, are Length of Stay in Hospital 
and Percentage of Return Oases. Both are discussed 
and in connection with the latter, the part which may 
be played by coincidence is particularly noted. 
THE ANTITOXIC SERUM TREATMENT OF SCARLET FEVER: - 
The value of any conclusions reached from observa- 
tion of the clinical course of Scarlet Fever in patients 
treated by means of specific antitoxin is modified by 
certain factors. Of these, the most important are 
(1) The uniformity of potency of the serum, (2) The 
dosage, (3) The Method of Administration and (4) The 
Day of Disease on which the therapy is instituted. 
In addition, in assessing the usefulness of specific 
therapy,/ 
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therapy, complications entirely due to the serum, such 
as serum rashes and anaphylaxis, require to be dealt 
with. 
At first, Scarlet Fever Antitoxin was unconcen- 
Crated, but previous experience in concentrating 
Diphtheria Antitoxin quickly opened up the way for 
dealing with the new product in a similar way. The 
result of concentration was, that in a given volume 
of serum, from four to six times the autotoxic content 
of the unconcentrated variety became possible; and in 
addition, the protein was reduced by one half. The 
standardisation of Scarlet Fever Antitoxin presents 
great difficulties. Attempts have been made to specify 
antitoxic value in terms of units of toxin and by 
means of the Schultz Charlton Reaction. Both are 
scientifically inaccurate and at best they are largely 
empirical. 
The dose of antitoxin employed varies widely, 
some workers giving comparatively small quantities, 
while others use the preparation liberally. Probably 
10 cc. are sufficient in ordinary cases; toxic and 
septic cases should have doses which are judged to be 
adequate for the particular patients under treatment. 
Septic cases do better if given polyvalent antistrepto- 
coccic serum along with Scarlet Fever Antitoxin. 
If the throat lesion closely resembles diphtheria, 
there should be no hesitation in giving Diphtheria 
Antitoxin/ 
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Antitoxin in addition to the specific treatment, for 
the evaluation of any therapy necessarily implies 
that co- existent conditions receive appropriate treat- 
ment. 
Some authorities consider that Scarlet Fever Anti- 
toxin need not be employed in all cases of the disease. 
The difficulty in prognosing in Scarlatina negatives 
(57) 
such an argument. O'Brien is strongly in favour of 
treating all cases specifically when he states that, 
given early, its beneficent action approaches that of 
the specific antitoxin used in Diphtheria. 
With regard to the method of administration, there 
seems no justification for employing any other than 
(3 & 4) 
the intramuscular route in ordinary cases. Banks of 
Leicester records very creditable results from the 
27) ( 
intravenous administration. Goodall prefers the sub- 
cutaneous route, because of the risk of abscess forma- 
tion after intramuscular injection. The writer has 
personally never seen an abscess formed, if the neces- 
sary and elementary precautions are observed at the 
time of injection. Sensitised patients may usually 
be successfully desensitised by giving 0.1 cc., followed 
by two injections of 1.0 cc. at hourly intervals; an 
hour later, the remainder of the antitoxin is given. 
The majority of sensitised persons do not give anaphy- 
lactic reactions to subsequent doses of the identical 
protein, so that simple sensitisation may not be the 
only/ 
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only requirement for this dramatic phenomenon. 
The Day of Disease on which antitoxin serum is 
given is, of necessity, very important, the prevention 
of the fixation of toxin by the tissues being more 
desirable than the neutralisation of toxins already 
fixed or fixing. The really early treatment of 
hospitalised cases of Scarlet Fever is almost impos- 
sible at present, because the majority of patients 
are not admitted before the third day of disease. 
But even if admitted late in the toxic phase, cases 
of Scarlatina should be given the benefit of antitoxin 
treatment. Some observers have noted distinct benefit 
from specific therapy instituted so late as the fifth 
day. 
66 
Robb of Belfast records that the disease was 
completely aborted in cases treated sufficiently early. 
The experimental results of various workers have been 
quoted, with reference to the period elapsing between 
the administration of Scarlet Fever Antitoxin and the 
return of the temperature to normal, according to the 
Day of Disease on which the serum was injected. 
The general consensus of opinion appears to be that, 
the earlier the treatment the earlier the fall of the 
temperature to normal. But there is one proviso, 
namely, that when the Day of Disease added to the 
period elapsing gives a result of five or more days, 
it is essential to keep in mind that a large proportion 
of/ 
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of untreated cases will have normal temperatures by 
then. 
In the writer's series of cases, only 10 out of 
106 were admitted and treated on the first day of 
disease; in these, the average period required for the 
return of the temperature to normal was 2.4 days. 
Patients treated on the second day of disease had 
normal temperatures after an average period of 2.8 
days. A study of the effect of antitoxin on the 
temperature in Scarlet Fever in the total (106) cases 
shows that at the end of the fourth day of disease, 
90% of cases treated on the first day, 47% of those 
receiving antitoxin on the second day and 27% of third 
day cases had normal temperatures. When given after 
the third day of disease, specific serum has no 
appreciable effect on the temperature curve. 
The dangers of anaphylaxis must be kept in mind 
and where there is even the most slender reason to 
suspect previous sensitisation, appropriate methods 
should be employed to desensitise the patient. The 
lymphatic type of child is probably most likely to 
give anaphylactic reaction. Intracutaneous tests of 
hypersensitiveness to serum are of little use. 
It is of particular importance to remember to de- 
sensitise patients in whom it is desired to confer a 
passive immunity to an accidentally introduced mixed 
infection in a hospital ward, if such patients are in 
the/ 
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the convalescent stage of a serum -treated disease. 
The incidence of Serum Rashes varies greatly in 
different communities and according to the particular 
make of antitoxin. The writer has consistently found 
that sera by Messrs Burroughs, Wellcome and Company 
give a much smaller percentage of Serum Reactions than 
do those prepared by Messrs Parke, Davis and Company. 
Various records of the occurrence of reactions to 
antitoxin are given in the text and the percentages 
(10) 
include Brocker's extremely low incidence of 3 %, 
(15) (33) 
Craig's 41% and in an intermediate position, Harries' 
20% of cases. 
In an attempt to overcome the dangers of anaphy- 
laxis, several manufacturing firms have advocated the 
use of different animals for the production of each 
particular antiserum. But unless there is complete 
agreement in this matter, the resulting confusion 
would probably add to, rather than reduce, the present 
difficulties. The writer suggests an International 
Scheme of tattooing all serum- treated casesa A definite 
selection of colours could be agreed upon, which, 
besides giving warning of sensitisation, would give 
definite information concerning previous attacks of 
the same disease. The inclusion of a thin sterilised 
rice -paper wafer, appropriately coloured with a harm- 
less indelible substance, in each package of antitoxin, 
would be the sole necessary addition to the present 
outfit/ 
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outfit. When giving the injection, the needle of the 
syringe would pass through the dyed wafer, previously 
applied to the area chosen for the administration of 
the antitoxin. 
CRITICAL DISCUSSION OF THE ANTITOXIC SERUM TREATMENT 
OF SCARLET FEVER. 
The effect on the toxic phase was previously noted 
in dealing with the benefit derived from the early 
treatment of Scarlet Fever by means of Antitoxic Serum. 
When the study of complications occurring in 
specifically treated cases is approached, there are, 
for the most part, three distinct collective opinions 
to be examined. Whether dealing with complications as 
a whole, or considering them under separate headings, 
one group of observers give unqualified praise to serum 
therapy in Scarlet Fever; a second group can find no 
reason for resorting to such treatment; while a third 
relates the effect of antitoxin to the Day of Disease 
on which it was given. At the outset, the analytical 
method chosen by the last mentioned appears the most 
rational. 
Notable among the records of those observers who 
make enthusiastic claims for the unqualified success 
of the antitoxin treatment of Scarlet Fever, are the 




(16) (32 & 33) 
Cushing and Harries. 
As a member of the directly opposing group, 
(20) 
Doolittle says "I myself have yet to see the data of 
a serios treated with intramuscular injections of 
Scarlet Fever Antitoxin, which I could not, without 
much discredit, match with a series of my own untreated 
(34) (82) (30) (75) 
cases ". Husler, Zingher, Gottsche, Toomey and Dolch, 
arion_r, others, all contribute to the same or a similar 
point of view. 
Of these observers who qualify the beneficial 
effects of Scarlet Fever Antitoxin by analysing them 
according to the Day of Disease on which injection was 
carried out, probably results are 
(17) (14 -) (15) 
those of Drs George and Gladys Dick, Chodzko, Craig, 
(66) (6) 
Robb and Benson and Eaciver. 
With regard to the incidence of total complica- 
tions, which is the aspect of the discussion at the 
moment, the writer's findings agree with those records 
failing to show a percentage decrease of complicated 
cases as a result of specific therapy. 
The great majority of complications in Scarlet 
Fever are conditions which do not endanger life, but 
a proportion consists of such conditions as nephritis, 
which, even if not proving fatal, may cause chronic 
ill -health. Reduction of the number of serious sequelae 
may make little alteration in the figures dealing with 
the/ 
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the total percentage incidence of complications, so 
it becomes necessary to discuss individual causes of 
protracted convalescence and especially to enquire into 
their relative frequency in cases of Scarlet Fever 
treated specifically on various days of disease. 
Nephritis and Late Albuminuria:- The incidence 
varies tremendously in cases not treated with antitoxin. 
Several investigators are quoted in the text in 
support of the beneficial effect of Scarlet Fever Anti- 
toxin on the percentage incidence of nephritis. The 
(4) 
series of cases detailed by Banks and i,iackenzie is of 
particular interest, in that no case of nephritis was 
(28) 
found in 404 patients treated intravenously. Gordon_ 
found that the total incidence of albuminuria was not 
reduced, but that actual nephritis cases were reduced 
in number by one half. This probably supports the 
view of a number of eminent authorities that late 




Cushing, Toomey and Dolch, Gottsche, husler and 
(20) 
Doolittle, among others, are all agreed that the 
incidence of kidney mischief is not lessened, as a 
result of the serum treatment of the toxic phase of 
Scarlet Fever. 
Analytical studies of the course of disease in 
scarlatina) patients, tabulated according to the day 
of disease when specific therapy was instituted are 
perhaps the most instructive. The general consensus 
of opinion of such reliable observers as BirkhàflA,/ 
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(8) 
(6) (66) (14) 
Birkhaug, Benson and i,laciver, hobb and Chodzko i>; that 
early administration of antitoxin reduces the percentage 
number of cases of nephritis occurring and that the 
frequency of this complication varies directly with 
the day of disease on which antitoxin is given. 
The writer's series of cases support the contention 
that nephritis is very definitely reduced in percentage 
incidence, if antitoxin is introduced on or before the 
third day. 
Adenitis:- As in Nephritis, qualified and un- 
qualified cases are stated with regard to the effect 
of specific therapy on the number of cases of late 
adenitis occurring. Among those workers who were 
favourably impressed in respect of the effect on 
(28) (69) (4) 
adenitis are Gordon, Schottmuller, Banks and iiiackenzie 
(J3) , (10) (25) 
and Harries. Such investigators as Brooker, Friedemann 
(77) (12) 
and Deicher, von Borman and Buscl_mann were unable to 
convince themselves of any real benefit on this 
particular complication. 
A third group of statistical surveys indicates 
that early therapy ensures a lessened percentage 
incidence of adenitis. These findings are recorded 
(66) (8) (51) 
in the treatises by hobb of Belfast, Birkhaug, McLachlan 
and Hunter and others indicated in the general text of 
this study. 
The writer's series of 106 cases of Scarlet Fever 
included 11 cases (10.4 %) of adenitis and there is no 
ground/ 
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ground for assuming that the percentage incidence was 
in any way modified by the early administration of 
antiserum. 
Arthritis: -- From 4% to 6% of ordinary Scarlet 
Fever cases suffer from joint pains. In serum -treated 
patients, it is essential to keep in mind that joint 
pains may occur as a manifestation of serum reaction, 
without any evidence of serum rash. The close corres- 
pondence of the periods of onset of both conditions 
leads to a little difficulty in differential diagnosis. 
(4) 
Banks and ì:iackenzie had no case of arthritis in 
404 patients treated intravenously. LcLachlan_ and 
(16) 
Hunter's cases enjoyed a similar immunity. Cushing 
and other observers record a favourable influence 
exerted on the incidence of arthritis. 
(74) (29) 
Toomey and Gordon' Bernbaum and Sheffield see no 
reason to believe that arthritis is less common in 
serum- treated cases. The latter found that polyvalent 
anti -streptococcic serum gave more favourable results 
than did specific antitoxin. 
Cases treated early are less likely to develop 
(15) (14) (17) 
arthritis, according to Craig, Chodzko, Drs George and 
(66) 
Gladys Dick and Robb. 
No case of arthritis occurred in patients treated 
during the first two days of disease in the writer's 
series; one of the 31 patients treated on the third 
day developed the complication; the other instance 
occurred/ 
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occurred in a patient treated after the third day. 
Both patients were females. Probably, antitoxin given 
early tends to inhibit joint complications. 
Arthritis is a toxic complication and as such, 
should benefit from early specific treatment -of the 
toxic phase. 
Otitis Media:- Opinions are again divided as to 
the effect of Scarlet Fever Antitoxin in controlling 
(10) (16) (1) 
complications. Bipoli, Brooker, Cushing, Archibald, 
Harries and Gordon are notable among those who are 
convinced that the incidence of otitis is definitely 
less, when antitoxin is used in treating scarlatina. 
(16) 
Cushing elaborates his argument by pointing out that 
only 8% of cases of otitis media occurring in serum- 
treated patients progressed to mastoiditis, as against 
18% prior to the institution of antitoxin therapy. 
An imposing group of investigators can also be 
cited to argue for the direct negative to the above. 
14) 
Included in it are such names as Husier, von Borg, 
(12) (45) 
Busdhman.n and Lunin. 
The qualification of specifying the day of disease 
on which antitoxin was given and grouping cases accord- 
(66) 
ingly enhances the value of the investigations of Robb, 
(17) (6) (15) (8) 
The Dicks, Benson and iaaciver, Craig and Birkhaug. 
All of these observers have formed the opinion that 
otorrhoea is less common in Scarlet Fever, when cases 
receive/ 
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receive early specific therapy. 
Four cases of otitis media occurred in the 106 
cases of Scarlet Fever under special review. All were 
in the age group 1 -5 years and three of the four were 
females. The distribution according to the day of 
disease when antitoxin was administered was such as to 
negative the deduction that any definite inhibitory 
influence was exerted by serum treatment. 
rhinitis : -- Whereas about 8% of cases of untreated 
(4) 
Scarlet Fever develop Rhinitis, Banks and 1:iackenzie 
had only three instances of the complication in 404 
(33) (28) 
patients treated intravenously. Harries, Gordon, 
(1) 
Archibald and others mentioned in the full text had 
either equally or even more encouraging results. Many 
equally responsible workers could find no diminution 
of the number of cases of rhinitis, resulting from 
(66) (14) 
serum treatment. Such observers as Robb and Chodzko 
concluded that very early specific therapy of Scarlet 
Fever completely obviated the complication. 
The writer's cases do not show any real reduction 
in the number of cases of rhinitis as a result of 
treatment with Scarlet Fever Antitoxin; there is no 
regular increase in the percentage incidence in cases 
treated on successive days. 
Cardiac Complications: - These are relatively 
uncommon, even in untreated cases, but their serious- 
ness/ 
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seriousness makes them extremely important. 
As is the case in the records dealing with the 
complications enumerated above, there are great dif- 
ferences of opinion with regard to the merits of 
Scarlet Fever Antitoxin treatment in the prevention or 
(32 & 33) (4) 
mitigation of cardiac complications. Harries, Banks 
(66) (15) 
and Mackenzie, Hobb and Craig all note the complete 
freedom from cardiac complications of patients treated 
(5 1) (29) 
specifically. McLachlan and Hunter and Gordon and his 
co- workers were less fortunate in their surveys. 
The writer had two cases in the series of 106 patients, 
which, although not occurring in patients treated on 
the first two days of disease, is a higher incidence 
than might be expected when ordinary non -specific 
methods of treatment are employed. 
A few minor complications are mentioned in the 
text but their study allows of no useful conclusion. 
Septic and Toxic Cases : - Both varieties are 
complicated from the time of onset. Theoretically, 
toxic cases should benefit very materially from a 
specific antitoxic serum and the findings of such 
investigators as Schottmuller, Lautierland Dreyfus 
and indeed, those of the majority, are in keeping with 
this hypothesis. 




satisfactorily to early treatment, as also did Craig 
(81) (5) (57) 
and Zikowsky. On the other hand, Baxter, O'Brien 
) 
and Benson and Laciver, among others, were disappointed 
with the serum therapy of Septic Scarlet Fever, 
There were three cases of the septic form of the 
disease among the writer's patients and the clinical 
course of the disease in these does not suggest any 
definitely beneficial effect resulting from antitoxin 
therapy. 
Deaths:- Serum- treated patients should only 
succumb to the disease if it is initially septic or 
because late septic sequelae develop. The death -rate 
from toxic cases is definitely less in antitoxin 
treated patients, if early treatment is possible. 
Examination of the records shows that the case 
(1) 
mortality is reduced by specific therapy. Archibald 
had a case mortality of only 1% among severe cases 
treated. The only deaths recorded by Baxter, Lenthe) 
(45) (81) 
Lunin and Zikowsky occurred in septic cases or from 
septic complications or where antitoxin treatment was 
carried out relatively late in the disease. Toomey) 
records 4 deaths from anaphylaxis in 283 patients 
treated. 
The foregoing discussion on the specific therapy 
of Scarlet Fever does not offer convincing proof of 
the usefulness of antitoxin in lessening the incidence 
of/ 
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of all complications, although nephritis and arthritis 
appear to benefit. Several theories may be put forward 
in explanation.. Variations in the findings of individ- 
ual observers may be due to the existence of a number 
of sub-groups of the Streptococcus scarlatinae, in 
which case some records may be those of cases not 
specifically treated (unidentical toxin and antitoxin) 
in the strict scientific sense. The consistently good 
results recorded on the toxaemia of the disease negative 
this. The empirical standardisation of antitoxin has 
also to be remembered, as it implies considerable 
variation of dosage. 
Early fixation of toxins may prevent access by 
antitoxin for the purpose of neutralisation. Probably 
such fixation is inversely proportional to the rate of 
tissue fluid exchange; if so, it can be argued that the 
kidneys and joints are peculiarly fortunate in possess- 
ing the necessary exchange system for speeding up the 
local concentration of antitoxin. Tissues having a 
slow exchange of fluids should coincide with those 
liable to sepsis in the late stage of Scarlet Fever, 




EFFECT OF SCARLET FEVER ANTITOXIN ON THE LENGTH 
OF STAY IN HOSPITAL. 
The failure of antitoxin to reduce septic com- 
plications leads to the conclusion that the average 
duration of stay in hospital can be but little affected 
as a result of specific therapy. 
(15) (28) (33) (2 & 3) (66) 
Craig, Gordon, Harries, Banks and Robb are all 
agreed that patients' residence in hospital was 
definitely lessened. 
Quite a number of workers appear to have taken 
unjustifiable risks in discharging serum-treated 
(2 & 3) 
patients. Banks considered the treatment complete in 
sixteen days in a large proportion of adult patients. 
It has to be granted, however, that he treated all of 
them intravenously, which may give results profoundly 
different from those in intramuscular therapy. 
Interpreted from as many points of view as were 
considered useful, the writer's cases could not be 
shown to have the average period of convalescence 
shortened as a result of intramuscular antitoxin 
treatment. 
EFFECT OF SCARLET FEVER ANTITOXIN 0N THE PERCENTAGE 
OF "RETURN" CASES. 
Patients who have had septic complications are 
chiefly responsible for "return" cases, but coincidence 
must/ 
must also be kept in mind. The latter fact is illus- 
trated in the text from personal experiences. 
(51) 
McLachlan and Hunter give a very useful detailed 
study of the following up of patients after discharge 
from hospital They show that not only were there 
recrudescences of septic processes but also that 
"clean" cases developed septic sequelae for the first 
time after leaving hospital. Their work demonstrates 
the difficulty of assessing freedom from infection in 
examining convalescents. 
A comparatively rapid laboratory method of dealing 
with patients whom it is proposed to discharge, would 
be of inestimable value. 
Several investigators quote a very low percentage 
of "return" cases following early discharge after 
antitoxin treatment. But this may be partly due to 
the more rapid and complete recovery from any septic 
sequela which occurs after discharge on account of 
removal from the massive sepsis of a Scarlet Fever 
Ward housing a number of complicated cases. 
There should be no time-limit used in calculating 
the percentage of "return" cases, if definite relation 
between a discharged case and the "return" case can be 
established and Streptococci scarlatinae can be 
isolated from the naso- pharyngeal region of the 
supposed "infecting" case. 
More/ 
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More exhaustive search by trained investigators 
woulc:_ undoubtedly raise the percentage of "return" 
cases, if direct relationship between cases were the 
criterion and the time elapsing disregarded. 
THE PROPHYLACTIC USE OF SOAi -LET FEVER ANTITOKIIN . 
To ensure any uniform success in this connection, 
a dose of at least 5.0 cc. is required. If the Dick 
Reaction is very strongly positive, as much as 10.0 cc. 
may be required. It is quite safe to assume a period 
of fourteen days as the duration of the passive immunity 
conferred; many patients treated prophylactically are 
(35) 
still Dick- negative at the end of three weeks. Joe 
states that 10.0 cc. should be used as a routine, if 
the Dick Reaction is not applied as a control, 
(37) 
Kirkhope's experimental work shows that 5.0 cc. of 
Scarlet Fever Antitoxin is a suitable average prophy- 
lactic dose for a child-contact. The general con- 
sensus of opinion is that 5.0 cc. and 10.0 cc. are 
adequate minimum and maximum doses respectively. 
The well -known "immunity" enjoyed by a large 
proportion of very young children may be a simple 
failure of the immature organism to react specifically 
to certain infections. 
223. 
CONCLUSIONS. 
1. Experimental evidence is overwhelmingly in favour 
of a definite haemolytic streptococcus as the 
causative organism of Scarlet Fever. There may 
be sub-groups of the Streptococcus scarlatinae 
which are toxigenically identical. 
2. Acute and chronic carriers are probably pre- 
! 
eminently important in the method of spread of 
Scarlet Fever. 
3. The diagnosis of mild and atypical cases of 
Scarlet Fever remains a clinical proposition. 
Serological methods are seldom helpful, except 
that the definite change from a positive to a 
negative Dick Reaction during the course of the 
disease is proof that the condition undergoing 
treatment is Scarlet Fever. It is presumed, of 
course, that antitoxin has not been administered. 
4. Considerable help in the diagnosis of difficult 
cases would be afforded if every child were 
submitted to the Dick Test on entering school 
and periodically thereafter. Close co- operation 
between the School Medical Services and Infectious 
Diseases Hospital Authorities would then make it 
possible to have useful information regarding the 
personal/ 
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personal history of every child suspected of 
having Scarlet Fever. 
5. Scarlet Fever is, on an average, diagnosed too 
late for the full benefit to be derived by the 
majority of seram- treated patients. 
. Scarlet Fever Antitoxin is specifically antitoxic. 
7. The lack of a scientific method of standardising 
Scarlet Fever Antitoxin is a serious handicap to 
experimental therapy with this particular immune 
serum. 
8. The average intramuscular dose of 10 cc. of con- 
centrated Scarlet Fever Antitoxin is a suitable 
one. Toxic cases should receive at least 20 cc. 
intramuscularly. 
The appropriate treatment of co- existent 
diseases (e.g. Diphtheria) does not detract from 
the value of observations on the results of the 
specific treatment of Scarlet Fever. 
. The antitoxic treatment of the toxic phase of 
Scarlet Fever is valuable. The earlier the 
administration of the serum, the more rapid is 
the amelioration of the toxicity. 
10./ 
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10. The problem of sensitisation to horse serum re- 
quires attention. An International Scheme which 
would permit of harmless indelible substances 
being used for tattooing the site of injection 
would be a valuable safeguard against anaphylaxis. 
Accurate records of second and subsequent attacks 
of a particular zymotic disease would also be 
made possible by such a procedure, if an agreed 
colour represented a particular disease. 
11. Specific Antitoxic Therapy does not reduce the 
percentage of total complications appreciably, 
but the incidence of nephritis is definitely 
lessened and probably it could be entirely 
obviated by adequate early antitoxin treatment 
of Scarlet Fever. Arthritis is less evident in 
cases receiving early specific therapy. 
12. Toxic Scarlet Fever is markedly benefited by 
treatment with antitoxin. The treatment has no 
appreciable effect on cases of Septic Scarlatina. 
13. Antitoxin treatment lowers the case mortality by 
its great curative influence on toxic cases and 
by preventing nephritis in patients subjected to 
the therapy early in the toxic phase. 
14./ 
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14. The Length of Stay in Hospital is not reduced as 
a result of antitoxin treatment. This is ex- 
plained by the fact that the serum appears in- 
capable of preventing or mitigating septic 
sequelae, which are the most important causes 
of protracted convalescence. 
15. "Return" cases may be less common in Hospitals 
practising antitoxin treatment of Scarlet Fever, 
but if so, the reason for the reduction is pro- 
bably the early discharge of patients. By this 
means, massive sepsis occurring in wards is 
avoided. If septic complications develop after 
discharge, recovery is more rapid and more com- 
plete than is the case when complicated cases 
are housed in the same hospital ward. 
16. There is no room for argument as to the outstanding 
value of Scarlet Fever Antitoxin as a prophylactic. 
With adequate dosage, a passive immunity lasting 
for at least fourteen days can be guaranteed to 
contacts of the disease. 
227. 
VIII. APPENDIX I . ANALYTICAL TABLES. 
106 Cases of Scarlet Fever. 
1. Age- andr Sex- Distribution. 
g 
Period 4 0 -1 1-5 5 -10 10- 1515 -25 25-35 35-45 Totals 
40 Males 17 9 2 + 9 __3 - 
5 1 Females - 15 17 6 
_ 
22 66 
2. Day of Disease on Admission arranged in 
Age and Sex Groups. 
-A-°g`e- ú 
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3. Average Day of Disease on Admission; for each 
Age and Sex Group. 









(in Days ) 
3 4 2.5 2.25 3 2.5 3.25 3.5 
4. Number in each Age and Sex Group, treated with 
Scarlet Fever Antitoxin on various Days of Disease. 
Age roup 1- 
-7----/E-- 
- S- -w0 2 
Sex i7 o Ji m 
1st Day of Disease 2 3 1 2 - 1 - - - - 
2nd Day of Disease 6 2 5 5 - 3 1 4 3 - 1 
3rd Day of Disease 1 3 2 7 2 - 4 7 irm_ - - 
After 3rd Day of 
Disease 5 6 1 3 - 2 4 10 1 3 - - 
5. Average Day of Disease, on which Scarlet Fever Anti- 
toxin was given: Arranged in Age and Sex Groups. 
ge roup . I 5`-45 




3.0 4.0 2.5 Ill 3.0 2.5 3.5 3.5 3.25 3.0 - 2.0 




6. Periods and Average Periods elapsing between the 
Administration of Scarlet Fever Antitoxin and the 
Return of the Temperature to normal, when the Serum 
was given on the 1st Day of Disease. (a) For Total 
Cases. (b) For Total Males. (c) For Total Females. 
esD crcrip h 
and Number 
of Cases 
Period Elapsing verage 
Period 







Total (10) 2 4 3 - 2.4 Days 
Males (3) 1 2 - - 1.7 Days 
Females (7) 1 2 3 - 1 - 2.7 Days 
7. Periods and Average Periods elapsing between the 
Administration of Scarlet Fever Antitoxin and the 
Return of the Temperature to normal, when the Serum 
was given on the 2nd Day of Disease. (a) For Total 




Period Elapsing verage 
Period 
Elapsing. 1 Day 2 Days 3 Days 4 Days 5 Days 6+ Days 
Total (30) 4 10 10 4 - 2 2.8 Days 
Males (12) 2 6 4 - - - 2.2 Days 
Females (18) 2 4 6 4 - 2 3.2 Days 
8./ 
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8. Periods and Average Periods elapsing between the 
Administration of Scarlet Fever Antitoxin and the 
Return of the Temperature to normal, when the Serum 
was given on the 3rd Day of Disease. (a) For Total 
Cases. (b) For Total Males. (c) For Total Females. 
'escr p on 
and Number 
Period Elapsing Average 
Period 
Elapsing of Cases 1 Day 2 Days 3 Days 4 Days 5 Days 6+ Days 
Total (3 1) 8 14 3 3 1 2 2.5 Days 
Males (14) 4 1 1 1 2 2.9 Days 
Females (17) 4 9 2 2 - - 2.1 Days 
9. Periods and Average Periods elapsing between the 
Administration of Scarlet Fever Antitoxin and the 
Return of the Temperature to normal, when the 
Serum was given after the 3rd Day of Disease. 
(a) For Total Cases. (b) For Total Males. (c) For 
Total Females. 
Description 
and Number Period Elapsing 
Average 
Period 
Elapsing of Cases 1 Day 2 Days 3 Days14 Days 5 Days 6+ Days 
Total (35) 14 7 5 3 3 3 2.8 Days 
Males (11) 7 1 1 - 2 - 2.0 Days 
Females (24) 7 6 4 3 1 3 3.0 Days 
10./ 
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10. Periods and Average Periods elapsing between the 
Administration of Scarlet Fever Antitoxin and the 
Return of the Temperature to normal: Analysis of 




Period Elapsing Average 
Period 
Elapsing 1 Day 2 Days 3 Days 4 Days 5 Days 6+ Days 
1 -5 
M 9 5 3 - - - 1.7 Days 
F 5 7 2 - - 1 2.25 Days 
5 -10 M 3 4 
1111 
- - 1.9 Days 
F 5 6 1 - 2.1 Days 
10 -15 
M 
- - - 2.0 Days 
F 2 1 1 1 - 2.8 Days 
15-25 
M 2 3 1 - 2 1 3.0 Days 
F 2 6 6 5 1 2 3.3 Days 
25-35 M - - - 1 1 1 5.7 Days 
F 1 - - 2 - 2 4.8 Days 
35 -45 
M- - - - - - - 
F - - 1 - - - 3.0 Days 
11. Periods and Average Periods elapsing between the 
Administration of Scarlet Fever Antitoxin and the 
Return of the Temperature to normal. (a) For Total 
Males. (b) For Total Females. (c)For Total Oases. 
lescrip lon 
of Cases 
Period Elapsing Average 
Period 
1 Day 2 Days+3 Days Days 5 Days 6+ Days Elapsing 
Total Males 14 14 6 
4 
1 u 2 2.3 Days 
Total Females 14 21 15 9 2 5 2.8 Days 
Total Cases 28 55 21 10 5 7 2.6 Days 
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12 Percentages of Cases, in which the Temperature 
reached normal in the various Periods noted after 
the administration of Scarlet Fever Antitoxin, when 
analysed for (a) Total Males (b) Total Females 
































1 - 5 43.75 37.5 15.63 - - 3.12 
5 - 10 30.8 38.6 26.9 3.8 - - 
10 - 15 12.5 50.0 12.5 12.5 12.5 - 
15 - 25 12.9 29.0 22.6 16.1 9.7 9.7 
25 - 35 12.5 - - 37.5 12.5 37.5 
35 - 45 100.0 
13./ 
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13. Course of Disease and Length of Stay in Hospital. 


























034 n z_, 
Compile- Day of Disease 










iihinitis Otitis Adenitis 
2 2 5 27 53 52 
2 2 5 33 67 65 
3 3 5 * 48 45 
2 2 3 28 26 
3 3 4 26 47 45 
5 7 9 30 92 88 
6 6 6 29 23 
3 3 3 16 31 29 
2 3 4 31 30 
2 2 4 28 26 
4 5 6 27 31 27 
1 1 2 28 27 
4 4 5 28 24 
2 2 4 23 40 38 
4 4 5 *45 41 
2 2 5 27 25 
1 1 3 28 27 
* Debilitated after the toxic phase. 
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14. Course of Disease and Length of Stay in Hospital. 
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* Debilitated after toxic phase. 
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15. Course of Disease and Length of Stay in Hospital. 
Age Group 5 - 10 years. Males. 9 Cases, 
----------i--- Complications. Day of 
: Day ór-biseásé 
_--/ 
Disease on of Days 
Z when occurring. p Discharge in 
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3 11 18 










* Pre -existing Chronic Otitis Media. 
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16. Course of Disease and Length of Stay in Hospital. 
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3 4 24 6 37 34 
2 2 1 3 i « 63 * 43 41 2 ' , 2 ! 0 28 
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1 4 44 43 
2 2 5 29 27 
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36 
40 _-.<__« 
34 2 3 4 12 
3 3 5 
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28 25 





3 3 6 
4 6 8 
* Post- operative Abdominal Wound. 
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17. Course of Disease and Length of Stay in Hospital. 
Age Group 10 - 15 years. Males. 2 Cases. 
ay 
cd 0 05 AO lAW 
Complication. Day of 
Disease on 
Discharge 
a), Day of Disease from 
o 
ca i 
when occurring. ; Hospital. 
m 
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18. Course of Disease and Length of Stay in Hospital. 
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3 4 7 30 27 
1 1 M 14(A). 21(P) 32 31 
2 2 4 8 28 26_ 
14 28 26 
2 2 4 28 26 
5 5 6 21 34 29 
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19. Course of Disease and Length of Stay in Hospital. 
Age Group 15 - 25 years. Males. 9 Cases. 
Complications. r - 
Day of Disease Day of Number 
ó o when occurring. Disease on of Days 
.,.4 ;.. Discharge in 
ó 
o , from Hospital. 
m ó m m z0 , Hospital. 
itl ri 02 +3 0 m O 4 r-i 
Aui fq4 A m Ì 
Ó ÓS"-, 0 .;{ x m 
i vi i U r 9 rt O 
.tia ya ? Pa m 03 .ri Si m 





















28 24 4 
* Debilitated after Toxic Phase. 
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20. Course of Disease and Length of Stay in Hospital. 
Age Group 15 c 25Ryears. 
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3 3 7 29 26 
2 3 0` 28 
4 4 8 33 
_ 
29 
2 3 5 39 37 
4 4 6 10 32 28 
6 6 
1 '1 
7 9 35 30 
4 k 39 39 
3 3 7 32 30 
2 
9 
2 9 11 32 30 
2 2 5 14 31 29 
6 6 11 30 25 


























3 3 5 8 35 32 
4 4 13 33 29 
2 2 6 28 26 
4 4 6 28 24 
* Increased Length of Stay due to Septic Finger. 
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21. Course of Disease and Length of Stay in Hospital. 













































22. Course of Disease and Length of Stay in Hospital. 
abr 
Age Groups 25-35 years and 35-45 years. Females. 
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